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Abstract

Epidemiological evidence has shown that dietary factors, as part of lifestyle behaviours, have
significant positive effects on the onset and progression of neurodegenerative disorders including
dementia and other chronic diseases. Plant-rich diets especially, have been shown to have significant
protective effects on overall health. This is due to the presence of phytochemicals, minerals, vitamins
and dietary fibre in these foods. Phytochemicals are classified under carotenoids and polyphenols;
which include flavonoids, phenolic acids, and stilbenes/lignans. Anthocyanins are a subclass of
flavonoids responsible for the dark red-purple colours in fruits and vegetables. In the last decades,
there has been an increased research interest in anthocyanins which is attributed to their antioxidant
characteristics - the ability to reduce oxidative stress in living cells. The association between
anthocyanin from dietary sources and cognitive function is yet to be fully established. Available
evidence suggests that anthocyanins may exert protective effects on cognition, including memory and
executive processing, either through a direct effect on brain function or indirectly by reducing blood
pressure. In order to determine the clinical effects of anthocyanins, a better understanding is required
of the uptake and metabolism of these bioactive compounds found in fruits and vegetables. Intact
anthocyanins are believed to reach the large intestine and colon where they undergo intensive
metabolism and transformation with observed modulatory effects on gut microbiome. Following
further degradation, they are absorbed into the bloodstream, with some of the subsequent metabolites
showing potential to be more biologically active than the intact anthocyanins.

The primary aim of this doctoral thesis was to determine the health benefits associated with both acute
and longer-term effects of consumption of dietary anthocyanins, delivered in a fruit variant, Queen
Garnet plum (QGP), on cognition, blood pressure and other health parameters in younger (acute) and
older adults (acute and longer-term). In order to contextualise the findings for dietary guidance to the
target population, the anthocyanin intake of the Australian population was assessed using a novel
anthocyanin food composition database developed during the course of this research. This thesis
addresses the following research questions:
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1.

What is the current level of evidence on the beneficial health effects of plums that contain
considerable amount of anthocyanins?

2.

Does consumption of anthocyanin-containing plum juice have an acute effect on various
domains of cognitive functioning, and blood pressure, and is there significant difference in
the gastro-intestinal metabolism of anthocyanins between young and older adults, assessed
using urinary metabolite biomarkers?

3.

What is the current level of evidence on the effects of anthocyanins on the gut microbiota in
relation to health outcomes?

4.

What are the longer-term effects of anthocyanin-containing plum juice consumption on
cognition, cardiovascular responses, inflammatory biomarkers (Brain-Derived Neurotrophic
Factor (BDNF) and C - reactive protein (CRP)) and gut microbiota in older adults?

5.

What is the current dietary anthocyanin intake and sources thereof in the Australian
population included in the National Nutrition and Physical Activity Survey (NNPAS)
component of the Australian Health Survey (AHS), and is there an association between
intake and blood pressure in older adults aged 50+ years?

Five different studies were designed to answer the above research questions. A systematic literature
review assessed the current level of evidence on the beneficial health effects of plums known for their
high levels of anthocyanins. Results showed that consumption is associated with improved cognitive
function, bone health parameters and cardiovascular risk factors. Most of the human trials used the
dried version of plums (prunes) rather than fresh fruit thus limiting translation to dietary messages of
the positioning of plums in a healthy diet.

A crossover study assessed the acute effects of different dose-timing of Queen Garnet plum juice
consumption on cognition, blood pressure, as well as urinary phenolic profile. Queen Garnet plum
juice significantly reduced blood pressure but dose-timing did not appear to be a significant factor in
the potential acute BP-lowering effect. Native QGP anthocyanins, as well as methylated /
glucuronidated metabolites were detected in the urine of participants but there were no significant
differences between age groups or dose-timing. No effect was observed on cognition.
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A second systematic literature review was carried out to determine the level of current evidence on the
effect of anthocyanin treatment/intake on changes in the gut microbiota population, and to compare
different techniques used in microbiota determination. With very limited clinical trials done in this
area, results showed that anthocyanins induced a significant proliferative effect on Bifidobacterium
spp., known for their wide use in probiotics and for the treatment of Irritable Bowel Syndrome (IBS).
There was also an observed inhibition of Clostridium histolyticum, which has been shown to be
pathogenic in humans. Comparison of different techniques used for microbiota determination showed
that depth of analysis, with respect to a comprehensive, high-resolution microbiota analysis or
analysis of the main microbiota taxa. and budgeted cost are important considerations for future
research.

A second clinical trial (8-week randomised controlled crossover study) aimed to assess the longerterm effect of fruit anthocyanins from the Queen Garnet plum juice in comparison to a control
(cordial) juice on cognition, cardiovascular responses, gut microbiota, and inflammatory biomarkers
in healthy older adults aged 55+ years. Participants consumed 200mL of plum juice (≈ 50mg/L of
anthocyanins) or cordial daily for 8 weeks in a cross-over design. Across treatment periods, there was
no significant difference on the different domains of cognition measured, blood pressure or antiinflammatory biomarkers. No intervention effect was found for genera or classes of gut microbes, but
there was a trend towards significance in total bacterial count between the control arm and the
intervention arm (P= 0.06).

Finally, in response to the lack of a region-specific food anthocyanin database, a first stage (fruits and
vegetables) development of anthocyanin food composition database specific to Australian foods was
undertaken. Original analytical values for Australian foods were combined with borrowed values from
the USDA Database for the Flavonoid content of selected foods and the European Phenol-Explorer
database. This novel database was applied to the dietary intake data obtained in a representative
national sample of Australians in the Nutrition and Physical Activity component of the 2011-12
Australian Health Survey. Mean intake of anthocyanins in the Australian population was 24.17 ± 0.32
mg/day which is above average in comparison to the world composite database (18.05±21.14 mg/d).
Across age-groups, berries were the top food sources: mainly blackberry (5-65%); cherry (2-24 %);
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blueberry (2-13%) and raspberry (3-12%). There was a significant inverse association between
anthocyanin intake and systolic BP (β= -0.04, p<0.01) and diastolic BP (β= -0.01, p<0.01), in models
that adjusted for covariates (age, gender, BMI, high blood pressure diagnosis, smoking status and
physical activity) in adults aged 50+years.

The significance of this body of research can be grouped into three categories including;
•

Knowledge inquiry: Acute study (to determine metabolism, dose-effect on acute BP) and 8
week Cross over randomised clinical trial of QGP juice.

•

Knowledge synthesis: Systematic literature reviews.

•

Knowledge translation: Contextualisation and translation of the clinical trials findings to
dietary messages as well as framing of dietary messages in the context of usual dietary
practices through assessment of usual intake of anthocyanins in Australians (secondary
analysis of national nutrition survey data, using a novel anthocyanin food composition
database).

Collectively, this body of research is an original contribution to science. Knowledge gaps in relation
to the acute and longer-term health effects of dietary anthocyanins were summarised and addressed. In
addition, an Australian anthocyanin food composition database was developed. In a larger context,
this body of research further highlights how bioactive components in food (phytonutrients) can impact
health outcomes in humans. As projections indicate rapid increases in the prevalence of cognitive
impairment and other chronic diseases, dietary interventions offer adjunctive measures to potentially
reduce their incidence and progression in the absence of successful conventional treatments.
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1 Chapter 1
1.1 INTRODUCTION

This chapter provides the background of this thesis from scientific literature. It introduces
anthocyanins and describes their beneficial health effects, as well as provides an overview of their
metabolism and absorption, and the plausible mechanisms involved. Dietary anthocyanin sources and
available methods of anthocyanin-intake measurement in epidemiological studies are described which
highlight the gaps in literature and informed the objectives of this thesis. The primary and secondary
objectives of this thesis, as well as the conceptual framework for the thesis, are presented in this
chapter.

1

1.1.1

Anthocyanins

Incorporating fruits and vegetables into the usual human diet has been shown to exert protective
effects on health. These observed effects have been attributed to the presence of phytochemicals,
minerals, vitamins, and dietary fibre in these food groups [1]. Phytochemicals are classified under
carotenoids and polyphenols; which include phenolic acids, flavonoids, and stilbenes/lignans. The
polyphenols are the largest class of phytochemicals [2]. These bioactive compounds, independently as
chemical extracts, and as a group in fruits and vegetables have been associated with reduced
premature mortality [3], weight loss [4], and reduced risk of cardiovascular diseases [5] and some
cancers [6].

Flavonoids are the most common group of polyphenols and are further divided into six sub-classes
namely: ﬂavones, flavonols, flavanones, isoflavones, flavanols, and anthocyanins [7] (Fig. 1-1). In the
last decades, there has been increased interest in anthocyanin-based research [8]. This increased
research interest has been attributed to the antioxidant characteristics of anthocyanins i.e. the ability to
reduce oxidative stress in living cells, which has been shown to prevent certain chronic diseases [8].
Anthocyanins are water soluble plant pigments that are particularly conspicuous in fruits and flower
tissues as they are responsible for the diverse range of red, blue and purple colours. High levels of
anthocyanins have been observed in some common fruits and vegetables including blueberries, black
grapes, raisins, blackberries, plums, purple cabbage, eggplant, purple cauliflower and purple potatoes
[9]. In plants, anthocyanins are known to protect the chloroplast from photodegradation by absorbing
high energy quanta, while scavenging free radicals and reactive oxygen species (ROS). They are
usually present in plants as glycosides (i.e. sugar molecule bound to anthocyanin compounds via a
glycosidic bond) or acylglycosides of their respective aglycone anthocyanidins [9]. Anthocyanins are
one of the most versatile subgroups of flavonoids. The key characteristic which differentiates
anthocyanin glycosides from the rest of the flavonoid group is their ability to form flavylium cations
[10]. Flavylium cations are species of a multistate of different molecules reversibly interconverted by
external inputs such as pH, light and temperature [11]. In nature, about 17 different anthocyanins have
been discovered but only six (cyanidin, delphinidin, petunidin, peonidin, pelargonidin and malvidin)
have been shown to be of dietary importance and are ubiquitously distributed in the food supply [10].
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Figure 1-1: Diagram showing the classification of polyphenols and food sources.
Source: [12]

The richest dietary sources of anthocyanins are berries, cherries, apples, red and purple grapes, plums
and pomegranates [13, 14] while red wine and certain vegetables (e.g. cabbage, onions and radishes)
are also significant sources [15]. Although there is inconclusive evidence regarding the health
benefits of anthocyanins, promising findings relate to their anti-inflammatory activity [16], as well as
their role in risk factors for CVD [16], weight management [16], alleviation of elevated blood sugar
[16] and impaired cognitive functioning [17]. The exact manner in which they exert these protective
effects is yet to be fully established as this research area is still emerging [18].
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1.1.1.1 Beneficial health effects of anthocyanins

Anthocyanins are regarded as an important component of the human nutrition [19]. Historically,
before scientific evidence, they have been used to treat diverse ailments including hypertension,
pyrexia, liver disorders, kidney stones and urinary tract infection [8]. Even though research evidence
shows their beneficial health effects [20, 21], research in these areas is inconclusive, on-going studies
continue to show promising results. Antioxidant activity has been described as one of the most
important aspects of anthocyanins in relation to disease prevention [22]. Evidence shows that the
antioxidant capacity (molecules able to donate a free electron or hydrogen atoms to reactive free
radicals) of a molecule is significantly correlated to its ability to oxidise easily [21]. This ability of
anthocyanins to capture free radicals by donation of phenolic hydrogen atoms has been identified as
the potential reason for their anti-inflammatory activity [22]. Some studies have suggested that the
anthocyanin content in fruits is directly proportional, to some degree, to their corresponding
antioxidant activity and in turn related to the protective effects exhibited by the fruits and vegetables
against degenerative and chronic diseases [23-25].

1.1.1.2 Absorption and metabolism

Absorption and metabolism are important aspects of understanding the association between
anthocyanins and their reported beneficial health effects. Following consumption, the initial
absorption of most polyphenols, including anthocyanins, occurs in the small intestine before moving
on to the colon where further metabolism and absorption takes place [26]. Evidence from both animal
studies and randomised clinical trials (RCTs) have shown that some anthocyanins (delphinidin 3-Orutinoside, cyanidin 3-O-rutinoside, delphinidin 3-O-glucoside, and cyanidin 3-O-glucoside) are
directly absorbed and excreted in their intact glycosylated forms [27], while anthocyanin arabinosides
have been observed to be the most resistant to absorption and microbial degradation in the intestines
[28]. The primary site of anthocyanin absorption and transformation is the duodenum and jejunum
with approximately 10-50% of ingested content being absorbed in these regions of the small intestine,
mainly as aglycones (the product when a glycoside is replaced by a hydrogen atom) after
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deglycosylation of the original compound [29, 30]. After the glycosides enter the enterocytes in the
small intestine, hydrolysis by cytosolic β-glucosidase (CBG) occurs to get rid of glycosidic moieties.
In the enterocyte cytosol, polyphenol aglycones are either transferred to the blood stream via passive
diffusion or transformed to phase II metabolites via phase II pathways [30]. Enteric and enterohepatic
recycling usually leads to isomeric modification before partitioning of anthocyanin metabolites into
the urine [31] (Fig. 1-2). The initial absorption of anthocyanins in the intestine is determined, to a
large degree, by their hydrophobicity. It has been shown that glycosides that are more hydrophilic
than their resultant aglycones cannot readily cross the enterocyte cellular membrane via passive
diffusion [16]. Following the initial absorption from the small intestine, the resulting metabolites, and
some of the initial intact glycosides travel through the hepatic portal vein to the liver where further
metabolism takes place. Anthocyanin interconversion in vivo is due to xenobiotic and gut bacterial
metabolism involving addition and removal of methyl and hydroxyl groups. Enteric and enterohepatic
recycling leads to isomeric modification of anthocyanins before separating some of the resulting
metabolites into urine (Fig.1-2)

The exact mechanism involved in anthocyanin absorption and metabolism has not yet been confirmed.
Two mechanisms have been described; one of these mechanisms is the cleavage of glycosidic
moieties by lactase-phlorizin hydrolase (LPH), a brush border enzyme on the surface of enterocytes.
This is known to be very reactive toward flavonoid-O-β-D-glycoside [32]. The second mechanism,
first described by Hollman et al. [33], proposes that intact absorption of anthocyanin glycosides could
actually occur in the small intestine, using the sodium-dependent glucose transporter 1 (SGLT1). Prior
to this theory, it was believed that the typically large and highly polar molecules were not absorbed
after oral consumption but underwent hydrolysis to their aglycones by bacterial enzymes in the lower
part of the intestine [34]. However, current evidence shows that polyphenol conjugates with sugar
moieties that move into the colon are those that are resistant to the action of LPH/CBG [35]. A study
on the bioavailability and bioactivity of flavonoids and phenolic acids showed that the absorption and
metabolism of different cranberry phenolics occurs at different locations and in different quantities
along the gastrointestinal tract (GIT) [36]. An animal study on the metabolism of flavonoids via
enteric recycling metabolism observed that the quantity of genistein (a soy isoflavone) and apigenin (a
flavone analogue of genistein) that was absorbed differed across various regions of the intestine [37].
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For genistein, the highest absorption occurred in the duodenum (44% of perfused amount). The
absorption in the duodenum and the colon (35%) was significantly higher than the quantity absorbed
in the jejunum (16%) and the terminal ileum (21%). In addition, the metabolism of these two
compounds followed a similar trend; apigenin was metabolised faster than genistein, with the highest
metabolism of the two compounds occurring in the jejunal microsomes and more readily in the colon,
and negligible amount of metabolites observed in the perfusate. The study findings suggested that the
rate of metabolism of different flavonoids in the intestinal microsomes could be higher than what is
observed in the liver microsomes [37].

Other physio-chemical properties such as molecular size and configuration also regulate the
absorption of anthocyanins. Anthocyanins with higher molecular weights tend to have poorer
absorption in the body [38]. In food, anthocyanins exist mainly as glycosylated derivatives, the
chemical structure of which has been shown to significantly facilitate their absorption through the gut
barriers [39]. These glycosylated derivatives are able to survive the acidic environment of the stomach
[40] which means that they remain intact for longer. Inter-individual variation is another important
factor that determines the rate of absorption, metabolism and excretion of anthocyanins. Interindividual variation suggests that some individuals are better absorbers than others, possibly due to
particular polymorphisms for intestinal enzymes or transporters [41]. To control for this in clinical
trials, crossover study designs are usually employed meaning that for each of the trials, participants
act as their own control [42].

6

Phase I & II Metabolism

Enteric Recycling

±Glucuronide
Enterohepatic
Recycling
±OH

Anthocyanins

±CH3

-Glycoside

Colonic Metabolism
Urine

Phenolic acids

Blood stream

Figure 1-2: Schematic outline of anthocyanin inter-conversion in vivo due to xenobiotic and gut
bacterial metabolism involving addition and removal of methyl and hydroxyl groups. Enteric and
enterohepatic recycling will lead to isomeric modification before partitioning of anthocyanin
metabolites into urine.
Source (Published with permission): [31].
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1.1.1.3 Bioavailability

Bioavailability is defined as “the rate and extent to which the active ingredient or active moiety is
absorbed from a drug product and becomes available at the site of action” [43]. For anthocyanins,
which are provided from food and ingested orally, bioavailability would be simply defined as the
amount or fraction of the ingested quantity that is absorbed.

In addition to the health benefits of dietary anthocyanins, there is also increased interest in their
bioavailability. This is due to very low levels observed in the circulatory system following
consumption. Studies have shown that the body treats metabolites of anthocyanins and polyphenols in
general as xenobiotics (chemical or substance that is foreign to the biological system) by getting rid of
them from the body system. This, aside from the issues of their low absorption, may explain the
reduced rather than accumulated levels noticed in the circulatory system over time [44].

Bioavailability studies aim to determine which subclasses of dietary anthocyanins are better absorbed
and which are associated with the formation of active metabolites [42]. Anthocyanins which are
commonly found in some diets are usually the primary dietary phenolic components for people who
regularly eat berries and drink red wine [43]. Studies on the bioavailability of anthocyanins have
reported low plasma concentrations ranging from 10-50nmol/L with Cmax mean time of 1.5h (range
0.75-4h ) [45] while the Cmax mean time for anthocyanin metabolites to appear in the urine is 2.5h
(range 2-4h) [46]. The exact reason for the low bioavailability, reported as less than 1% of ingested
anthocyanins, is not known [45] but low recovery in the plasma and urine has been attributed to
dietary anthocyanins undergoing intensive metabolism after ingestion and the subsequent metabolites
are the main transport forms in vivo [31, 47-49]. Taking into account the different metabolites of
anthocyanins, the percentage recovery of consumed anthocyanins found in plasma and urine has been
estimated as being 15% and higher [47]. Generally, endogenous factors such as; molecular weight,
glycosylation, metabolic conversion and interaction with colonic microbial flora are the main factors
that determine anthocyanin bioavailability[50]. Another important factor is the food-matrix.
Available evidence shows that dietary fibre (such as hemicellulose), divalent minerals, and viscous
and protein-rich meals have the potential to inhibit anthocyanin bioavailability while digestible
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carbohydrates, dietary lipids as well as additional antioxidants able to enhance their
bioavailability[50]. In the colon, intact anthocyanin compounds are broken down to smaller different
metabolites, including phenolic acids and aromatic catabolites [51, 52]. The metabolism and action of
anthocyanins in the colon is a bidirectional relationship with the gut microbiota able to enhance the
metabolism of anthocyanins in the gut [52] and the anthocyanins able to have a proliferative/inhibitory
effect on gut microbiota [53]. Available evidence indicates that colonic metabolites make up a
significant portion of the overall metabolic profile following anthocyanin consumption [54, 55]. In
vitro studies have demonstrated that these colonic metabolites exert more vascular and antiinflammatory effects in comparison to the metabolites that are formed and absorbed in the small
intestine [52]. This highlights the importance of the microbiota–gut-brain axis with evidence showing
that the gut microbiota may have a significant association with mental illnesses [56]. Following the
metabolism of anthocyanins in the gut, subsequent changes in the gut microbiota composition have
been shown to relate with their neuroinflammatory properties [57].

1.1.1.4 Mechanism of Action

There are a number of plausible mechanisms that have been proposed to explain how anthocyanins
exert beneficial effects on cognition and other health parameters. Ageing, which is associated with a
reduction in the neuronal population and loss of synaptic plasticity leads to reduced cognitive function
over time. Spencer (2010) [18], suggested that anthocyanins may exert protective effects on cognition
through their ability to act directly (interaction with neuronal signalling and synaptic function in the
brain) or indirectly (influence on blood flow and neuroinflammation [58]) on the brain’s innate
architecture for memory (Fig.1-3). The structural characteristics of in vivo metabolites of anthocyanins
determine, to some extent, their access to the brain with smaller, lipid-soluble, nonionized compounds
able to cross the blood-brain-barrier [59]. Hence it is unclear whether anthocyanins modulate brain
plasticity directly or indirectly [58]. Interestingly, substantial evidence continues to support clinically
significant beneficial effects of anthocyanins on blood pressure [55, 60, 61]. Blood pressure as part of
the vascular system is therefore important for maximum functioning of the brain, as any dysfunction
in this process would ultimately affect cognitive function and behaviour [53]. The presence of
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vascular risk factors, as a result of chronic inflammation, impact on brain degeneration, leading to
cognitive decline [62]. For example, alterations in mean arterial pressure over time are associated with
brain degeneration [62]. Prospective studies report an association between hypertension in mid-life
and incidence of dementia at an older age [63] and a higher systolic and diastolic blood pressure
(>160mmHg and >95mmHg, respectively) 10-15 years earlier was significantly associated with the
onset of Alzheimer’s disease [64]. It has been suggested that anthocyanin effects on blood pressure
may be facilitated by the actions of absorbed anthocyanin metabolites on arterial nitric oxide (NO)
bioavailability by either activating endothelial nitric oxide synthase (eNOS) and/or inhibiting
nicotinamide adenine dinucleotide phosphate (NADPH) oxidase in the endothelium [58]. This shows
the significance of increase in cerebral blood flow (CRF) in the observed beneficial effects [65]. As
the effectiveness of the brain function is dependent on 20% of the body’s total oxygen supply and
other nutrients supplied via the vascular system [66], the activity of anthocyanins on brain function is
highly dependent on the ability of their metabolites to cross the blood brain barrier (BBB) and enter
the brain [67]. A number of studies have observed the presence of anthocyanin metabolites in brain
tissues following oral administration [68-71] . In addition, it has been suggested that anthocyanins
may also exert beneficial effects on cognition and memory by activating MAP (Mitogen Activated
Protein) kinases and PI3 kinase pathways in the hippocampus of aged animals [72] as well as
modulating mRNA BDNF (Brain-Derived Neurotrophic Factor ) levels [73].

Evidence from the last decade has shed more light on the possible mechanism of action of
anthocyanins. An updated review on the health benefits of anthocyanins and their molecular
mechanisms suggest that some crucial signalling pathways as well as cellular processes, such as cell
cycle, apoptosis, autophagy, and biochemical metabolism, are involved in the observed beneficial
health effects of anthocyanins [74]. Extensive research on the molecular mechanism of anthocyanins
in vivo suggests that anthocyanins may have the potential to inhibit a number of signalling pathways
that are involved in endothelial function, inflammatory processes as well as tumour proliferation and
apoptosis. Delphinidin 3-O-glucoside and cyanidin 3-O-glucoside have been demonstrated to improve
endothelial function through the activation of the NO-cGMP (Nitric Oxide Cyclic guanosine
monophosphate) signalling pathway in hypercholesteraemic individuals [75]. The NF-kB (Nuclear
Factor kappa-light-chain-enhancer of activated B cells) pathway regulates inflammatory processes.
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The plausible role of anthocyanins in inflammatory processes has also been studied. Anthocyanin-rich
extract from wild blueberry reduces the activation of NF-kB in the presence of the pro-inflammatory
stimulus IL-1b in human Caco-2 intestinal cells [76]. In addition, anthocyanins induce cell cycle arrest
in colon cancer cells by increasing the expression of p21WAF1 and p27KIP1 (cyclin-dependent
kinase inhibitors) and decreasing the expression of cyclin A and cyclin B (proteins that function in
regulating progression through the cell cycle) [77]. The Wnt signalling pathway is crucial for the
regulation of cell proliferation, differentiation, and survival. A primary component of the Wnt
pathway is b-catenin (a protein that is involved in the regulation and coordination of cell–cell
adhesion and gene transcription). The over activation of b-catenin in the cytosol is related to cancer
metastasis, which is normally regulated by dephosphorylated glycogen synthase kinase 3b (GSK3b).
Results from an in vitro study showed that anthocyanin extract from the Korean wild berry, Meoru,
significantly inhibited liver cancer Hep3B cell migration and invasion by reducing the expression of
phospho-GSK3b and b-catenin[78].

In addition, anthocyanin metabolites have become the main point of interest as recent evidence shows
that anthocyanins are absorbed and transported in the body in the form of their resultant metabolites
[74]. Protocatechuic acid (PCA), a major anthocyanin metabolite has been shown to significantly
slow the progression of esophageal cancer in rats [79]. While other anthocyanin metabolites, gallic
acid, 3-O-methylgallic acid, and 2,4,6-trihydroxybenzaldehyde, showed a significant reduction in cell
viability, cause cell cycle arrest and apoptosis in colon cancer Caco-2 cells [80], which emphasizes the
potential benefits of anthocyanin metabolites in vivo.
With a number of plausible mechanisms that have been described here, there is still need for extensive
confirmatory research on the beneficial health effects of anthocyanins and their possible mechanisms
of action.
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AKT-Protein kinase B (aka Akt); PKA-Protein Kinase A; ERK1/2- Extracellular signal-regulated kinase 1/2; eNOS-Endothelial
nitric oxide synthase; NO- Nitric oxide; BBB-Blood-brain-barrier; BDNF- Brain-derived neurotrophic factor; ARC- Activityregulated cytoskeleton; nNOS- Neuronal nitric oxide synthase; CREB- cAMP response element binding (protein); NMDAR- Nmethyl-D-aspartate; TrkB- Tropomyosin receptor kinase B

Figure 1-3 Plausible mechanism of anthocyanin effect on memory and learning via direct or indirect
routes
Source (Published with permission): [58]

1.1.1.5 Sources of dietary anthocyanins

Anthocyanins are commonly found in a diverse range of red, blue and purple fruits. High levels of
anthocyanins have been observed in blueberries and as a result, blueberries have been the major focus
of anthocyanin-based research [81]. A number of other fruits also contain similarly high levels of
anthocyanins but have not been widely investigated in anthocyanin research. One such fruit is the
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plum, a drupe fruit which belongs to the subgenus prunus (Family Rosaceae). The subgenus can be
differentiated from other subgenera (peaches, cherries, etc.) as the shoots have a terminal bud and
unclustered single side buds. The flowers combine in groups of one to five on short stems, and
the fruit have a crease running down one side and a smooth seed. Between 19 and 40 different species
of plum exist. Of these, only two; the hexaploid European plum (prunus domestica) and the diploid
Japanese plum (prunus salicina and hybrids) are of commercial significance across the globe [82].
In the last decade, there has been an increased interest in plum-based research because of the fruit’s
high levels of polyphenols, and more recently identification of its high anthocyanin content [75]. The
major anthocyanins found in the plum are cyanidin (3-rutinoside, 3-glucoside and 3-xyloside) and
peonidin (3-rutinoside and 3-glucoside) [83]. The increased interest in plum-based research has also
resulted in fruit breeders cultivating different varieties through hybridisation. One of these hybrids is
the Australian Queen Garnet plum (QGP), a hybrid of the Japanese plum developed through a
breeding program funded by the Queensland Government in Australia. The QGP is known for its
exceptionally high anthocyanin levels, reaching up to 277 mg/100 g fruit [84]. Although fruit
anthocyanin levels increase progressively during fruit development and ripening, the anthocyanin
levels in the QGP is more than two times the total anthocyanin content of regular plums (range of 5 to
173mg/ 100g across harvest years for regular plums [13]) and other common fruits. Preliminary
studies using this variant of plum have demonstrated antithrombotic activity in humans [85] and a
beneficial effect on metabolic syndrome in rat models, as well as in vivo and in vitro bioactivity [86].
The proposed research will contribute to the current evidence on the beneficial health effects of plums
in general, and for the clinical studies, the Australian QGP will be utilised for its higher levels of
anthocyanins, as well as its accessibility to the research team.

1.1.1.6 Anthocyanin food levels and measurement

The ability to measure anthocyanin accurately and specifically is essential in order to investigate the
association between anthocyanin intake and health outcomes. Accurate measurement of anthocyanins
in food sources, as well as through dietary assessment of individual intake and biomarkers that

13

indicate absorption and excretion is required. In addition, no consistent biomarkers exist as the ‘gold
standard’ proxy for dietary intake.

For the levels of anthocyanin in major food groups, a number of international databases have been
developed including the American USDA Database for the Flavonoid Content of Selected Foods [87]
and the European Phenol-Explorer [88]. These databases are freely accessible and usually employed
globally to determine individual anthocyanin intake. The problem though is that these databases have
been developed overseas and are tailored mainly to foods accessible in those regions of the world.
Nutritional content of foods is known to be affected by region, climate and soil conditions [89, 90].
The ability to be able to accurately determine anthocyanin intake across various populations in
different regions would involve developing food composition databases tailored to specific regions.
As part of this research, a first stage development of an anthocyanin database for Australian foods was
carried out. This, together with borrowed values from the USDA Database for the Flavonoid content
of selected foods and the European Phenol-Explorer, was used to measure dietary intake of
anthocyanins in the Australian population.

1.1.2

Problem statement

Anthocyanin research has mainly focused on (blue) berries because of their high anthocyanin content
with less focus on other anthocyanin-containing (different anthocyanin profile) fruits and vegetables
which has limited research conclusions and generalisability to dietary messaging.
Further understanding of the metabolism and mechanism of action of anthocyanins and their
metabolites in the body as well as how dose (timing) might affect this process and whether it is agedependent remains to be addressed.

In addition, the absence of specific food composition databases for anthocyanins, and larger flavonoid
subclasses, tailored to countries and regions to measure anthocyanin intake in epidemiological studies
continues to limit research evidence and diminishes population estimates.
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1.1.3

Hypothesis

Following the problem statement, this research hypothesises that supplementing the diet with plum
anthocyanins will have significant positive effects on cognitive function and other health parameters
in older adults, while being age- and dose-dependent.
To test this hypothesis the following objectives were developed.

1.1.4

Research Objective

To determine the acute and longer-term effects of consumption of dietary anthocyanins (delivered
from plum juice) on cognition and other health parameters in older adults.

1.1.4.1 Specific Objectives:

1) To collate and synthesise the current level of evidence on the beneficial health effects of plum –
an anthocyanin-rich fruit.
2) To determine if consumption of anthocyanins from QGP juice has an acute impact on various
domains of cognitive functioning, blood pressure, and urinary phenolic profile.
3) To determine the longer-term effects of anthocyanin consumption from QGP juice on cognition,
blood pressure, inflammatory biomarkers (BDNF, CRP) and gut microbiota in older adults.
4) To collate and synthesise the current evidence on the effects of anthocyanins on gut microbiota.

5) To determine the anthocyanin intake of older Australian adults from the National Nutrition and
Physical Activity component of the Australian Health Survey 2011-13 (a nationally
representative sample) in order to obtain current dietary levels of anthocyanin intake and the
common food sources thereof.
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1.1.5

Conceptual Framework

To test the above hypothesis, acute and longer-term effects of high anthocyanin QGP juice on
cognition and other health parameters will be studied in younger and older adults. To achieve this,
four studies were developed to answer the above research objectives. These studies were classified
under three theoretical research frameworks (Figure 1-4); current evidence synthesis, evidence
generation, and evidence translation.

With the dramatic increase in the prevalence of dementia and other CVDs, research continues to find
ways to improve the overall wellbeing of the general population especially in older adults. Modifiable
risk factors including nutrition have become an area of interest stem the global epidemic of chronic
diseases, especially cognitive impairment. Evidence is emerging that anthocyanins, known to be
natural antioxidants may exert beneficial effects on memory and cognition, as well as improve
metabolic risk factors (blood pressure, insulin resistance etc.).

Two systematic reviews were conducted to synthesise existing knowledge and identify gaps in the
literature on the beneficial health effects of plums and the effects of anthocyanins on gut bacteria.

Intervention studies aimed to investigate the effect of acute and chronic consumption of different
doses of anthocyanin-rich QGP juice on cognition and blood pressure as main outcome measures, and
other health parameters including anthocyanin metabolite excretion, inflammatory biomarkers and gut
microbiota as secondary outcomes. A crossover study determined the acute effect of the high
anthocyanin QGP on cognition, blood pressure and metabolism (urinary excretion of polyphenolics)
in younger and older adults, while an 8-week RCT also assessed these effects, including inflammatory
biomarkers and gut microbiota, over the longer term in generally healthy older adults.

The lack of an Australian food composition database related to the anthocyanin content (and
flavonoids generally) of local foods hampers interpretation of food-based research. Substitution of
values from the U.S. Department of Agriculture (USDA) database and/or the European Phenol-
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Explorer database have been used in past studies, but this project further refined research
methodology in this area by developing an anthocyanin database tailored to Australian foods (fruits
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METHODOLOGICAL

RESEARCH STUDIES

STUDIES/APPLICATION
Phase 1: Current Evidence Synthesis

Phase 2: Evidence Generation

Phase 3: Evidence Translation

Figure 1-4: Research Conceptual framework
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and vegetables as a first step). This developed database was applied to nationally representative
nutrition survey data in order to determine anthocyanin intake in the Australian population. This
methodological component of the project will contribute to application of clinical trials data to
translation of the findings into practical dietary guidance.

1.1.6

Significance and Summary

The role of nutrition as a protective factor in chronic diseases is a promising research area; however,
results have been inconclusive. It is important to establish a reliable and robust body of evidence. A
review on the health effects of plum will summarise the available evidence to date and identify gaps in
the published literature for future plum-based anthocyanin research.

This thesis will make a significant contribution to the area of anthocyanin research. Knowledge
synthesis in the systematic reviews will identify gaps for current and future research while the
proposed clinical trials would expand the clinical evidence on the health benefits of anthocyanins from
a different, less popular anthocyanin source – plum juice. Additionally, differences in anthocyanin
metabolism between young and older adults will be investigated in the acute trial in order to inform
future clinical trials in older people who may be at an increased risk of cognitive impairment.

The development of an Australian anthocyanin database will facilitate better estimation of the current
dietary anthocyanin intake of the Australian population and thereby contribute to dietary
methodology. In doing so, it will address some of the gaps in the literature related to the estimation of
dietary anthocyanin intake, as is required in studies to determine their beneficial health effects.

In summary, this doctoral thesis addresses significant gaps in the literature, with each study providing
novel and significant contributions to the body of evidence in anthocyanin research and advances the
scientific knowledge thereof.
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2

Chapter 2

2.1 A SYSTEMATIC REVIEW ON THE HEALTH EFFECTS OF
PLUMS (PRUNUS DOMESTICA AND PRUNUS SALICINA)

Plum as a source of anthocyanin has contributed to the evidence on the beneficial health effects of
anthocyanins but the major focus of this bioactive component in food has been blueberries (for their
significantly higher anthocyanin content). Little is known about the effectiveness of plum
supplementation, as a source of anthocyanin, on health parameters. A systematic review of literature
was carried out to summarise the available evidence on the impact of plums (prunus species;
domestica and salicina) on disease-related risk factors and health outcomes. Findings from this review
highlighted the low level of evidence for plum-anthocyanin research, with the primary focus on
cognitive function in animal models, and bone health parameters in human clinical trials. This review
concluded that evidence on the health effect of plums has not been extensively studied and that the
available evidence needs confirmation with further well-designed studies.

The majority of this chapter forms the substantive content of a published article: Appendix C

Igwe, E.O. and Charlton, K.E., 2016. A systematic review on the health effects of plums (Prunus
domestica and Prunus salicina). Phytotherapy Research, 30(5), pp.701-731.
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2.1.1

Introduction

The European plum (prunus domestica) is believed to have been discovered about 2000 years ago
with its origin somewhere near the Caspian Sea. The fruit was introduced into the U.S. in the 17 th
century by pilgrims while the Japanese plum has its origin in China but derived its name from the
country where it was mostly cultivated and developed; Japan. The Japanese plum (prunus salicina and
hybrids) was introduced into the U.S in the late 19th century. Today, the main producers of
commercially grown plums are the United States, Serbia, China, and Romania. [91]. The nutritional
composition of the two species is considered similar (Table 2-1).

Prunes are the dried version of plums and are known for their laxative effect which is commonly
attributed to its high fibre content [92]. Earlier studies attributed the laxative effect of prunes to the
presence of phenolics (chlorogenic acid) [93] and sorbitol [94] that are in the fruit, together with its
high fibre content [95]. In the U.S., prunes are referred to as dried plums. This name change was
effected in a bid to promote prunes as a health food instead of being associated with old age [96].
Prunes are produced industrially by drying plums at 85-90oC for 18 hours. This process is believed to
have originated thousands of years ago also near the Caspian Sea, the same region where the
European plums were discovered. With migration and civilisation, prunes spread throughout Europe.
Today, California, USA is the leading producer of prunes (dried plums) worldwide [97].

In classifying whole and natural foods based on their unique nutritional composition, anthocyanin
content has become a widely utilised method of classification [98]. The high levels of phenolic
compounds including flavonoids, and particularly the subclass of anthocyanins observed in the plum
has resulted in a dramatically increased interest in plum based research since the 1990s [99, 100]. A
number of health benefits have been associated with the plum fruit and these include improved bone
health, cognition and memory, antioxidant anti-inflammatory effects, and easement of constipation.
These health promoting properties have been attributed to the plum’s antioxidant capacity as a result
of the high phenolic content [101-105]. These beneficial health effects have been reported from
studies that have used different research designs (in vitro, animal studies and clinical studies) and have
investigated both plums, and related products and extracts [106].
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The aim of this systematic literature review was to determine the level of current evidence on the
beneficial health effects of plum and its associated products.

22

Table 2-1: Major nutritional composition of European (P. Domestica) and Japanese (P. Salicina)
plums (per 100g)

Component

European plum (p.domestica) and Japanese plums (p.salicina)
Fresh plums
Dried prunes
Plum juicea

Water/moisture (g)
Energy (kj)
Carbohydrate (g)
Protein (g)
Fat (g)

87.23
192
11.42
0.70
0.28

30.92
1006
63.88
2.18
0.38

84.02
243
15.15
0.51
0.02

Sugars, total
Glucose (g)
Fructose (g)
Sucrose (g)
Total Dietary fibre (g)

5.07
3.07
1.57
1.4

25.46
12.45
0.15
7.1

14.22
23.3a
11.8a
3.7a
0.9

Minerals
Calcium (mg)
Iron (mg)
Magnesium (mg)
Phosphorus (mg)
Potassium (mg)
Sodium (mg)
Zinc (mg)
Copper (mg)
Manganese (mg)
Fluoride (µg)

6
0.17
7
16
157
0
0.10
0.057
0.052
2.0

43
0.93
41
69
732
2
0.44
0.281
0.299
4.0

10
0.34
8
15
154
1
0.11
0.054
0.033
-

Vitamins
Ascorbic acid (C) (mg)
Thiamine (B1) (mg)
Riboflavin (B2) (mg)
Niacin (B3) (mg)
Pantothenic acid (B5) (mg)
Pyridoxine (B6) (mg)
Total Folate (µg)
Vitamin A, RAE (µg)
Vitamin E (mg)
Vitamin K1 (µg)

9.5
0.028
0.026
0.417
0.135
0.029
5
17
0.26
6.4

0.6
0.051
0.186
1.882
0.422
0.205
4
39
0.43
59.5

2.8
0.023
0.059
0.473
0.072
0.027
3
50
0.18
4.3

Carotenoids
Carotene, beta (µg)
Carotene, alpha (µg)
Cryptoxanthin, beta (µg)
Lutein + zeaxanthin (µg)

190
0
35
73

394
57
93
148

554
0
102
49

Phenolic compoundsb
Total (mg)
Neochlorogenic acid (mg)
Chlorogenic acid (mg)
Anthocyanins (mg)
Catechins (mg)

111
81
14.4
7.6
5.4

184
131
44
-

121c
198.5a
46.5a
0.172c
-

Table adapted from [106] and [107], a[106] (plum juice concentrate/100mL), b[108], c [105], - No available data. Amount
reported per 100g weight [109]; data are a mix of Japanese and European plums
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2.1.2

Materials and methods

A systematic literature review was conducted according to the guidelines of the PRISMA (Preferred
Reporting Items for Systematic Reviews and Meta-Analysis) statement and checklist [110] (Figure 2-1). A
number of electronic databases were searched: Scopus, Web of Science, Cochrane library, CINAHL,
MedLine, and ScienceDirect up to June 2015 with a combination of search terms, including, plum or prune
or prunus or prunus domestica or prunus salicina and health effects used as keywords (see appendix B for
sample search strategy (Medline)).

Inclusion criteria for journal articles included:
1.

Studies carried out in vitro, on animal and clinical studies.

2.

Studies that utilised the fresh, dried, juice version or extracts of the plum species prunus
domestica or prunus salicina.

3.

All studies assessing any health outcome associated with plum consumption/treatment.

4.

Studies reported in English. Only studies reported in English were included due to language
barrier, reasons of time efficiency and cost of translation not being feasible.

Exclusion criteria for journal articles included:

1.

Studies on the quantification of the nutritional composition and antioxidant properties of plums.

2.

Studies that utilise a different species of plums e.g. the Japanese apricot also known as Japanese
plums in the prunus mume specie.

3.

Studies assessing properties related to plum cultivation, harvest and the commercial aspects of
the plum fruit.

Articles were assessed for peer-reviewed status using Ulrich’s Web (available at:
http://ulrichsweb.serialssolutions.com.ezproxy.uow.edu.au/). A hand search yielded one additional article
which was relevant to this review.
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For the clinical trials, all the relevant studies retrieved were classified as either confirmatory or exploratory
studies. They were rated for their quality using relevant criteria from The Delphi List, Cochrane Back
Review Group and The CONSORT Statement (Appendix A). The strength of evidence of study design was
assessed using the Australian NHMRC (National Health and Medical Research Council) hierarchy levels
of evidence with rankings from level I - IV. The NHMRC evidence hierarchy has 6 levels according to
type of research question with systematic review of level II studies classified as levels I and randomised
controlled trials, classified as level II. Studies ranging from a pseudo-randomised controlled trial to a
comparative study without concurrent controls are classified as levels III-1 to III-3, and case series with
either post-test or pre-test/post-test outcomes classified as level IV [111].

2.1.3

Results

A total of 73 studies were eligible for inclusion in this review (Fig.2-2), most of which were conducted in
the last decade. Of these, 18 investigated bone health (2 in vitro, 12 animal studies and 4 human clinical
trials), and 20 investigated its anti-cancer and anti-inflammatory properties (13 in vitro studies, 6 animal
studies and 1 human clinical trial). Eleven studies reported on plums’ antioxidant properties and their effect
on cognition (2 in vitro studies, 5 animal studies and 4 human clinical trials) while nine studies investigated
the effect of plums on different components of the metabolic syndrome (cholesterol, high blood pressure
and anti-thrombosis; 3 animal studies and 6 human clinical trials). For prunes commonly known laxative
effect and satiety, 8 clinical studies in humans, including 2 randomised clinical trials were carried out. Five
studies examined its anti-allergic, anti-microbial and immune-enhancing properties (2 in vitro studies and 3
animal studies) and 2 clinical studies examined its effects on liver function and risk factors for kidney stone
formation. Some of the findings reported from the in vitro studies such as parameters related to improved
bone health and anti-inflammatory properties have also been confirmed in animal and human studies [112115]. Tables 2-2 to 2-8 summarise the experimental and clinical studies and Appendix A summarises the
quality of the clinical studies included in this review.

The quality of the clinical studies included is at best of moderate quality. There were 6 confirmatory
studies of moderate quality (1 on bone health, 2 on different components of metabolic syndrome, and 3 on

25

satiety and laxative effect) and 19 exploratory studies. Evidence on the health effect of plums has not been
extensively studied and the available evidence needs further confirmation.
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Scopus (n=73)
Web of Science (n=1970)
Cochrane library (n= 107)
CINAHL (n=93)
MedLine (n=338)
ScienceDirect (n=865)

Screening

Identification

Records identified through
database searching: 3446
Additional records identified
through hand searching (n= 5)

Records screened: 3451

Articles assessed for eligibility based

Eligibility

on title: n= 196

Included

Scopus (n=14)
In vitro (n=4)
Animal studies
(n=2)
Clinical studies
(n=8)

Web of Science
(n=61)
In vitro (n=20)
Animal studies
(n=27)
Clinical studies
(n=14)

Cochrane
library (n= 23)
In vitro (n=0)
Animal studies
(n=0)
Clinical studies
(n=23)

Records excluded:
Reason: relevance to review
topic
n= 3255

Hand searched articles (n=5)
Animal studies (n=4). Clinical
studies (n=1)

CINAHL
(n=27)
In vitro (n=4)
Animal studies
(n=11)
Clinical studies
(n=12)

Total number of studies
included: n= 73
In vitro (n=19)
Animal studies (n=29)
Clinical studies (n=25)

MedLine (n=47)
In vitro (n=14)
Animal studies
(n=22)
Clinical studies
(n=11)

ScienceDirect
(n=19)
In vitro (n=6)
Animal
studies (n=10)
Clinical
studies (n=3)

Articles excluded: 123
Reasons:
Duplicates (n=107)
No full text articles (meeting /
conference abstracts) n=10
Study that utilised a mixture of
fruits including prunes (n=2)

Figure 2-1: Figure 2-2 PRISMA flow diagram for study selection process
Studies on a different species of
plums e.g the Japanese apricot also
known as Japanese plums in the
prunus mume specie 27
(n=4)

2.1.3.1 Bone health

Based on results from 18 studies (2 in vitro, 12 animal studies and 4 clinical trials) reported in this review,
promising evidence exists on the effect of plum on bone health. This body of evidence has mostly been in
agreement and also confirmed in human trials. Bu et al. (2008) [116] in their in vitro study involving two
groups investigated the effect of dried plum polyphenols on osteoclastogenesis in which one group was
stimulated with lipopolysaccharide (LPS) to induce inflammation and the other group stimulated with
hydrogen peroxide (H2O2) to induce lipid peroxidation. It was observed that the LPS stimulated sample
produced NO (nitric oxide) detectable at 8h which further increased at 16hr while the H 2O2 stimulated cells
did not produce NO. This increase in NO associated with LPS was downregulated by different doses (10,
20, 30µg/mL) of plum polyphenol at both 8h and 16h. The authors concluded that dried plum polyphenols
directly inhibit osteoclastogenesis which leads to reduced osteoclast activity by downregulation of NFATc1
(Nuclear factor of activated T-cells, cytoplasmic 1) and inflammatory mediators. The results from the
above in vitro experiment have also been confirmed in animal studies [103, 117-119]. However, one study
[119] differed slightly by studying the mechanism of action of dried plum alteration of bone metabolism in
comparison to the longer-term effects of dried plum on systemic biochemical markers of bone metabolism
and alteration in gene expression [103, 117, 118]. Regulators of osteoblast and osteoclast differentiation
and osteoblast activity were studied over a period of 6 weeks. Compared to the anabolic therapy using PTH
(parathyroid hormone) that significantly increased systemic and local indicators of bone formation with no
effect on systemic marker of bone resorption, dried plum supplementation suppressed bone turnover with
no effect on the indices of bone formation at the endocortical surface. In another study by the same
research team, dried plum supplementation initially suppressed cancellous bone turnover but demonstrated
a biphasic response over time, exerting positive effects on bone mass and bone structure [120]. Plum
extract has also been shown to be effective in increasing bone calcium retention by 20% [104].

Rendina et al. (2013) [112] compared dried plum to other dried fruits (apple, apricot, grape and mango) and
observed that only the dried plum had an anabolic effect on trabecular bone in the vertebra and prevented
bone loss in the tibia. This demonstrates a potentially unique effect of plum that was absent in the other
fruits studied. This anabolic effect of dried plum supplementation has also been observed by others in
animal models [113]. Prevention of age-associated bone loss was evident because of this anabolic effect,
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while bone volume increased, and already lost bone was restored. Investigating further, Monsefi et al.
(2013) [114] observed the effect of plum extract on bone parameters in the offspring of pregnant mice as
well as in non-pregnant mice. Plum extract was orally administered to the sample population and results
showed that in the non-pregnant mice, there was an increase in the femoral and tibial lengths and serum
calcium content, while the foetuses and new-borns of the pregnant mice had higher osteogenesis index
which was calculated by dividing the ossified length by the total length of each bone.

Ovarian hormone deficiency which is evident in postmenopausal women is a known major risk factor for
osteoporosis [121]. For this reason, effect of plum consumption on bone health in human trials has been
carried out mostly on postmenopausal women. A dietary supplementation trial compared the effects of
consumption of dried plum (100g) with dried apple (75g) for 3 months on markers of bone turnover in
postmenopausal women [115]. The difference in the amount of dried plum and dried apple compared was
related to comparable quantities of energy, carbohydrates, fat and fibre, obtainable from 100 g of dried
plum. Baseline and post-treatment values of serum and urinary biochemical markers of bone status showed
that only dried plums significantly increased serum levels of insulin-like growth factor-1 (IGF-1) and bone
specific alkaline phosphatase (BSAP) activity.

A similar longer term randomised controlled study compared the effects of dried plum and dried apple on
osteopenic postmenopausal women for one year [122]. In addition to similar results in [115], the authors
observed that dried plum significantly increased bone mineral density (BMD) of the ulna and spine.
In a slightly different study examining the effects of resistance training and dried plum consumption on
strength, body composition, blood markers of bone, and inflammation in breast cancer survivors, results
showed that even though breast cancer survivors increased upper and lower body strength, no
improvements were observed in their body composition and Bone Mineral Density (BMD)[123].
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Table 2-2: Evidence on the effect of plums and its associated products on bone health

Reference

Location

Plum product
investigated

In vitro studies
Bu et al., 2008 [116]

USA

Dried plum
extract
(P.Domestica)

Bu et al., 2009 [124]

USA

Polyphenols
extracted from
dried plum
(P.Domestica)

Animal studies
Smith et al., 2014a
[119]

USA

Level of
evidence*

Effects observed

RAW 264.7 murine macrophage cells.

NA

Inhibition of osteoclastogenesis under
inflammatory and oxidative stress
conditions possibly by polyphenol content.

MC3T3-E1 cells pre-treated with dried plum
polyphenols (0, 2.5, 5, 10 and 20 μg/mL) and 24
h later stimulated with TNF-α (0 or 1.0 ng/mL).

NA

Improvement of osteoblast activity and
function by up-regulating Runx2, Osterix
and IGF-I and increasing lysyl oxidase
expression, and reduction in
osteoclastogenesis signalling.

6wk dietary supplementation of dried plum
(5%, 15% or 25%) in adult, osteopenic
ovariectomized rats.

NA

Restoration of bone Mineral Density by 2
higher doses and bone turnover
suppression.

Deyhim et al., 2005 [117]

USA

Dried plum
(P. Domestica)

Dietary supplementation of dried plum (5%,
15% and 25%) in adult, osteopenic
ovariectomized (OVX) rats for 40days.

NA

Bone quality improvement (restoring bone
density) with all doses.

Franklin et al., 2006 [103]

USA

Dried plum
(P. Domestica)

Dietary supplementation of dried plum (5%,
15% and 25%) in orchidectomized rats for
90days.

NA

Prevention of osteopenia in androgen
deficient male rats.

Bu et al., 2007 [118]

USA

Dried plum
(P. Domestica)

Dietary supplementation of dried plum (25%) in
osteopenic orchidectomized rats for 90days.

NA

Reversion of bone loss due to
orchidectomy.

Smith et al., 2014b [120]

USA

Dried plum
(P. Domestica)

Dietary supplementation of dried plum (25%) in
adult mice for 4 or 12 weeks.

NA

Improvement in bone mass and structure.

Rendina et al., 2013 [112]

USA

Dried plum
(P. Domestica)

8wk dietary supplementation of dried plum
(25%) in adult, osteopenic ovariectomized mice.

NA

Bone loss prevention with anabolic effect.

Dried plum
(P. Domestica)

Sample/Method
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Reference

Location

Plum product
investigated

Sample/Method

Level of
evidence*

Effects observed

Halloran et al., 2010 [113]

USA

Dried plum
(P.Domestica)

Dietary supplementation of dried plum (15% or
25%) in adult and aged (old) male mice for 6
months.

NA

Restoration of lost bone and increase in
bone volume.

Rendina et al., 2012
[125]

USA

Dried plum
(P.Domestica)

Dietary supplementation of dried plum (5%,
15% or 25%) in ovariectomized adult mice for 4
weeks.

NA

Improvement of bone structure and
biomechanical properties and suppression
of lymphocyte TNF-α production by higher
doses.

Pawlowski et al., 2014
[104]

USA

Dried plum
powder extract
(P.Domestica)

Dietary supplementation of plum extract (9% or
20%) in ovariectomized rats for 6 intervention
(10days) and washout (10 days) cycles.

NA

Improvement in bone calcium retention.

Monsefi et al., 2013
[114]

Iran

Plum extract
(P.Domestica)

Oral administration of plum extract (1.6 g/kg) in
distilled water in pregnant mice for 30 days.

NA

Increased osteogenesis index in foetuses of
mice treated with plum extract.

Arjmandi et al., 2010
[126]

USA

Dried plum
(P.Domestica)

180 3-month-old female Sprague-Dawley rats
assigned to 15 groups (n=12) and either
ovariectomized (14 groups) or sham-operated
(Sham, one group) then placed on different
dietary treatments including one supplemented
with 5% Fructooligosaccharides (FOS) and
7.5% dried plum (DP) for 60 days.

NA

Diets supplemented with 5% FOS and 7.5%
DP was most effective in reversing both
right femur and fourth lumbar bone mineral
density and fourth lumbar calcium loss
while significantly decreasing trabecular
separation.

Johnson et al., 2011
[127]

USA

Dried plum
(P.Domestica)

72 3-month-old female Sprague-Dawley rats
assigned to 6 groups (n=12/group) and either
ovariectomized (5 groups) or sham-operated
(Sham, one group) then placed on a semi
purified, powdered casein-based diet for 45
days to induce bone loss. Thereafter the groups
were placed on different dietary treatments
including one supplemented with 5%
Fructooligosaccharides (FOS) and 7.5% dried

NA

In combination with soy protein, dried plum
and fructooligosaccharides had the most
pronounced effect in increasing lumbar
bone mineral density.
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Reference

Location

Plum product
investigated

Sample/Method

Level of
evidence*

Effects observed

plum (DP) for 60 days.
Clinical trials
Hooshmand et al., 2011
[122]

USA

Dried plum
(P.Domestica)

Hypothesis: Dried plums reverses bone loss in
osteopenic postmenopausal women.
n=160 osteopenic postmenopausal women
Study design/Methods: Randomized
controlled trial. Postmenopausal women
randomly assigned to treatment groups of dried
plum (100g/d) or dried apple (75g) daily for 1
year. Blood and urine samples collected.
Sample size power: not stated.
Dose: 100g/day.
Duration: 1 year.

II
Confirmatory

Statistically significant increase in
bone mineral density of ulna and
spine with decreased serum levels
in bone turnover markers (bonespecific alkaline phosphatase and
tartrate-resistant acid
phosphatase-5b) observed.

Arjmandi et al., 2002
[115]

USA

Dried plum
(P.Domestica)

Hypothesis: Addition of dried plums to the
diets of postmenopausal women would
positively influence markers of bone turnover.
n=58 postmenopausal women.
Study design/Methods: Randomized
controlled trial. Postmenopausal women
randomly assigned to treatment groups of dried
plum (100g/d) or dried apple (75g) daily for 3
months. Blood and urine samples collected.
Sample size power: not stated
Dose: 100g/day.
Duration: 3 months.

II
Exploratory

Statistically significant increase
in serum levels of insulin-like
growth factor-1 (IGF-1) and
bone-specific alkaline
phosphatase associated with
increased rates of bone
formation.

Hooshmand et al., 2014
[128]

USA

Dried plum
(P.Domestica)

Hypothesis: Dried plum has an effect on
circulating levels of sclerostin and bone
metabolism measured in serum levels of
RANKL (receptor activator of NF-kB ligand)
and OPG (osteopotegerin).
n=160 women with mild bone loss.
Study design/Methods: RCT. Subjects
randomly assigned to one of 2 groups of dried

II
Exploratory

Increase in bone mineral density
of the ulna and spine and also
the RANKL and OPG levels. A
reduction in in serum sclerostin
was also observed.
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Reference

Location

Plum product
investigated

Sample/Method

Level of
evidence*

Effects observed

plum or dried apple and provided with 500mg
Caplus 400 IU (10µg) vitamin D.
Sample size power: not stated.
Dose: 100g dried plum per day.
Duration: 1 year.
Simonavice et al., 2014
[123]

USA

Dried plum
(P.Domestica)

Hypothesis: 6-month intervention with
resistance training (RT) and a combination of
resistance training and dried plum (DP) would
improve total and regional (lumbar spine,
femur, and forearm) BMD. Increase lean body
mass, skeletal muscular strength and decrease
fat body mass. Additionally, it was
hypothesized that the biochemical analyses for
both groups would reveal increased levels of
bone formation markers, decreased levels of
bone resorption markers, and decreased levels
of inflammation markers, with the RT+DP
group having the most improvements in these
areas in breast cancer survivors.
n=23 female breast cancer survivors.
Study design/Methods: Case-control. Subjects
stratified into 1(RT) or 2(RT+DP) treatment
groups.
Sample size power: not stated
Dose: 90g dried plum per day
Duration: 6 months.

II
Exploratory

No difference between groups
or any group-by-time interaction
observed for any of the
variables.

*Only clinical trials were ranked for level of evidence
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2.1.3.2 Antioxidant and anti-inflammatory activity

The antioxidant property of plums has mostly been attributed to its high phenolic content [129, 130].
Research on this health effect has mostly been carried out with the ripe plum fruit or its products. However,
evidence has shown that immature plums may contain higher levels of polyphenols with more significant
antimicrobial, antioxidant, and antitumor properties in comparison to mature plums [131]. Studying the
antioxidant effect of immature plum extract (IPE) on selected cancer cells in vitro, it was observed that
even though the IPE was effective in inhibiting growth of the cancer cells (Human hepatocellular
carcinoma HepG2 cells, Kato III gastric cancer cells, HeLa human cervical carcinoma cells, U937
leukaemia cells, and MCF 7 hormone-dependent breast cancer cells). This inhibitory effect was not
observed in the hormone dependent breast cancer cells and as the fruit ripened, there was a reduction in its
inhibitory effect [131]. Another study [102] aimed to identify the phenolic fraction responsible for the
potential chemo-preventive and/or chemotherapeutic action in plum. The authors observed that all extract
fractions were effective in exerting antioxidant effect on studied cancer cell lines, with the flavonols and
procyanidins more effective than the phenolic acids and anthocyanins. In addition, a similar study
suggested that the synergistic effect of the total phenolic content of the plum extract significantly increased
its antioxidant activity [130].

Investigating this antioxidant effect on human colon cancer cells using prune [132] and plum extract [130],
there was no significant reduction in the viable cell number of the human normal colon fibroblast cells
while inducing apoptosis of cancer cells. Similar results were also observed with breast cancer cell lines
[102]. These results have also been confirmed in animal studies with immature plum extract (IPE)
inhibiting the growth of hepatoma HepG2 cells as well as exerting a protective effect against
benzo(α)pyrene induced liver toxicity by decreasing serum aminotransferase and hepatic contents of lipid
peroxide [133]. In addition, an anti-ulcer effect has also been observed in Wistar albino rats. Following a 7day feed with 100, 150 or 200mg kg-1 of plum extract, peptic ulcer was induced by pyloric ligation. Results
from gastric ulcerative index estimation showed that the group pre-treated with plum extract had a
significantly reduced gastric volume and a significantly lower ulcerative index [134]. This anti-ulcer effect
has also been observed in an acute setting following oral treatments including prune polysaccharides which
showed a reduction and inhibition of the gastric lesion area. [135]. Further investigation on the effect of
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plum on colon cancer risk factors showed that even though dietary supplementation with dried plum
showed no inhibitory effect on aberrant crypt foci formation at the initiation stage of cancer and early
progression, it was able to inhibit several risk factors associated with colon carcinogenesis. These include
reduction in faecal total and secondary bile acid concentration, decrease in colonic β-glucuronidase and 7αdehydroxylase activities and increased antioxidant activities [136].

Even though similar results have been observed in in vitro and animal studies, results from human trials
have not been in agreement. A study that investigated the plasma antioxidant capacity changes after a meal
observed that consumption of a meal containing dried plum or dried plum juice did not alter plasma
antioxidant capacity (hydrophilic and lipophilic ORACFL) [137]. Contrary to this, another study observed
that 9 different fruit juices, including plum juice, exhibited significant antioxidant effects in human plasma
within 30 mins of consumption by suppressing reactive oxygen species generation [129]. Similar effects
were also observed in young, middle-aged and elderly adults after consumption of 195g of plum twice a
day for 5 days [138] and QGP juice in an acute setting [107].
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Table 2-3: Evidence on the anti-cancerous and anti-inflammatory properties of plums and its associated products

Reference
In vitro studies
Yu et al., 2009 [101]

Noratto et al., 2009
[102]

Location

Plum product
investigated

Korea

Immature Plum
extract (IPE)
(P.Salicina)

USA

Level of
evidence*

Effects observed

Human hepatocellular carcinoma HepG2
cells, Kato III gastric cancer cells, HeLa
human cervical carcinoma cells, U937
leukaemia cells, and MCF 7 hormonedependent breast cancer cells.

NA

Cell growth inhibition by IPE i.e. induction
of cancerous cell apoptosis.

Mature redfleshed plum
extract
(P. Domestica)

MCF-7; the estrogen-positive human breast
cancer cell line, MDA-MB-453; the estrogen
negative human breast cancer cell line, and
MCF-10A; the breast epithelial cells.

NA

Inhibition of breast cancer cell
proliferation and significantly reduced
toxicity on the normal cells.

USA

Plum extract
(P.Salicina)

Chicken spleen, RP9 tumour cells and HD11
macrophages.

NA

Stimulation of spleen lymphocyte
proliferation and NO production by
cultured macrophages and inhibition of
tumour cell growth.

Japan

Prune extract
(P. Domestica)

Caco-2 human colon carcinoma cell line,
KATO III human stomach carcinoma cell line
and CCD-18Co normal human colon
fibroblast cell line

NA

Induction of cell apoptosis of cancer cells
but not normal cells.

USA

Plum extract
(P. Domestica)

SW1116, HT29, Caco-2 human colon cancer
cells and NCM460 human colon cells.

NA

Growth inhibition and induction of
differentiation on colon cancer cells.

USA

Dried Plum
polyphenol
extract
(P. Domestica)

Stimulation of macrophage RAW 264.7 cells
with either 1µg mL-1 (for measurement of NO
production) or 1ng mL-1 (for measurement of
COX-2 expression) of lipopolysaccharide
(LPS) to induce inflammation and treated
with different doses of dried plum
polyphenols.

NA

Reduction in Nitric oxide and
malondialdehyde production with highest
dose treatment (1000 µg mL-1). Reduction
in LPS-induced expression of COX-2 by
the 100 and 1000 µg mL-1 dose.

Lee et al., 2009
[139]

Fujii et al., 2006
[132]

Lea et al., 2008
[130]
Hooshmand et al., 2015
[140]

Sample/Method

36

Reference

Location

Plum product
investigated

Sample/Method

Level of
evidence*

USA

Plum
polyphenol
extract
(P. Domestica)

Treatment of two cancer cell lines (HepG2
human liver cancer cells and DLD1 human
colon cancer cells) with polyphenol extract of
plum.

NA

Antiproliferative activities on both cancer
cell lines in a dose dependent manner.

Japan

Plum pectin
extract
(P. Domestica)

Incubation of heparan sulfate in differentiated
Caco-2 cells with pectin extracted from
plums.

NA

There was an obvious change in the
sulphated structures of HS following pectin
administration. Also, pectin upregulated
human HS 6-O-endosulfatase-2 (HSulf-2)
expression and inhibited HSulf-1
expression.

Japan

Plum pectin
extract
(P. Domestica)

Incubation of differentiated Caco-2 cells
(cultured in 6-well plates at a cell density of
1.0x105 cells/well), with pectin, extracted
from plums.

NA

Pectin-treated differentiated Caco-2 cells
promoted growth of IEC-6 cells and also
an upregulation of relative mRNA and
protein expression levels of Wnt3a protein.

Russia

Plum pectic
polysaccharide
extract
(P. Domestica)

0.05mL of plum pectic polysaccharide added
to peritoneal cell suspension and incubated in
a 96-well flat-bottom tissue culture plate in
the absence or presence of phorbol-12myristate-13-acetate at 37oC for 15 mins.

NA

Reduction in the adhesion of peritoneal
leukocytes. Inhibition of the production of
superoxide anion radicals by reducing
xanthine oxidase activity.

USA

Plum
polyphenol
extract
(P. Domestica)

Oestrogen independent MDA-MB-435,
estrogen dependent MCF-7 breast cancer cell
lines and one non-cancerous breast line MCF10A exposed to varying concentrations of
plum extracts for 24 hours.

NA

Dose-dependent cytotoxic effect against
MDA-MB-435, weak activity against
MCF-7 and small or no activity against
MCF-10A observed.

Korea

Immature, midmature and
mature plum
extract
(P.Salicina)

6 human cell cancer lines (Hep G2 human
hepatocellular carcinoma cells and Kato 111
human gastric carcinoma cells, Hela human
cervical carcinoma cells, U937 human
leukemia cells, MCF 7 hormone-dependent
human breast cancer cells, and MDA-MB-231

NA

Cytotoxic effects observed, and apoptosis
observed in MDA-MB-231 cells mediated
by the immature plum extract.

Kim et al., 2003
[141]

Nishida et al., 2014
[142]

Nishida et al., 2015
[143]

Popov et al., 2014
[144]

Vizzotto et al., 2014
[145]

Yu et al., 2007
[131]

Effects observed
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Reference

Location

Plum product
investigated

Sample/Method

Level of
evidence*

Effects observed

hormone-independent human breast cancer
cells) incubated with varying concentration of
plum extract.
Korea

Immature plum
extract
(P.Salicina)

Incubation of PMA-induced HepG2 human
hepatocellular carcinoma cells with Immature
plum extract.

NA

Antimigrative property in (phorbol 12myristate 13-acetate) PMA-induced
HepG2 cells observed. A strong inhibitory
effect on the PMA-induced MMP-9
secretion through suppression of the
transcriptional activity of the MMP-9 gene
independently of the TIMP gene in HepG2
cells was also observed.

Korea

Immature plum
extract (IPE)
(P.Salicina)

Intraperitoneal injection of IPE (2.5 or 5 g/kg
bw/day) dissolved in phosphate buffered
saline for 5 days in male mice with
benzo(α)pyrene induced liver toxicity.

NA

Chemopreventive efficacy by inhibiting the
induction of CYP1A1 expression and
reducing the activity of glutathione
peroxidase, superoxide dismutase and
catalase.

Brazil

Polysaccharides
from prunes
(P. Domestica)

Inducement of acute gastric ulcer in rats using
intragastric administration of ethanol P.A.
after 4 different oral treatments including
polysaccharides from prunes fraction (3 and
10 mg/kg).

NA

Reduction and inhibition of gastric lesion
area by prune polysaccharides fractions.

USA

Plum juice
(P.Salicina)

Administration of plum juice in drinking
water to obese Zucker rats ad libitum for 11
weeks.

NA

Antiadipogenic and anti-inflammatory
effects. Reduction in blood glucose,
triglycerides and HDL cholesterol levels.

India

Plum extract
(P. Domestica)

Inducement of peptic ulcer by pyloric ligation
in Wistar albino rats after administration of
plum extracts (100, 150 or 200mgkg-1) for 7
days.

NA

Antioxidant and anti-ulcerogenic activity.

USA

Dried plum
(P. Domestica)

Dietary supplementation of dried plum (4.75
or 9.5%) in male Wistar rats for 10 days

NA

Inhibition of risk factors associated with
colon carcinogenesis (reduction in faecal

Yu et al., 2009b
[146]

Animal Studies
Kim et al., 2008
[133]

Cantu-Jungles et al.,
2014 [135]

Noratto et al., 2015
[147]

Mishra et al., 2012
[134]

Yang and Gallaher,
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Reference

Location

Plum product
investigated

2005 [136]

Gallaher and Gallaher,
2009 [148]
Clinical trial
Kasim-Karakas et al.,
2002 [149]

Sample/Method

Level of
evidence*

Effects observed

followed by administration of 2 doses (1wk
apart) of azoxymethane and dietary
supplementation for 9 more weeks.

total and secondary bile acids
concentration, reduction in colonic βglucuronidase and 7α-dehydroxylase
activities and increased antioxidant
activity).
Development of atherosclerosis Impeded.

USA

Dried plum
(P. Domestica)

Dietary supplementation of dried plum (4.75
or 9.5%) and cholesterol in apolipoprotein Edeficient mice for 5months.

USA

Dried plum
(P. Domestica)

Hypothesis: Prune intake may alter the
metabolism of estrogens because prunes are a
rich source of both soluble and insoluble fibre
and cinnamates and decrease intestinal transit
time.
n=19 healthy premenopausal women
Study design/Methods: Crossover study.
After consuming habitual diets for 3
menstrual cycles (control run-in period),
participants replaced dietary simple sugars
with prunes for another 3 menstrual cycles
(intervention period).
Sample size power: not stated
Dose: 100g dried plum per day
Duration: 6 months.

III-2
Exploratory

Decrease in the independent excretion of
2OHE1 and 16αOHE1 observed but not
statistically significant change in the
2OHE1 - 16αOHE1 ratio following prune
supplementation.

*Only clinical trials were ranked for level of evidence
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2.1.3.3 Cognitive improvement

Cognitive improvement associated with consumption of plum has not been extensively studied in humans.
Most of the available evidence is from animal studies. This effect on cognition has mainly been attributed
to the antioxidant property of plums as a result its high polyphenolic content. In a study in which four
groups of mice were fed a high cholesterol diet, with either 2% or 5% plum powder supplementation, a
significant difference was observed in the time taken to complete the Morris water maze task between the
group fed just the high cholesterol diet and the control group, as well as both the 5% and 2% plum powder
supplementation groups [150]. A similar study reported slightly contradictory results when comparing the
effects of 100% plum juice and 2% dried plum powder supplementation to modify age-related deficits in
cognitive function in aged rats. It was observed that there was an improvement in cognition with the plum
juice, but not with the dried plum powder [105].

Using plum extract to supplement the diets of three groups of mice with different doses (75, 100,
150mg/kg), there was a statistically significant difference in the number of trials to acquisition in the
passive avoidance test (evaluates learning and memory) between the control group and the plum extract
treated groups. The retention test also showed that the treated groups had increased STLr (step through
latency in the retention) in comparison to the control group [151]. These results are in line with similar
animal studies [152, 153] that demonstrate a beneficial health effect of plum on cognition.

Examining the effect of chlorogenic acid from plums on anxiety-related behaviours in mice using the
light/dark test, the elevated plus maze and the free exploratory test, results showed a decrease in anxiety
related behaviours (anxiolytic-like effect) and protection of granulocytes (white blood cells) from oxidative
stress. Plum consumption protected against oxidative stress induced by radiation with special attention to
spatial learning [154]. A different study observed that plum possesses prophylactic ability against
radiation-induced metabolic disorders, and its consumption also improved spatial learning. Exposed mice
that had received plum performed better by taking less time to reach the coloured platform in the circular
water tank apparatus (proxy for spatial learning and memory) [152]. Similarly, the effect of plum
consumption for 2 months on cognitive performance and expression of cerebral neurodegeneration-related
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protein in streptozotocin-induced diabetic rats has also been studied. Cognitive performance, assessed
using the Morris water maze, showed that the plum supplemented diet had a significant beneficial effect on
spatial memory and learning. There was also a significant reduction in expression of cerebral beta-amyloid
which is evident in Alzheimer’s disease. Significant decreases in hyperglycaemia, insulin resistance and
oxidative stress in the sample of rats were also observed [153].
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Table 2-4: Evidence on the antioxidant property and effect on cognition of plums and its associated products

Reference

Location

Plum product
investigated

Sample/Method

Level of
evidence*

In vitro studies
Bouayed et al., 2009
[155]

France

Phenolics from
plums
(prunus
domestica)

Polyphenolics extracted from 7 varieties of
plum and quantified. Their antiradical
activities and protection against oxidative
stress evaluated in peripheral blood
granulocytes.

NA

Antioxidant activity and protection of
blood granulocytes from H2O2-induced
oxidative stress by preventing
granulocytes from intracellular ROS
accumulation.

USA

Prune/ prune
juice extract
(prunus
domestica)

Human LDL from plasma prepared from
blood collected from healthy volunteers.

NA

Inhibition of LDL oxidation.

USA

Plum juice/dried
plum powder
(P. Domestica)

Two groups of aged rats with either
consumption of a mixture of water and
plum juice (100%) (Group 1) or dietary
supplementation with dried plum powder
(2%) (group 2) for 8 weeks

NA

Improved cognitive function assessed by
Morris Water Maze.

(Shahidi et al., 2013
[151]

Iran

Plum extract
(P. Domestica)

Plum extracts (75, 100, 150 mg/kg)
administration by oral gavage to male mice
once a day for 7 days

NA

Improvement in learning and memory in
mice assessed by the passive avoidance
test.

Kao-Ting et al., 2013
[153]

Taiwan

Dried plum
powder
(P.Salicina)

Dietary supplementation of dried plum
powder (2%) in
nicotinamide/streptozotocin-induced
diabetic rats for 2 months

NA

Improvement in cognitive performance,
antioxidant activity and improvement in
insulin sensitivity.

Sharma and Sisodia,
2013 [152]

India

Plum extract
(P. Domestica)

Administration of optimum dose of plum
extract in distilled water to mice for 15
days pre/post whole-body exposure to 10
Gy gamma-radiations

NA

Antioxidant capabilities and improved
spatial learning.

Donovan et al., 1998
[156]

Animal Studies
Shukitt-Hale et al.,
2009 [105]

Effects observed
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Reference

Location

Bouayed et al., 2007
[154]

France

Plum product
investigated
Chlorogenic acid
from prunus
domestica

Sample/Method
Administration of chlorogenic acid
(20mg/kg) to mice and antioxidant effect
on peripheral blood granulocytes.

Level of
evidence*
NA

Clinical trials

Effects observed
Decrease in anxiety related behaviours
(anxiolytic-like effect) and protection of
granulocytes from oxidative stress by
chlorogenic acid in vitro.

Prior et al., 2007
[137]

USA

Dried plum/dried
plum juice
(P. Domestica)

Hypothesis: Changes in AOC following
consumption of plum juice may be used to
assess its potential to alter in vivo
antioxidant status and provide estimates of
dietary antioxidants necessary to prevent
postprandial oxidative stress.
n=6 healthy volunteers.
Study design/Methods: Randomized
cross-over study. Fasting blood sample
collected, and participants fed test juices
and blood samples collected at 1, 2, and 4
h post juice consumption.
Sample size power: not stated
Dose: 315 mL of dried plum juice (DPJ);
or dried plums (DP) (131 g blended in 315
mL water
Duration: 2 weeks (with 2 weeks washout
period)

II
Exploratory

No effect on plasma hydrophilic (H-) or
lipophilic (L-) antioxidant capacity
measured as Oxygen Radical Absorbance
Capacity (ORACFL).

Ko et al., 2005
[129]

Korea

Plum juice
(P.Salicina)

Hypothesis: Consumption of fruit juices
could scavenge ROS generated in human
plasma.
n=10 healthy men.
Study design/Methods: Cross-over study.
Consumption of single dose of 150mL of
plum juice. Blood samples collected at 0,
30, 60, 90, and 120 minutes after
consumption
Sample size power: not stated
Dose: A single dose of 150mL
Duration: 1 day (with 1-day washout

IV
Exploratory

Improved antioxidant activity in human
plasma measured by dichlorofluorescein
(DCF) fluorescence.
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Reference

Location

Plum product
investigated

Sample/Method

Level of
evidence*

Effects observed

period)
González-Flores et al.,
2011 [138]

Netzel et al., 2012)
[107]

Spain

Plum
(P.Salicina)

Hypothesis: There is a possible
antioxidant effect associated with diets
enriched with Japanese plums (Prunus
salicina Lindl. cv. Crimson Globe) in
young, middle-aged and elderly
individuals.
n=18(6 per young, middle aged and older
group).
Study design/Methods: Consumption of
plums (390 g/d) divided into two
portions: lunch dessert (195g) and dinner
dessert (195g) for 5 days. First-void
morning urines were collected before
treatment (basal values), the immediate
day after the last ingestion of plums
(assay) and 1 day afterwards (post-assay).
Sample size power: not stated
Dose: 2 portions 390g (195g each) daily.
Duration: 5days.

IV
Exploratory

Statistically significant increase in
antioxidant capacity and urinary 6sulfatoxymelatonin (aMT6-s).

Australia

Plum juice
(P.Salicina)

Hypothesis: There is a possible
antioxidant effect associated with QGPJ
ingestion on the urinary antioxidant
capacity and the concentration of
malondialdehyde, a biomarker for
oxidative stress.
n=2 healthy male subjects
Study design/Methods: Crossover study.
Consumption of 400 mL of QGPJ or 400
mL of water
Sample size power: not stated
Dose: single dose of 400mL.
Duration: 1 week (1week washout
period).

IV
Exploratory

Increase in urinary antioxidant capacity
and decrease in malondialdehyde
excretion (biomarker for oxidative
stress).
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2.1.3.4 Cardiovascular disease risk factors

Insulin resistance, a major risk factor for metabolic syndrome and selected cancers presents a major public
health concern [157]. Studying the beneficial health effects of plums on CVD risk factors, Noratto et al.
[147] compared the effect of plum juice with peach juice and a placebo group which received the same
amount of sugar in either peach or plum juice in obese Zucker rats. Their results showed that the plum juice
group had the lowest weight gain and also that plum polyphenols exerted the highest anti-adipogenic and
anti-inflammatory effects in fat tissues. This provides evidence of the reduction of mRNA (messenger
Ribonucleic acid) levels of PPAR (peroxisome proliferator activated receptor) associated with plum intake.

Negishi et al. (2007) [158] studied the effect of prune extract on blood pressure elevation in stroke-prone
spontaneously hypertensive rats for 5 weeks. They observed that prune extract supplementation in diet
suppressed the elevation of systolic blood pressure but not diastolic blood pressure. A study by Gallaher
and Gallaher (2009) [148] on apoE-deficient mice, known to be susceptible to rapid development of
atherosclerotic lesions when fed cholesterol, investigated the ability of dried plum supplementation to
reduce atherosclerosis. The percentage arterial tree atherosclerotic lesion area was significantly lower in
groups fed the dried plum supplemented diet (4.75%), either with or without cholesterol, compared to the
group fed cholesterol without dried plum supplementation.

In human trials, results have been inconclusive. Chai et al. (2012) [159] studied the effect of daily dried
plum consumption in comparison to dried apple on cardiovascular disease risk factors in postmenopausal
women over a 1-year period. Results showed that serum total cholesterol levels were significantly lower in
the dried apple group in comparison to the dried plum group only at 6 months. There was also a
cholesterol-lowering effect for serum total and low-density lipoprotein cholesterol at 12 months, but this
was not significant. Neither dried apple nor dried plum had a significant effect on the serum levels of
atherogenic cholesterol. Contrary to this observation, Tinker et al. (1991) [92] observed that in adult men
with mild hypercholesterolemia, supplementation with prunes significantly lowered plasma low-density
lipoprotein cholesterol compared to a grape juice control group. A significantly lower faecal bile acid
concentration of lithocholic acid was also reported.
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Regarding the effect of prunes on high blood pressure, Ahmed et al. (2010) [160] conducted a study with
three groups of pre-hypertensive patients who were randomized to receive on a daily basis, either a single
dose of prunes (11.5g), a double dose (23g) or a glass of water (control) for 8 weeks. Participants who
received either the single dose or a glass of water on empty stomach in the morning showed significant
reduction in both systolic and diastolic BP, while the double dose was associated with only a reduction in
systolic blood pressure. The control (water) group also had significant increase in serum HDL that was not
seen by prune treated groups. The authors attributed this placebo effect to the common factor between
intervention and control- water.

Santhakumar et al.,(2015) [85] observed an inhibition of platelet aggregation induced by adenosine
diphosphate, collagen and arachidonic acid from plum juice supplementation with Queen Garnet plum that
has higher anthocyanin concentrations than the usual variant.

2.1.3.5 Laxative effect

With a focus on the laxative effect of prunes, Piirainen et al. [161] studied the effect of prunes on
individuals with mild gastrointestinal symptoms. This study observed that consumption of prune juice
reduced the occurrence of difficulty in defaecation. Similarly, consumption of a daily portion of plum juice
before a meal in adults with chronic constipation softened the stool, provided immediate relief and
participants showed more preference to prune juice than apple juice [162]. Similar results were also
observed with dried plum in patients with mild to moderate constipation by Attaluri et al. [163] in which
the effect was attributed to a synergistic effect provided by sorbitol, dietary fibre and polyphenols.
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Table 2-5: Evidence on the effect of plums and its associated products on the different components of metabolic syndrome

Reference
Animal studies
Negishi et al., 2007
[158]

Kuo et al., 2015
[150]

Lucas et al., 2000
[164]

Clinical trials
(Tinker et al., 1991
[92]

Location

Plum product
investigated

Japan

Prune extract
(P. Domestica)

Dietary supplementation of prune extract
(25%) in stroke-prone spontaneously
hypertensive (SHRSP) rats for 5 weeks

NA

Suppression of High (systolic) blood
pressure.

Plum powder
(P.Salicina)

Dietary supplementation of plum powder
(2% or 5%) in high cholesterol diet in mice
for 5 months

NA

Amelioration of some symptoms of
neurodegenerative conditions like
increased cholesterol and β-amyloid (Aβ)
concentration in the brain by both doses.

USA

Dried Plums
(P. Domestica)

Dietary supplementation (5% or 25% dried
plum) with dried plum in 48 ovariectomized
(ovx) 90-day old female Sprague-Dawley rats
for 45 days.

NA

With elevated serum total cholesterol
brought about by ovariectomy, 25% prune
diet prevented this increase without
affecting HDL cholesterol concentration
and also reduction in liver total lipids was
observed.

USA

Dried Plums
(P. Domestica)

Hypothesis: a) Prunes as a source of fibre
can lower plasma cholesterol in men with
mild to moderate hypercholesterolemia (5.27.5 mmol cholesterol/L). b) Faecal bile acid
excretion is increased in response to the
ingestion of prunes as a source of fibre which
may help explain the cholesterol lowering
effect of fibre.
n=41 free living men with mild
hypercholesterolemia.
Study design/Methods: Crossover study. 8
wk period split into two experimental diet
periods; each lasting 4 wk. Subjects
randomly assigned a diet sequence, starting
with either consumption of a grape juicecontrol supplement (GJ control) or a prune

II
Confirmatory

Plasma LDL- cholesterol was statistically
significantly reduced after the prune
period than the control, faecal bile acid
conc. of lithocholic acid was also
statistically significantly lower with prune
consumption and both faecal wet and dry
weights were statistically significantly
higher with prune consumption.

Taiwan

Sample/Method

Level of
evidence*

Effects observed/Conclusion
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Reference

Location

Plum product
investigated

Sample/Method

Level of
evidence*

Effects observed/Conclusion

supplement.
Sample size power: not stated
Dose: 12 prunes (~100 g/d)
Duration: 8 weeks.
Chai et al., 2012
[159]

USA

Dried Plums
(P. Domestica)

Hypothesis: Regular intake of apple
favourably improves lipid profiles, reduces
atherogenic risk ratios, lowers C-reactive
protein (CRP) levels, and decreases levels of
oxidative stress marker in postmenopausal
women
n=160 postmenopausal women
Study design/Methods: Case-control study.
Subjects randomly assigned to treatment
groups of dried apples (75g) or dried plum
(100g/d)
Sample size power: 95%
Dose: 100g/day
Duration: 1 year.

II
Exploratory

No statistically significant difference
between treatment groups in altering
serum levels of atherogenic cholesterols
observed. For the dried apple group, total
cholesterol was statistically significantly
reduced at 6mth.

Afaghi et al., 2009
[165]

Iran

Prunes

Hypothesis: 8 fruits (Golab apples, Green
apples, fresh apricots, prunes, cherries,
blueberries, Golden no-seed grapes, and Red
sultanas) are low GI and recommendable for
diabetics and weight loss.
n=8
Study design/Methods: Crossover study. 8
subjects (healthy, young men aged 20-28,
normal weight with body mass index: 20-25
Kg/m2) randomly assigned to one of 8 fruits
and blood glucose measured at 0, 15, 30,
45,60, 90 and 120 mins after consumption.
Sample size power: 95%
Dose: 143g
Duration: Not stated - Different occasions
after overnight fasting.

II
Exploratory

Serving size of prunes was low glycemic
load (GL) fruit. Prunes among other tested
fruits were low GI and can be
recommended for diabetics and weight
loss management.
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Reference

Ahmed et al., 2010
[160]

(Santhakumar et al.,
2015 [85]

Location

Plum product
investigated

Sample/Method

Level of
evidence*

Effects observed/Conclusion

Pakistan

Prunes
(P. Domestica)

Hypothesis: Use of prunes is useful in
cardiovascular disorders to bring about
changes in blood pressure or prevention of
atherosclerosis.
n=259 pre-hypertensive patients (BP
=120/80–139/89 mmHg)
Study design/Methods: RCT. Patients
randomly assigned to 3 groups of A-single
dose, B-double dose or C- control group.
Blood pressure was recorded fortnightly, and
blood samples were taken at 0 and 8 weeks.
Sample size power: Not stated.
Dose: group A-11.5gm. Group B-23gm.
Control- glass of water.
Duration: 8 weeks.

II
Confirmatory

Reduction of blood pressure (6mmHg
drop) by single dose of prunes daily group
and the controls with the double dose of
prunes showing a reduction in just systolic
BP. There was an increase in serum HDL
of the control group whereas test groups
had significantly reduced serum
cholesterol and LDL. The data predicts
cardiovascular protective effects of
prunes.

Plum juice
(P.Salicina)

Hypothesis: Anthocyanin-rich Queen Garnet
Plum Juice may ameliorate platelet activation
related thrombogenesis and maintain
haemostatic function by: (1) reducing platelet
aggregation and activation through
blocking/inhibiting various platelet activation
pathways; (2) prolonging clotting time and
reducing fibrinogen concentration; and (3)
exhibiting favourable effects on lipid profile
and inflammation.
n= 21
Study design/Methods: Randomised, double
blind, placebo Crossover Trial. Healthy
volunteers randomly assigned to 3
supplement groups of A-Queen Garnet plum
juice, B-prune juice or C- colour matched
placebo. Blood samples were collected at
least 8h pre-prandial and mid-stream fasting
urine samples collected.

II
Exploratory

QGPJ supplementation inhibited platelet
aggregation induced by adenosine
diphosphate (ADP), collagen and
arachidonic acid. There was reduction in
platelet activation-dependent surfacemarker P-selectin expression of activated
de-granulated platelets. Increase in
activated partial thromboplastin clotting
time and reduction in plasma-fibrinogen
and malondialdehyde levels, a plasma
biomarker of oxidative stress. Prune juice
supplementation did not affect blood cell
counts, lipid proﬁle, or inﬂammation
markers

Australia
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Reference

Location

Plum product
investigated

Sample/Method

Level of
evidence*

Effects observed/Conclusion

Sample size power: Not stated.
Dose: 200mL/day of each juice.
Duration: 28 days with 2 weeks washout
period.
Santhakumar et al., 2015
[166]

Australia

Plum juice
(P.Salicina)

Hypothesis: Anthocyanin-rich QGPJ may
impart anti-thrombotic effects via (a)
inhibition of platelet aggregation by
simultaneously targeting different platelet
activation pathways (adenosine diphosphate:
ADP-P2Y12/P2Y1; collagen: GPVI/α2β1
and arachidonic acid: cyclooxygenase-1–
COX-1), (b) reducing platelet hyperactivation and de-granulation by blocking
surface receptors responsible for activation,
and (c) favourably altering coagulation
parameters and lipid profile.
n= 13
Study design/Methods: Randomised, double
blind, placebo Crossover Trial. Healthy
volunteers randomly assigned to 2
supplement groups of A-Queen Garnet plum
juice or B-a flavoured and coloured
formulated cordial placebo. Oxidative stress
was induced by constant load exercise bout
for 1h at 70% of their VO2PEAK Blood
samples were collected at fasting state and at
least 8-12h pre-prandial on day 1 and day 29.
Sample size power: Not stated. Dose:
200mL/day of each juice.
Duration: 28 days with 2 weeks washout
period.

II
Exploratory

QGPJ supplementation inhibited
adenosine diphosphate-induced platelet
aggregation both without and under
exercise induced oxidative stress, as well
as inhibition of arachidonic acid-induced
aggregation under oxidative stress. Also,
there was reduced platelet activation
dependant P-selectin expression both
without and under oxidative stress.
Favourable effects on coagulation
parameters both with and without
oxidative stress were also observed for
QGPJ.
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Table 2-6: Evidence on the satiety and laxative effect of plums and its associated products
Reference
Clinical trials
Piirainen et al., 2007
[161]

(Cheskin et al., 2009
[162]

Location

Plum product
investigated

Sample/Method

Level of
evidence*

Effects observed

Finland

Prune juice
(prepared from
plum juice
concentrate,
prune puree,
water and 7%
fructose)
(P. Domestica)

Hypothesis: prune juice alone may have a
laxative effect on the bowel function of those
adults with certain gastrointestinal symptoms
but are otherwise healthy.
n=54 volunteers with mild GIT symptoms.
Study design/methods: 1-week baseline
period, 2-week prune juice (consumption)
period followed by 1week follow-up period
with daily record of bowel habit
Sample size power: not stated.
Dose: 125 mL twice a day.
Duration: 4 weeks.

IV
Confirmatory

Laxative effect with increased flatulence.

USA

Plum juice
(P. Domestica)

Hypothesis: Plum juice supplementation diet
would induce significant improvements in
bowel frequency, and consistency, and
possibly decrease appetite compared to
baseline as well as placebo and psyllium
treatments.
n=36 adults with chronic constipation
symptoms.
Study design/Methods: Randomized
controlled crossover trial. Consumption of a
daily portion of plum juice in comparison to
psyllium and apple juice in adults with
chronic constipation symptoms.
Sample size power: Not stated.
Dose: 8 ounces (237mL) per day.
Duration: 14days.

II
Confirmatory

Constipation relief and stool softening
evident with consumption of plum juice.
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Reference

Location

Attaluri et al., 2011)
[163]

USA

Farajian et. al., 2010
[167]

Greece

Plum product
investigated
Dried plum
(P. Domestica)

Prunes
(P. Domestica)

Sample/Method
Hypothesis: Dried plums are as effective as
psyllium in the treatment of adults with
chronic constipation.
n=40 patients with chronic constipation.
Study design/Methods: Single blind,
randomized cross-over study. Consumption
of a daily portion of dried plums or psyllium
for a treatment period of 3 weeks after which
participants continued on their usual
remedies for constipation for another 6
weeks. For the duration of the study, subjects
maintained daily symptom and stool diaries.
Sample size power: 80%.
Dose: 50 g twice a day with meals.
Duration: 14 weeks (with 1-week washout
period between treatments).
Hypothesis: A preload including dried
prunes consumed as a snack before a meal,
compared to an isoenergetic bread product
preload, would reduce; a) meal time energy
intake,
b) appetite for dessert offered after lunch and,
c) energy intake for the next 24 h.
n=45 normal weight subjects.
Study design/Methods: Randomized crossover study. Fasting participants offered a
standardized breakfast followed by a preload
of either dried prunes or bread product after 2
hours. 3 hours after the preload, a
standardized lunch and desert was provided.
Subjects also rated their hunger, thirst, desire
to eat, motivation to eat and satiety on 100
mm line visual analogue scales (VAS) just
before and right after the preload
consumption, every 45 min up till the 180th

Level of
evidence*
II
Confirmatory

II
Exploratory

Effects observed
Effective treatment with dried plum on
mild to moderate constipation observed.

Reduced consumption of dessert with
lower energy intake observed. An
Increased satiety at all time points between
snack and meal was also observed.
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Reference

Location

Plum product
investigated

Sample/Method

Level of
evidence*

Effects observed

min. On completion of the test day, detailed
record of all foods and beverages intake for
the next 24 h was collected.
Sample size power: not stated.
Dose: 5 prunes (40g) before meals on each
testing day.
Duration: 2 days (with 1-week washout
period).
Furchner-Evanson et al.,
2010 [168]

USA

Dried plum
(P. Domestica)

Hypothesis: Snack choices similar in fat,
protein, carbohydrate and sugar contents
while differing in fibre content have an effect
on satiety, subsequent food intake and plasma
glucose, insulin and ghrelin responses.
n=19 healthy female subjects
Study design/Methods: Randomized
crossover study with at least 1-day washout.
Subjects randomly assigned to receive 4
different test foods including dried plums.
Blood samples collected at baseline and
every 15mins in 1hr then 90 and 120 mins.
Sample size power: Not stated.
Dose: served in a 238kcal (1000kj) portion.
Duration: not stated.

II
Exploratory

Satiety index AUC greater for dried plum
trial. Consumption of the dried plum
elicited lower plasma glucose and insulin
AUC and tended to promote a greater
plasma ghrelin AOC.

Howarth et al., 2010
[169]

USA

Dried plum
(P. Domestica)

Hypothesis: Snack selection (dried plums vs
common carbohydrate-rich low-fat cookies)
influences daily energy consumption, nutrient
intake and metabolic responses.
n=26 healthy female subjects
Study design/Methods: Randomized
crossover study with 2 weeks washout.
Subjects randomly assigned to receive either
dried plums or low-fat cookies for 2 separate
2-week feeding. A 7-day bowel habit
questionnaire was completed.

II
Exploratory

No change observed with energy intake or
weight. In comparison to cookie, dried
plum promoted greater intake of fibre,
potassium, riboflavin, niacin and calcium.
There was an observed reduction in total
fat as well as cholesterol intake with dried
plum snacks. Dried plum did not alter
plasma triglyceride concentration, but
softer stool consistency was observed with
dried plum consumption.
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Reference

Location

Plum product
investigated

Sample/Method

Level of
evidence*

Effects observed

Sample size power: 80%
Dose: served in a 100-kcal portion twice a
day.
Duration: 4weeks.
Lucas et al., 2004)
[170]

USA

Dried plum
(P. Domestica)

Hypothesis: Gradual incorporation of 100g
of dried plum into the daily diet of healthy
postmenopausal women would not cause
significant changes in self-reported bowel
habits including frequency of defecation,
faecal bulk, and stool consistency.
n=58
Study design/Methods: RCT.
Postmenopausal women randomly assigned
to treatment groups of dried plum (100g/d) or
dried apple (75g) daily for 3 months. A 7-day
bowel habit questionnaire was completed.
Sample size power: not stated
Dose: 100g/day.
Duration: 3 months.

II
Exploratory

With both dried plum and apples, no
statistically significant differences for any
of the parameters used to assess bowel
function, showing the absence of any
negative side effects associated with prune
consumption.

Pasalar et al., 2013
[171]

Iran

Prunes
(P. Domestica)

Hypothesis: Prunes and flixweed (herbal
Iranian traditional medicine) are effective in
the prevention of constipation among Iranian
pilgrims who attended the Hajj ceremony in
2010 in the kingdom of Saudi Arabia for 3
weeks.
Study design/Methods: RCT. 170 Iranian
Hajj pilgrims randomly assigned to two
groups of case and control. Case group
received measured doses of prunes and
flixweed daily before lunch and dinner and
control group had their meals with no
intervention.
Sample size power: not stated
Dose: 40-50g/day with 10-15g of flixweed.

II
Exploratory

Using Rome III criteria to define
constipation (less than three times of
defecation/week, with straining, difficulty
in defecation, unproductive urges, feeling
of anorectal obstruction, hand manoeuvre
to facilitate stool extraction and feeling of
incomplete evacuation), a statistically
significant difference was observed
between the groups with the case group
less constipated.
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2.1.3.6 Antiallergic and antimicrobial property

On the anti-allergy capability of plum, it was observed that supplementing the animal diet with prune
extract following injection of mite allergen for 3 weeks, there was a significant reduction in the number of
sneezing events, total and mite allergen-specific immunoglobulin E levels even though there were no
identifiable anti-allergic components in the prune extract [172]. Studying the antibacterial property of
plums, it was observed that when tested on 5 different gram positive bacteria, ethanol extracts of prunes
exhibited an antibacterial property [173]. A similar effect was also observed by a different study [174]

2.1.3.7 Other Effects

Other reported beneficial health effects of plum include its effect on liver function in healthy individuals.
In a clinical trial, there was a significant reduction in serum alanine transaminase and serum alkaline
phosphatase (clinical biomarkers of liver health) with no changes observed in serum aspartate transaminase
and bilirubin [175]. Studying the effect of plum juice on urinary stone risk factors, results showed no
significant effect on urinary composition [176]. However, another study using the Australian Queen Garnet
plum reported an increase in urinary antioxidant capacity [107]. In normal weight individuals, a preload of
prunes in comparison to a bread product before a meal has been observed to result to lower energy intake at
later meals, including lunch and the desert (910 kcal ± 233 on prunes day vs 971 kcal ± 249 on bread
product day; p = 0.010), as well as increased satiety at all time points tested between the snack and meal
[167]. Similar results have also been observed in other studies [168, 169].
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Table 2-7: Evidence on the anti-allergic, anti-microbial and immune-enhancing property of plums and its associated products

Reference
In vitro Studies
Cevallos-Casals et al.,
2006 [174]

Location

Sample/Method

Level of
evidence*

Effects observed

Plum extract
(P.Salicina)

Plum extract placed in a well with diluted
bacteria inoculum.

NA

Inhibitory effects against Escherichia coli
0157:H7 and Samonella Enteritidis.

Prune extract
(P. Domestica)

Ethanol extracts of prunes tested against nine
bacteria; five Gram positive bacteria
{Staphylococcus aureus, Streptococcuc
intermedias. Bacillus cereus. Bacillus
pumilus) and four Gram negative bacteria
{Eschrichia coli, Proteus mirabilis Shigella
flexneri. Salmonella typhi and Klebsiela
pneumoniae).

NA

Antibacterial activity observed. Several
bacteria groups (e.g. Lactobacillus and
members of Ruminococcacea) were found
to be more abundant in the plum group.
There was also a distinct contrast between
the microbiota of control and treatment
groups.

Japan

Prune extract
(P.Salicina)

Dietary supplementation with 25% ovalbumin
and 1% prune extract over 6 weeks in rats
injected 20L of distilled water containing 20g
of mite allergen between the 3rd to 6th week

NA

Reduction in allergic response in
comparison to control group

(Lee et al., 2008
[177]

USA

Plum powder
(P.Salicina)

Dietary supplementation with 0.5% or 1.0%
plum in one day old chickens and oral
inoculation with 5000 sporulated oocysts of E.
acervulina at day 12 post-hatch.

NA

There was a reduction in faecal oocyst
shedding and chickens fed the plum
supplemented diets exhibited greater spleen
cell proliferation

Noratto et al., 2014
[178]

USA

Plum Juice
(P. Domestica)

Administration of plum juice in obese Zucker
rats for 11 weeks. Body weight recorded once
a week.

NA

Increase in body weight gain, levels of
MRNAs for interferon-ϒ and interleukin15.

Yaqeen et al., 2013
[173]

Animal studies
(Karasawa et al., 2012)
[172]

USA

Plum product
investigated

Pakistan

*Only clinical trials were ranked for level of evidence
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Table 2-8: Evidence on the effect of plum and its associated products on liver function and kidney stone risk factors

Reference

Location

Plum product
investigated

Sample/Method

Level of
evidence*

Effects observed

Clinical trials
Ahmed., et al., 2010[175]

Pakistan

Prune juice
(P. Domestica)

Hypothesis: Prune juice does not alter liver
function.
n=107 healthy volunteers
Study design/Methods: Case-control study.
Participants randomly assigned to 3 different
groups of A (single dose of 1 pack of prunes =
11.43kg i.e. 3 prunes), B (control; a glass of
water) and C (double dose of grp A)
consumed daily. Blood samples were taken on
Week Zero and Week 8 for liver function tests
(LFTs) i.e. serum alkaline phosphatase (ALP),
bilirubin, aspartate transaminase (AST) and
alanine transaminase (ALT).
Sample size power: not stated
Dose: 3prunes (~11.43g) or a double dose of
6 prunes (~22.86g) per day.
Duration: 8 weeks.

II
Exploratory

Liver function test showed significant
reduction of serum alanine transaminase
and serum alkaline phosphatase but no
effect on serum aspartate transaminase and
bilirubin

(Keßler et al., 2002 [176]

Germany

Plum juice
(P. Domestica)

Hypothesis: Plum-, cranberry- and
blackcurrant juice may have an influence on
the urinary composition and therefore on
multiple risk factors of kidney stone
formation.
n=12 healthy male subjects.
Study design/Methods: Participants controlfed a standardized diet daily with plum juice.
24h urine sample collected.
Sample size power: not stated
Dose: 330mL of plum juice.
Duration: 5days

II
Exploratory

No significant effect on urinary
biochemical or physiochemical parameters

*Clinical trials ranked using [111] Levels of Evidence Hierarchy where I is a systematic review (highest rating) and IV is a case series or cross-sectional study (lowest rating) and also classified as exploratory or
confirmatory studies.
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2.1.4

Discussion

This systematic literature review identified 73 peer-reviewed journal articles on the health effects of plum
and its associated products. All identified studies were grouped according to outcome measures but
differed considerably based on the plum fraction studied, study design, as well as intervention methods.
Despite an increase in plum-based research that has emerged over the past decade, the level of evidence
remains low. Of 25 clinical studies in human, nine studies included randomisation to a plum
supplementation group but only one of these studies adequately described the method of randomisation and
blinding. Nonetheless, results from some of the study outcomes are consistent. Considering bone health as
the main study outcome, the polyphenols present in the plum appear to be responsible for the benefits.
However, it has been suggested that even though dried plum polyphenols have some bone modulating
properties, the synergistic effect of these polyphenols, together with potassium and vitamin K, is required
to produce potent effects on bone mass and microarchitecture and to reverse OVX (ovariectomy)-induced
bone loss in mature animals [179]. Regardless, compared to other dried fruits (apple, apricot, grape and
mango), only the dried plum exhibited an anabolic effect on trabecular bone in the vertebra and prevented
bone loss [112].

Some of the findings from the in vitro studies have been confirmed in animal studies but remain to be
confirmed in human clinical trials. Most of the available human trials used a dried version of plums
(prunes) rather than fresh fruit, thus limiting translation to dietary messages of the positioning of fresh
plums in a healthy diet. The drying process significantly decreases (more than 90%) anthocyanin and
flavanol content of plums [180]. The effect of other processing methods on the antioxidant properties of
plums has been studied [181]. Blanching decreased the tannins and antiradical efficiency of the fruits but
increased the total polyphenol content, while osmotic dehydration had no effect on the total polyphenol and
ferric reducing power. This increase in total polyphenol content was attributed to the thermal disruption of
the polyphenol–protein complexes [182]. Fresh plums also have higher free radical scavenging capacity
(superoxide and peroxy radicals) and antioxidant activity than dried plums [183]. However, prunes are
known to contain higher levels of phenolic compounds than most dried fruits and also possess higher
radical scavenging activity, even possibly the highest in dried fruit and vegetable products present in
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human diet [184]. Further studies are required to compare the health effects of fresh plum, plum juice and
dried plum in human trials.

Extraction methodology is also an important factor in plum based research as different solvents have
shown some disparity in extracts. Estimating the antioxidant capacity of the whole plum fruit, results
showed that in extracting the bioactive compound in plum, the ethyl acetate and butanol fraction showed
the most antioxidant potential in comparison to the hexane and aqueous fraction [185].

Evidence included in this systematic review was gathered from studies that differed in a number of ways
including population studied, study design, outcome measures, and methods of randomisation. This limits
comparison between studies. Limitations related to different study designs are particularly evident in the
animal studies that show inconsistent results. For example, in one of the studies with cognitive outcomes, a
significant effect was observed using the Morris water maze task in mice fed a high cholesterol diet that
had been supplemented with 2% dried plum [150]. On the contrary, another study [105] showed that plum
juice, but not dried plum powder (2% concentration), was effective in alleviating cognitive deficits in aged
rats. This may possibly be explained by a difference in the dosage of bioactive compounds provided in the
two studies, or the food matrix of this supplement, or both [186] but remains to be elucidated in dose
response studies. In addition, even though the nutritional content of study fruits and beverages were
described, the anthocyanin contents were lacking. Of all the studies included in this systematic review, only
five [85, 137, 138, 166, 187] provided anthocyanin content which ranged from 0-112mg/100mL. The
absence of anthocyanin content, an active component, of interventions also limits results comparison across
studies.

There have been no reports on the side effects associated with daily consumption of plum and its associated
products. Studies have shown that consumption of dried plum over a long period has no significant effect
on the levels of insulin and glucose or bowel function [170, 188]. Plums are known to contain considerable
levels of oxalates which occur naturally and may increase the risk of kidney stone formation [189]. High
levels of oxalate in the body inhibit the absorption of calcium, thereby resulting in precipitation of calcium
which can result in stone formation in the kidney and bladder [190, 191]. However, plum juice
consumption did not seem to have any significant effect on the risk factors associated with kidney stone
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development [176]. In as much as these potential side effects have not been reported with usual plum
consumption, it is important for future studies to identify the upper level of safe intake.

With increased interest in plum research which has led to the development of a plum hybrid (QGP), it

is

important that similar studies be performed with this hybrid, as well as with other hybrids of plum as they
become available, to confirm these observed effects and to allow generalisation of plum research findings.
Other parts of the plum fruit that are usually discarded or used in animal feed may also provide both
nutritive and non-nutritive food components that confer health benefits. For e.g. the plum pomace, a byproduct (pulpy residue) obtained during plum juice production has been reported to contain 38-49%
dietary fibre and have antioxidant and anti-inflammatory properties that have been demonstrated in vitro
[192].

2.1.5

Conclusion

In conclusion, this systematic review has identified an emerging body of evidence that demonstrates the
beneficial health effects of plum consumption. The largest amount of evidence to date relates to prevention
and management of osteoporosis, which shows promising evidence as an adjunctive therapy. However,
many of the study designs were of low quality therefore it is important that well designed human trials are
conducted to confirm these observed effects. Consideration of the nutritional composition of plums and
prunes and the effects of processing on their bioactivity is also important for future research. Elucidation of
the mechanism of action of plum polyphenols, identification of potential adverse effects, and the effects of
dosage on outcomes is necessary to inform dietary guidelines for chronic disease prevention and
management.
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3

Chapter 3

3.1 ANTHOCYANIN-RICH PLUM JUICE REDUCES AMBULATORY
BLOOD PRESSURE BUT NOT ACUTE COGNITIVE FUNCTION
IN YOUNGER AND OLDER ADULTS: A PILOT CROSS-OVER
DOSE-TIMING STUDY

This chapter describes a pilot acute cross-over study that was conducted to investigate the impact of plum juice
on cardiovascular-related responses, cognitive function, and urinary anthocyanin excretion profiles. A sample of
24 (12 healthy older (65y+) and 12 younger (18-45y) adults) were recruited for this study. Participants received,
randomly, either a 1x300mL or 3x100mL QGP juice (QGPJ) over 3h on two different occasions with a 2-week
washout period. A battery of cognitive tasks was administered at 0h and 6h on each study day. BP and urinary
anthocyanin/metabolite excretion profiles were measured over 24h. Area under the curve for BP was calculated
(0-6h). Regardless of dose, QGPJ did not impact acute cognitive function. There was a significant reduction in
BP responses in both age groups which was more obvious in the older age group on the single dose for SBP,
DBP, Mean Arterial Pressure and Heart Rate (p-values=0.035, 0.028, 0.017 and 0.006 respectively). Dosetiming did not appear to be a significant factor in the potential acute BP-lowering effect. Native QGP
anthocyanins, as well as methylated/glucuronidated metabolites were detected in urine with no significant
differences between age groups or dose-timing. Results from this study suggests that dose-timing does not seem
to be an important factor in a QGPJ intervention.

The majority of this chapter is the substantive content of the published article: (Appendix E)

Igwe, E.O., Charlton, K.E., Roodenrys, S., Kent, K., Fanning, K. and Netzel, M.E., 2017. Anthocyanin-rich
plum juice reduces ambulatory blood pressure but not acute cognitive function in younger and older adults: a
pilot crossover dose-timing study. Nutrition Research, 47, pp.28-43.
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3.1.1

Introduction

Research on the beneficial health effects of fruit anthocyanins continue to show promising evidence both in
vitro and in vivo. However, its effect on cognition in humans has yet to be studied extensively. In Australia,
dementia which is preceded by a phase of mild cognitive impairment continues to have a substantial financial
burden on individuals as well as the economy [193]. In addition, high BP continues to pose significant health
risks. According to the World Health Organization (WHO), the prevalence of high BP in adults aged 18 years
and over was around 22% in 2014. This accounted for about 9.4 million deaths or 7% of all deaths [194]. In
Australia, between 2011 and 2012, almost one-third (31.6%) of all adults were diagnosed with hypertension,
which was more prevalent at older ages, with almost 9 in 10 (87.7%) people aged 85 years and older being
hypertensive [195]. In global strategies to address neurodegenerative and CVD prevalence, the significant role
of modifiable dietary risk factors, including an increased intake of fruits and vegetables is acknowledged [6].
Small (2-5mmHg) but steady decreases in mean BP have been shown to significantly decrease the incidence of
cardiovascular events [196]. Given the magnitude and burden of chronic diseases, cost-effective strategies,
including dietary intervention, are needed for the prevention and management of chronic diseases. Plant-based
foods are integral to a healthy human diet and a plant-rich diet has been found to be associated with prevention
of a vast array of diseases [197].

To fully grasp the mechanism of action of dietary anthocyanins in vivo, it is important to first understand their
absorption and metabolism. Even though anthocyanins have shown favourable health boosting effects in human
cell culture, experimental animal and human epidemiological studies, clinical trials are needed to confirm these
findings [27, 198, 199].

Inadequate understanding of the uptake, metabolism distribution and excretion of anthocyanins has limited the
design of clinical trials that investigate their effect on health outcomes. The body of evidence on the protective
effects of flavonoid-rich foods against CVD is based mainly on epidemiological studies, thus evidence remains
inconclusive and acute effects have not been well defined. Systematic reviews of available experimental studies
[200, 201] have highlighted an absence of knowledge regarding a ‘threshold dose’ or appropriate ‘dose-timing’
required to induce physiological protective effects. This is because the impact of anthocyanin dose has not been
studied extensively in humans and different experiments have used varied preparations e.g. juice, puree and
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whole fruit. Consequently, studies administer unfeasibly large doses of anthocyanin-rich foods in order to
elucidate a physiological response, and the selection of dose-timings is often unsubstantiated [202-204]. While
splitting a large daily dose of anthocyanin-rich food into three or more servings per day may reflect a more
feasibly tolerated serve, there is often no justification in studies as to the reason each dose was selected, and no
consideration generally given to the physiological effects thereof. Even though results from published studies
have mostly been in agreement, evidence shows that beyond a point, the bioavailability of anthocyanins
decreases with increasing dose [205]. For cyanidin-based anthocyanins, the maximum absorption has been
reported to be about 350µmol/L or less, peaking between 1.5-2.5h [206]. This is also believed to differ
according to the structure of different anthocyanins found in differing concentrations in foods, the attached
sugar moiety and because of wide inter-individual variation in anthocyanin metabolism. All of these factors
limit translation of research findings into practical dietary messages [207]. Taking these factors into
consideration, there is a need to better understand the acute effects of anthocyanins provided from different
foods and beverages, in order to identify any consistent potential health benefits.

The aim of this study was to determine the acute impact of differing doses of QGPJ on cognition and other
health parameters in young and older adults over a six-hour period. This study also determined and compared
the anthocyanin/metabolite profiles of human urine after oral consumption of high anthocyanin QGPJ in healthy
young and older adults.
It is hypothesised that the consumption of high anthocyanin QGPJ will have an acute impact by:
1.

Improving various domains of cognitive functioning and blood pressure;

2.

Demonstrating the bioavailability of QGP anthocyanins as assessed by their urinary excretion over a
24h period;

3.

Showing differences in the absorption rate and metabolism of anthocyanins between young and older
adults, assessed in urinary biomarkers (24h).

64

3.1.2 Methods

This study was conducted according to the guidelines laid down in the Declaration of Helsinki and all
procedures involving human subjects were approved by the University of Wollongong Human Research Ethics
Committee NSW, Australia (HE14/343). Written informed consent was obtained from all participants.

Study design
The study was an acute cross-over bioequivalence/non-inferiority study (with at least a two-week washout
period between clinic visits) to assess the acute impact differing dose-timings of high-anthocyanin plum juice
consumption on acute cognition and blood pressure over 24h. This study was considered a bioequivalence/noninferiority design due to the dosage for the two crossover arms being the same (a single 300mL and 3x100mL
over 3h) with the aim to determine whether three 100mL of plum juice taken over three hours would have a
different pattern of effect on BP in comparison to a single 300ml dose. Results from this pilot study will be used
to subsequently inform the methodology as well as sample size calculation for a future crossover randomised
clinical trial. This is in line with the assumptions of bioequivalence studies, whereby the future trial will be
designed as a crossover study [208-210]. (See Chapter 5).

Sample size
Twenty-four participants were recruited, including 12 younger (18-45y) and 12 older (65+y) adults in order to
compare responses between younger and older adult individuals. The sample size was determined according to
recommendations for planning a pilot study that investigates bioavailability and bioequivalence of components
within food. A sample size of 24 (12 per group), for a pilot study, is recommended based on feasibility, gains in
precision about the mean and variance, as well as guidelines for evidence required by regulatory bodies such as
the Food and Drug Administration (FDA) [208-210]. For a pilot crossover study, feasibility can be explained as
the number of possible period crossover trials (2,3,4 or 6) with balanced Williams square design (defined as a
balanced allocation to period trials in a small sample size). [208, 211]. One of the major aims of pilot studies is
to provide an estimate of the variance as this could be used in power sample size calculations for a larger follow
up study, in this case a larger RCT (Chapter 5). To determine the precision of the variance, the sensitivity of the
appropriately powered study to the estimate of the (unknown) variance would be ascertained. Thus, the sample
size of a pilot study is required to be adequate to have appropriate degrees of freedom in a sensitivity analysis in
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a larger follow-up study. Sim and Lewis (2012) [211] have demonstrated calculations based on this assumption
and showed that there were negligible gains in variance precision when the degrees of freedom exceeded 20.
Other authors, including Julious (2005) [208] and Van Belle [212] have demonstrated that for sample sizes
below n=30, calculations based on confidence interval, assuming a unit variance of s=1, gains in precision for
each increase of 1 in the sample size was no longer significant once the sample size reached 12 [208, 212].
Thus, the current study target sample size of 24 (12 per arm) could be considered adequate for the purpose of a
crossover pilot study.

A general recommendation for sample size calculation by the ICH is that the number of participants in a clinical
trial should always be large enough to provide valid answers to the questions posed [209]. For pilot
bioavailability and food investigating studies, the U.S Food and Drug Administration (FDA) guidance on
bioequivalence studies states that: “A minimum of 12 evaluable subjects should be included in any
bioequivalence study” [210]. Following these recommendations, a sample size of 24 was chosen for this pilot
study.

Participants
All participants were recruited from the University of Wollongong (UOW), Australia and the surrounding
Wollongong, NSW areas through poster advertising. Potential participants had the opportunity to discuss the
study over the phone prior to clinic visits and were screened to determine eligibility. Recruited eligible
participants were randomised to a dose-timing allocation and cognitive assessment order by a computergenerated block randomisation by an independent statistician. Participants attended two 6-h clinic visits at the
Illawarra Health and Medical Research Institute (IHMRI) at the University of Wollongong, NSW, Australia
between June and September 2015.

Exclusion criteria
Exclusion criteria included self-reported uncontrolled hypertension, any unstable physical or mental health
condition, inability to provide informed consent, consumption of specific daily health supplements related to
flavonoids, and inability to communicate in the English language.
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Data collection
On the first study day, a questionnaire was administered to determine participants’ socio-demographic
characteristics. The validated International Physical Activity Questionnaire (IPAQ) [213] was used to
determine habitual level of physical activity and blood pressure measurements were taken using an ambulatory
blood pressure monitor (ABPM) (SpaceLabs Inc., Issaquah, WA, Australia; Model 90207).

Dietary instruction and intervention meals
The QGPJ was used as the vehicle to provide a specific and consistent anthocyanin dose to study participants.
The plum juice was produced from a single seasonal batch and processed to juice by research partners at the
Department of Agriculture and Fisheries (DAF), Queensland Government. The study beverage was stored at 20oC and thawed (in the refrigerator) 24h prior to use on the days participants came into the study facility [107].
Prior to each study day, participants were advised to avoid consumption of purple/red fruits and vegetables
including wine, juices, jams and smoothies in the 24h periods immediately before and after interview day.
Verbal compliance to this was received prior to the study. On each study day participants arrived between 08:00
and 09:30 hours at the clinic facility following a 12h fast. A spot urine sample was collected, and a battery of
cognitive tests administered by two interviewers who had been trained by a senior psychologist (SR).
Thereafter, a standardized breakfast (Weet-Bix, milk and sugar) that was low in flavonoids was provided. QGPJ
was provided with breakfast in random order, as either (i) a single dose of 300mL (369 mg total anthocyanins)
[13] or (ii) 3 x 100mL servings (123mg total anthocyanins/serving) of the same plum juice at 0, 1 and 3h. A
standardized snack (ham and cheese sandwich) was provided at 4h and two (250mL) bottles of water provided
for the 6h duration spent in the study facility to be consumed ad libitum.

Ambulatory 24h blood pressure and anthropometric measurements
BP was measured using Ambulatory Blood Pressure Monitors (ABPM) for improved monitoring over 24 h, in
comparison to standard digital blood pressure monitors used in similar studies over a 6-hour period [61, 214].
Upon arrival at the testing facility participants were fitted with an ABPM (SpaceLabs Inc., Issaquah, WA,
Australia; Model 90207). The ABPM took BP measurements over the next 24h; every 15 minutes while at the
testing facility (first 6h) and thereafter once per hour whilst at home. The ABPM uses an oscillometric method
for the detection of systolic and diastolic blood pressure and has been shown to be more accurate than casual or
in-office BP measurements [215]. Participants were encouraged to go about their usual daily activities but were
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advised to stand still and relax their arm whenever the monitor recorded measurements i.e. cuff inflation and
deflation. After 24 hours, the monitor was removed and collected from participants’ homes and data
downloaded from the monitor for analysis.

Height (m) and weight (kg) were measured using a stadiometer (Seca, Hamburg, Germany) and an electronic
scale (Omron HN286 Digital Personal Body Weight Scale, (Omron, Australia)) respectively, to two decimal
places and BMI (weight/ (height 2)) was calculated.

Cognitive tasks
Five short cognitive interviewer-administered tests [216, 217] were administered by trained investigators at
baseline and 6h on both testing occasions to determine any acute changes in cognition (Table 3-1). The total
duration of the battery of tasks was approximately 30min. To control for cross-over effects, there were 4
versions of the cognitive battery so that each participant had a different version at baseline and at 6h, and in the
cross-over arm. Accuracy and response time were recorded for each task. These tasks were chosen based on
available evidence from the literature on cognitive tasks and corresponding cognitive domains that appear
sensitive to anthocyanin supplementation in acute settings [201].
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Table 3-1: Cognitive assessment task description

Instrument

Cognitive
Domain

Application

Scoring

Trail making
test [218]

Higher
executive
function

Participants alternate between
two simple tasks at once.

The Rey
Auditory Verbal
Learning test
[219]

Verbal
learning and
memory

Participants learn and recall a list
of words over 5 trials.

Pattern & letter
comparison task
[220]

Speed of
processing

Participant compares strings of
patterns or letters to determine if
it is the same or different.

Participants complete as many
examples as possible in 30
seconds and scores are tallied.

Reaction time
task[221]

General
alertness and
speed of
processing

A left or right arrow-shaped
stimulus is displayed on the
computer screen and participants
will be required to press the
corresponding mouse button (left
or right) as displayed on the
screen.

Scoring will be based on correct
and incorrect responses and
latency (response speed).

Stroop task
[222]

Executive
function

Participants say the colour of a
word, not what the word says.
E.g. for the word, RED, they are
expected to say "Blue."

Amount of time taken to
complete each set of words.

The difference in the number of
seconds required to complete the
task compared to a nonswitching version.
Each correct word that is
identified is associated with a
score.

Urine sample collection and preparation
Urine samples were collected at baseline prior to QGPJ consumption, and thereafter collected in sterilised urine
containers over the following time periods: 0-2h; 2-6h; 6-12h and 12-24h after QGPJ consumption. The volume
of collected urine samples were measured per container, recorded and an aliquot of 30mL of urine sample plus
9mL of formic acid (100%) stored in 50mL tubes, with additional 10mL urine for storage. The urine samples
were stored at -800C for batch analysis. Intact (non-metabolized) QGP anthocyanins (cyanidin-3-glucoside and
cyanidin-3-rutinoside), as well as their main/common conjugated and methylated metabolites such as peonidinglycosides and –glucuronides, were determined by HPLC-PDA-MS at the Queensland Allianz for Agriculture
and Food Innovation Laboratory, University of Queensland. The methodology was as described by Netzel et. al.
(2012) [187]. Acidified urine samples were thawed and maintained for 60 min at room temperature before Solid
Phase Extraction (SPE) to obtain the maximal yield of the coloured flavylium cations. The SPE cartridge was
activated with 10 mL of methanol and equilibrated with 10 mL of 12 mM aqueous HCl before use.
Subsequently, 5 mL of acidified urine was applied to the equilibrated cartridge. The cartridge was then washed
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with 10 mL of 12 mM aqueous HCl, and anthocyanins were eluted with 2 mL of 12 mM HCl in methanol. The
extracts were filtered (0.2 µm syringe filters; Palls, Cheltenham, VIC, Australia) before UHPLC-PDA-ESIMS/MS analysis.

3.1.3 Data Analysis

Data was analysed using IBM SPSS Statistics for Windows, Version 21.0. (IBM Corp., Armonk, NY, USA).
Descriptive statistics of participant characteristics was performed across age groups. Normal distribution of the
continuous variables was assessed using the Shapiro Wilk test, histogram, Q-Q plot and skewness and kurtosis.

Linear mixed modelling was used to estimate the effect of different timed doses of QGPJ on BP between the
two age groups, while adjusting for correlation due to repeated observations on each participant over 24h. Agegroup and dose (with interaction term) were entered in the model as fixed effects while controlling for age and
gender. Maximum likelihood method of estimation was used with a diagonal covariance structure. As BP
measurements were collected over 24h, there were a few missing data (less than 1%) and as a result linear
mixed modelling was chosen for analysis as it handles missing data better than the widely used ANCOVA.

Area Under the Curve (AUC) was calculated as a summation measure for the first 6h of BP measurements [223,
224] and the baseline observation carried forward (BOCF) approach was used for missing data (less than 1%).
To determine if the plum juice had a significant effect on BP, a z-test was used to analyze the AUC for the BP.
A series of t-tests was used to determine whether there was any significant difference between baseline BP and
different time points up to 6h. The period between 0 and 6h represents the time that the participants spent at the
study facility under standard resting conditions.

One-way analysis of variance (ANOVA) was used to determine differences in performance within each group at
baseline and 6h post-intervention and two-way ANOVA was used to determine the difference in cognitive
performance at baseline and 6h between the two age groups and dosing regimens as well as anthocyanin
excretion between the two age groups.
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3.1.4 Results
3.1.4.1 Subject characteristics
Twenty-four participants (12 younger and 12 older adults) were recruited to participate in the study and
sociodemographic characteristics are shown in Table 3-2. Participants were of Caucasian descent (n=21),
African descent (n=2) and Asian descent (n=1). All participants attended both visits and there were no
withdrawals throughout the study protocol. The average washout period for participants was 20 days (14-26
days), a deviation from the original 2-week washout period due to schedule clashes and illness. The washout
period chosen for our study was 2 weeks. This was informed by the FDA recommendation which states that for
bioequivalence studies, “The washout time should be approximately 10x the plasma apparent terminal
elimination half-life, to provide for 99.9% of the administered dose to be eliminated from the body.” [225]. For
the anthocyanin, cyanidin-3-glucoside, which is the main anthocyanin in QGPJ [85, 107], the half-life has been
shown to range between 12 and 51h [49].
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Table 3-2: Descriptive statistics
Characteristics

Younger adults (n=12)
n (%)

Gender
Male
Female

Older adults (n=12)
n (%)

p-value
Ns

4 (33.3)
8 (66.7)

3 (25.0)
9 (75.0)

Age (Mean & SD)

30.83 (8.04)

77.42 (6.10)

<0.001

BMI (Mean & SD)

22.49 (2.36)

26.36 (3.28)

0.003

Physical Activity
Low
Medium
High
Smoking status
Yes
No
Occasionally
Rarely

5 (41.7)
5(41.7)
2 (16.7)

1 (8.3)
10 (83.3)
1(8.3)

0.97

0(0)
11 (91.7)
0(0)
1 (8.3)

0(0)
12 (1000
0(0)
0(0)

Alcohol intake
Yes
No
Occasionally
Rarely

3 (25.0)
2 (17.7)
4 (33.3)
3 (25.0)

5 (41.7)
3 (25.0)
2 16.7)
2 (16.7)

Ns

0.67

Data are means ± SD or n (%) (n=12); BMI – Body Mass Index; P values were obtained from χ2 test for categorical variables; Ns- Not
significant

3.1.4.2 Cognitive tasks

Using two-way ANOVA, a significant difference was observed between the two age groups (p<0.001), both at
baseline and 6h, for performance on cognitive tests. After consumption of the juice, there was no significant
difference from baseline values within the groups or by dose-timing (Table 3-3).
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Table 3-3: Mean baseline measurements and mean difference of cognitive assessments over 6 hours according
to group

Cognitive Task

3 x 100mL QGPJ (0,1,3h)
Baseline
6h mean difference
Mean (SD)

1 x 300mL QGPJ
Baseline
6h mean difference
Mean (SD)

Younger adults (18-45)

n=12

Speed of processing
(measured by letter and
pattern comparison)a

2.39(0.51)

-0.16

2.10(0.48)

0

Stroop effect

18.42(7.63)

0.91

19.42(5.31)

0

Switch costb
(measured by task switching)

46.58(13.43)

-0.88

45.46(19.66)

0.84

RAVLT (total)c

54.00(9.41)

-1.75

51.50(9.78)

-0.34

RAVLT (20m delay) c

11.00 (2.79)

-0.10

11.00(2.87)

-1.78

501.98 (36.28)

12.85

555.31 (87.75)

0.08

Reaction time

Older adults (65+)
Speed of processing
(measured by letter and
pattern comparison)a

n=12

n=12

n=12

3.33(0.90)

0.33

3.24(0.60)

0.06

Stroop effect

35.58(16.21)

1

47.16(18.98)

3.75

Switch costb
(measured by task switching)

73.00(24.62)

8.59

69.21(19.21)

5.16

RAVLT (total)c

39.00(8.07)

3.17

38.17(7.73)

4.34

RAVLT (20m delay)

4.56(3.21)

0.17

5.11(3.72)

-2.50

682.54 (70.24)

10.61

781.67 (148.22)

-15.01

Reaction time

Pattern and letter comparison = number of correct answers in 90 secs; b Task switching = time taken to complete task; cRAVLT – Rey
Auditory Verbal learning Test (total) and (20min delay) = number of words recalled
a

3.1.4.3 24h ambulatory blood pressure

Hourly cardiovascular responses recorded during each of the 24h test periods are shown, according to plum
juice delivery mode in Figures 3-1 to 3-8. Comparison is made between the dosing regimen (single and triple
doses) and age groups with an interaction factor (dosing regimen x age-group). Figure 3-1 shows a more
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obvious drop in systolic blood pressure of the older adults with the single dose compared to the triple dose
(Figure 3-5). This observation was not evident with the younger adults, as shown in Figures 3-1 and 3-5. There
was no significant dose-timing effect observed for change in blood pressure following plum juice consumption
in the 24h period using the linear mixed model for longitudinal data (Table 3-4).

Area under the curve (AUC) was calculated for the cardiovascular parameters (systolic, diastolic, MAP and HR)
for the first 6h (Table 3-5 and Figures 3-9 – 3-12). For both age groups, using an independent sample t-test, BP
was significantly lower than baseline (p < 0.05) at different time points up to 6 h following consumption of the
plum juice. The greatest significant BP reduction was observed at 2h for both age groups and was more obvious
for systolic BP in the older group with a mean difference of 12.83mm Hg (SD; 16.51, p=0.001) from baseline.
For the single dose, z-test analysis of the AUC calculations for the younger adult group showed a significant
effect of the juice on diastolic BP, MAP and HR (p-values = 0.008, 0.012 and 0.025, respectively). Similarly, a
significant effect was seen for the older group: systolic BP, diastolic BP, MAP and HR (p-values = 0.035, 0.028,
0.017 and 0.006 respectively). For the younger age-group on the triple dose, significant effects were observed
for diastolic BP and MAP (p-values = 0.008 and 0.013, respectively) with a borderline significance on the HR
(p-value = 0.06). In the older group, significant effects of the triple dose were observed for diastolic BP (p-value
= 0.00007) and a borderline effect for systolic BP (p-value = 0.063). Plum juice consumption had a significant
effect on systolic BP, which was predicted by dose or age group but no interaction term effect (dose x age
group) and for MAP, predicted by only age-group. No significant effect was observed on other cardiovascular
parameters (Table 3-4).
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Table 3-4: Effect of dose-timed plum juice consumption on cardiovascular parameters across age groups

Parameter

Mean ± SEa

p-values

SBP
Intercept

123.7 ± 0.05

<0.0001^

Dose-timeb
1 x 300mL
3 x 100mL

122.3 ± 0.60
125.2 ± 0.67

0.001^

Groupc
Younger (n=12)
Older (n=12)

115.0 ± 0.66
132.8 ± 0.61

<0.0001^

Interaction (group*dose)
Younger * 1x300mL
Younger * 3x100mL

114.2 ± 0.84
115.8 ± 1.00

Older * 1x300mL
Older * 3x100mL

130.3 ± 0.87
134.5 ± 0.87

DBP
Intercept

0.154

72.9 ± 0.36

<0.0001^

Dose-time
1 x 300mL
3 x 100mL

72.5 ± 0.49
73.3 ±0.54

0.25

Group
Younger (n=12)
Older (n=12)

72.2 ± 0.53
73.6 ± 0.49

Interaction (group*dose)
Younger * 1x300mL
Younger * 3x100mL

72.0 ± 0.68
72.4 ±0.81

Older * 1x300mL
Older * 3x100mL

73.0 ± 0.69
74.1 ± 0.70

MAP
Intercept
Dose-time
1 x 300mL
3 x 100mL

0.11

0.62

<0.0001^
90.2 ± 0.37
0.077
89.4 ± 0.49
90.9 ±0.54
<0.0001^

Group
Younger (n=12)
Older (n=12)

86.4 ± 0.54
94.0 ± 0.50

Interaction (group*dose)
Younger * 1x300mL
Younger * 3x100mL

85.7 ± 0.68
87.0 ± 0.83

Older * 1x300mL
Older * 3x100mL

93.1 ± 0.70
94.9 ± 0.70

0.75

75

Parameter

Mean ± SEa

p-values

HR
Intercept

72.6 ± 0.36

<0.0001^

Dose-time
1 x 300mL
3 x 100mL

72.5 ± 0.49
72.7 ± 0.54

0.69

Group
Younger (n=12)
Older (n=12)

72.9 ± 0.54
72.4 ± 0.49

Interaction (group*dose)
Younger * 1x300mL
Younger * 3x100mL

72.8 ± 0.69
73.0 ± 0.82

Older * 1x300mL
Older * 3x100mL

72.2 ±0.70
72.5 ± 0.70

0.76

0.91

Data are means ± SE (n=12 per group); ^ Significant at p<0.05; aMeans and p-values were obtained from linear mixed model; b Dose-time
represents either a single dose of 300mL or 3 portions of 100mL taken at 0h, 1h and 3h; c“Younger” means younger age-group and “older”
means older age-group; SBP – Systolic blood pressure; DBP- Diastolic blood pressure; MAP- Mean arterial pressure; HR- Heart rate
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Table 3-5: Change in cardiovascular parameters of participants following consumption of different doses of
QGP juice

AUCa (0-6 h), mmHg
Cardiovascular parameters
3 x 100mL QGP (0,1,3h)

1 x 300mL QGP

n = 12

n = 12

Systolic BP

-49.36 ± 131.26

-44.45 ± 125.29

Diastolic BP

-123.45 ± 122.27*

-140.55 ± 175.93*

Mean Arterial Pressure

-96.80 ± 12.75*

-125.40 ± 136.31*

Heart Rate

-113.50 ± 208.69†

-164.42 ± 253.64*

n = 12

n =12

Systolic

-172.50 ± 321.86 †

-191.00 ± 313.93*

Diastolic

-156.00 ± 136.28 *

-121.33 ± 190.81*

Mean Arterial Pressure

-97.67 ± 278.55

-149.92 ± 217.91*

Heart Rate

-84.08 ± 195.42

-136.17 ± 171.35*

Younger adults (18-45)

Older adults (65+)

Data are AUC for mean change in cardiovascular parameters ± SD (n=12 per group)
a
AUC – area under the curve; BP- blood pressure; QGP – Queen Garnet plum
*
Z-test analysis showed statistically significant effect of the juice on the measured parameter.
† Z-test analysis showed borderline significant effect of the juice on the measured parameter.
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Figure 3-1: Single dose hourly systolic blood pressure of participants by age group over 24 hours after
consumption of QGPJ. Values are means n=12 with SE as error bars.
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Figure 3-2: Single dose hourly diastolic blood pressure of participants by age group over 24 hours after
consumption of QGPJ. Values are means n=12 with SE as error bars.
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Figure 3-3: Single dose hourly mean arterial blood pressure of participants by age group over 24 hours after
consumption of QGPJ. Values are means n=12 with SE as error bars.
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Figure 3-4: Single dose hourly heart rate of participants by age group over 24 hours after consumption of QGPJ.
Values are means n=12 with SE as error bars.
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Figure 3-5: Triple dose hourly systolic blood pressure of participants by age group over 24 hours after
consumption of QGPJ. Values are means n=12 with SE as error bars.
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Figure 3-6: Triple dose hourly diastolic blood pressure of participants by age group over 24 hours after
consumption of QGPJ. Values are means n=12 with SE as error bars.
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Figure 3-7: Triple dose hourly mean arterial blood pressure of participants by age group over 24 hours after
consumption of QGPJ. Values are means n=12 with SE as error bars.
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Figure 3-8: Triple dose hourly heart rate of participants by age group over 24 hours after consumption of QGPJ.
Values are means n=12 with SE as error bars.
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Figure 3-9: Change in systolic blood pressure (0-6h) following consumption of QGP juice.

Values are expressed as AUC for mean change in systolic blood pressure from baseline per hour up to 6h. Bars represent the sum of AUC
for ∆SBP (0-6h) ± SE (n=12 per age group). AUC, Area Under the curve; QGPJ, Queen Garnet plum juice; SBP, Systolic blood pressure
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Figure 3-10: Change in diastolic blood pressure (0-6h) following consumption of QGP juice.
Values are expressed as AUC for mean change in diastolic blood pressure from baseline per hour up to 6h. Bars represent the sum of AUC
for ∆DBP (0-6h) ± SE (n=12 per age group). AUC, Area Under the curve; QGPJ, Queen Garnet plum juice; DBP, Diastolic blood pressure
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Figure 3-11: Change in MAP (0-6h) following consumption of QGP juice.
Values are expressed as AUC for mean change in MAP from baseline per hour up to 6h. Bars represent the sum of AUC for ∆MAP (0-6h) ±
SE (n=12 per age group). AUC, Area Under the curve; QGPJ, Queen Garnet plum juice; MAP, mean arterial pressure
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Figure 3-12: Change in heart rate (0-6h) following consumption of QGP juice.
Values are expressed as AUC for mean change in HR from baseline per hour up to 6h. Bars represent the sum of AUC for ∆HR (0-6h) ± SE
(n=12 per age group). AUC, Area Under the curve; QGPJ, Queen Garnet plum juice; HR, heart rate.
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3.1.5 Urinary excretion of anthocyanins and anthocyanin metabolites

The anthocyanin content of the batch of QGP utilised for our study was 123mg/100g [13]. The consumption of
QGP juice as a single oral dose of 300mL or in 3 x100mL servings over 3h resulted in the appearance of both
intact/non-metabolised QGP anthocyanins (cyanidin-3-glucoside and cyanidin-3-rutinoside) and at least five
identified anthocyanin metabolites in the volunteers’ urine samples (Table 4). The excretion rates and urinary
anthocyanin/metabolite profiles were similar (p>0.05) between age groups and dosing regimen.

Table 3-6: Urinary excretion of anthocyanins and anthocyanin metabolites in different age groups following the
consumption of QGPJ as a single oral dose of 300 mL or as three 100 mL servings

Younger age
group (n=12)

Older age group
(n=12)

Dosing
(anthocyanins)

Absolute excretion
(µg/24 h)1

Relative excretion
(%)2

Relative excretion
of main
metabolites (%)3

1x300 mL
(369 mg)

811 ± 702

0.22

80

3x100 mL
(123 mg/dose)

759 ± 358

0.21

74

1x300 mL
(369 mg)

871 ± 602

0.24

80

3x100 mL
(123 mg/dose)

693 ± 458

0.19

75

Data are means ± sd; 1sum of cyanidin-3-glucoside, cyanidin-3-rutinoside, cyanidin-3-glucoside monoglucuronide, cyanidin
monoglucuronide, peonidin-3-glucoside, peonidin monoglucuronide and pelargonidin monoglucuronide; 2excreted amount vs. ingested
dose; 3excreted amount of peonidin-3-glucoside and peonidin monoglucuronide as the main metabolites vs. absolute excretion; compounds
were analysed by HPLC-PDA-MS and quantified by an external cyanidin-3-glucoside calibration curve [187].
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3.2

Discussion

Following consumption of a single dose of 300mL QGPJ, an acute reduction in SBP (p=0.035), DBP (p=0.028),
MAP (p=0.017) and HR (p=0.006) was observed in the older age group. A similar trend was also observed for
the triple dose with the absence of an effect on SBP. This acute effect was more pronounced in the older age
group and at 2h with a mean difference of 12.83mm Hg from baseline. Significant effects on DBP (p<0.001)
and MAP (p=0.013) were also observed in the younger age group on the single dose and DBP (p<0.001), with a
borderline effect on SBP (p=0.06) on the triple dose. The acute significant reduction in blood pressure at 2h
corresponds with evidence on the maximum absorption and bioavailability of anthocyanins that occurs within
2h post consumption [226]. Anthocyanin concentrations in the body have been observed to reach peak levels
between 1-2h and begin to clear from 6h, falling back to baseline levels as they get excreted from the body up to
48h postprandially [47]. The synergistic effect of other nutrients in the QGP cannot be overlooked. There is a
possibility that the observed blood pressure lowering effect may have been as a result of this synergistic effect,
as well as the presence of potassium in the QGP fruit [13] which is an electrolyte known to lower blood pressure
in humans [227]. Despite lack of a significant effect of dose by the different age groups on blood pressure, the
greater reduction in blood pressure in response to plum juice consumption in older adults may be explained by
their higher baseline blood pressure levels [196]. However, further adequately powered studies are needed to
confirm these findings. In the 6h following the QGPJ consumption, no significant effect was observed on the
SBP of the younger age group. Similar observation has also been made in a previous study [228] where it was
observed that the PacDASH (Pacific Kids Dietary approach to stop hypertension) trial did not affect overall diet
quality which was measured by SBP change among other parameters but had a significant effect on DBP by the
end of the intervention, by 12.2 mmHg. There is a possibility that the absence of a significant effect on SBP
could be associated with age, with interventions having a more pronounced effect among older populations
and/or those more prone to age-related vascular stiffening associated with an increased risk of developing CVD.

There was an observed dose-timing and group effect on SBP but not on other blood pressure parameters,
however, this was no longer significant after inclusion of an interaction term (age-group x dose-timing).
Previously, a similar study observed an acute reduction in blood pressure (SBP, DBP and HR) after
consumption of anthocyanin-rich cherry juice, which was found to be dose-timing dependent [214]. The
difference between the two studies may be explained by a much higher concentration of anthocyanins in the
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QGP juice (123mg/100mL vs 69mg/100mL, respectively), resulting in a physiological threshold that may have
been reached in each of the three single 100mL doses.

A possible explanation/mechanism of the observed blood pressure lowering effect of QGPJ could lie in the
molecular structure of its main in vivo anthocyanin metabolites. Methylation of cyanidin glycosides by catecholO-methyltransferase (COMT) results in the production of peonidin based metabolites which are the main
urinary anthocyanin metabolites after QGPJ ingestion. This reaction also results in a structural modification of
the B-ring in the flavonoid skeleton which is structurally analogous to apocynin, an established vasoactive drug
[229-231]. Mono-O-methylated anthocyanins/flavonoids can act as inhibitors of NADPH oxidase and as a result
can improve vasodilatory processes [231]. Another possible explanation for the blood pressure lowering effect
of anthocyanins and/or other polyphenols present in the plum juice is their potential to inhibit the oxidation of
Low-Density Lipoproteins (LDLs), a major risk factor for atherosclerosis, through free-radical scavenging and
removal of metal ions from catalytic sites via chelation [232]. One study tested this theory and observed that
when cells were incubated with OxLDL (100 µg/mL) for 24h, there was an increase in cell death while the
additions of mulberry water extracts and mulberry anthocyanin-rich extracts beyond the concentrations of 0.1
and 0.05 mg/mL, respectively, significantly increased the survival of these cell macrophages. In addition, the
authors observed that 1 mg/mL of mulberry water extract and 0.1 mg/mL of mulberry anthocyanin-rich extract
suppressed the lipid accumulation by approximately 55% and 58%, respectively [233].

Even though anthocyanins have been hypothesized to exert beneficial effects on cognitive functioning, results
from our study show that a 300mL serving of QGPJ, regardless of dose-timing or age of participants, had no
significant acute effect on various domains of cognitive function. Although previous studies have found no
significant acute effect of anthocyanins from fruit sources on cognitive processes [216, 234], the QGPJ used in
the present study had a significant higher content of anthocyanins and therefore it was hypothesized that it might
induce acute cognitive benefits. In addition, two different cognitive tests that have been shown to be sensitive
and target different domains were utilised, namely the Stroop and the Reaction time tasks [217, 235]. Extensive
research has been carried out on the long term effect of flavonoid supplementation on cognition [217] with less
attention on their acute effects. Recently, there has been an increase in the body of evidence on the acute effects
of flavonoids on cognitive processes such as attention, working memory and psychomotor speed in a general
population [236]. The precise mechanism by which anthocyanins affect cognition is still not clear but seems to
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be dependent on the exposure period. Acute effects on cognition are believed to be as a result of increased
cerebrovascular blood flow and possibly monoamine oxidase (MAO) inhibition which has been shown to
improve cognitive performance [18, 237]. Following consumption of high anthocyanin fruit/juice, evidence
shows that peaks in cerebral blood flow, vasodilation, and anthocyanin metabolite availability is detectable
within 2h post consumption [238]. Following blueberry supplementation, plasma anthocyanins and their
metabolites were observed to reach peak levels in plasma at 1–2h and 6h [55]. An investigation on the
bioavailability of anthocyanins observed an association between colonic microbiota metabolism of anthocyanins
and a significant increase in the content of generated polyphenols in the brain. There is a possibility that the
peak levels observed at 6h is as a result of re-uptake of polyphenols from the colon [239, 240]. For this reason,
repeat cognitive tasks were administered 6 h post consumption of the plum juice in our study. The absence of a
significant effect could be attributed to the timing of cognitive task administration, possibly missing the initial
peak action time. Previous research has reported conflicting results regarding the influence of flavonoids on
cognition in younger and older people. In one study, anthocyanin-rich blueberry fruit supplementation in
younger and older adults resulted in improvements in different acute cognitive domains, whereby a significant
improvement in updating ability (constant monitoring and tracking of working memory representations) was
reported for younger adults, while improvements in immediate word recognition in older adults were identified
[241]. In relation to cocoa flavonoids, consumption of dark chocolate for one week significantly improved
endothelial function and reduced BP in younger hypertensive patients, but not in older populations [242].
Overall there is little information that compares responses between younger and older adult populations thus
more work comparing these groups is required to elucidate any age-related differences in biological response.

The urinary recovery of intact anthocyanins and anthocyanin metabolites that had an intact flavonoid skeleton
(glucuronides, sulfates and methylated forms) was between 693 and 871 ug/24 h in the current study,
corresponding to 0.19 – 0.24% of the ingested anthocyanin dose. These ranges are consistent with those reported
in human studies for urinary excretion rates of anthocyanins and conjugated/methylated metabolites after
consumption of anthocyanin-rich food sources (0.01 – 5.10%) [21, 48, 107]. The bioavailability of anthocyanins
has been reported to be low however a recent review indicates that it may be higher than previously reported
[243]. Evidence from the review showed that the majority of ingested anthocyanins do reach the large intestine.
Here, they are catabolised by the microbiota, producing an array of phenolic components that are absorbed, and
some metabolised to phase II conjugates [243]. Furthermore, our finding that methylated and glucuronidated
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derivatives of cyanidin-based anthocyanins were the main urinary metabolites is also in agreement with others
[187, 244, 245]. The in vivo glucuronidation, sulfatation and methylation of anthocyanins by UDPglucuronosyltransferases, sulfotransferase and COMT in the intestinal epithelial cells, liver and kidney is a
common metabolic pathway of dietary anthocyanins and other polyphenolic compounds [246].

The presence of pelargonidin monoglucuronide, when QGPJ does not contain any (detectable) pelargonidin
based anthocyanins, could be explained by the in vivo xenobiotic and gut bacterial metabolism of
anthocyanins/flavonoids. This includes addition and removal of methyl and hydroxyl groups (pelargonidin is
lacking one hydroxyl group compared to cyanidin) [31]. This was also reported in a different study in which
significant amounts of pelargonidin based metabolites were detected in the urine of 17 study subjects following
consumption of blueberry juice which also did not contain any detectable pelargonidin glycosides [31]. Interconversion of anthocyanins due to xenobiotic and bacterial metabolism was suggested by these authors. In the
current study, there were no significant differences in the urinary anthocyanin/metabolite excretion profiles
either between the age groups or according to the different dosing regimens (1x300 mL dose or 3x100 mL
servings).

The main objective with the dose-timing design was to estimate the response according to the dose given. It is
worth noting that there were no adverse reactions recorded. Throughout the course of the study, the juice
provided was well tolerated and there were no reports of any adverse effects, however the tolerability to the
study protocol was not objectively measured. As there is large observed inter-individual variation in the
absorption, metabolism and excretion of polyphenols [41], the use of a cross-over study design is appropriate
since participants act as their own controls [247].

A notable limitation of our study is the absence of a placebo arm. A placebo (control) arm is essential in dietary
intervention studies that investigate the magnitude of effect related to a dietary factor of interest. In the case of
anthocyanins, Johnson et. al. (2015)[248] included a placebo control group in their blueberry powder (469mg of
anthocyanins/day) study and identified an intervention effect of a 7mmHg and 5mmHg drop in SBP and DBP
respectively after 8 weeks (P<0.05 and P<0.01, respectively). The main purpose of our acute study in which
each participant acted as their own control was to identify whether different dosing regimens of a high
anthocyanin fruit juice resulted in differences for ether cognitive performance and/or BP. Information related to
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the dose-timing administration of an intervention is an important consideration in clinical trial designs in freeliving participants. Furthermore, neither intact anthocyanins nor their common metabolites such as glucuronides,
sulfates or methylated forms are usually detectable in urine of placebo/control groups, as was demonstrated in a
pilot study of QGPJ [107]. Food or beverages used for placebo/control treatments are usually anthocyanin-free
or contain only negligible amounts of these pigments. Previous chronic flavonoid trials have instructed
participants to consume an amount of food or beverage over the period of a day, but without specific guidelines
on whether this needs to be consumed in totality at a single setting or whether smaller portions can be spread
across the day. Nonspecific information on timing of the test food or beverage may relate to a poor
understanding of how dose-timing may affect biological responses.

Another notable limitation is the absence of a blinding strategy. This, in addition to cognitive testing time, could
have resulted in the absence of a significant effect on cognitive performance after consumption of the plum
juice. A consideration for future studies could be to test cognitive effects at 2 h and 4-6 h post consumption in
order to reflect metabolic processes and thus consolidate available evidence. Another important consideration
for future clinical trials may be to screen for individuals with arterial narrowing who may benefit most from
blood vessel dilation related to dietary interventions [249, 250]. There is a possibility that a greater BP response
would result in more pronounced benefit to cognitive functioning, which was not evident in the current study. In
addition, it is recommended that blood and fecal samples are included in future human studies in order to allow
a more comprehensive analysis of in vivo metabolites, specifically generated by the gut microbiota and thereby
elucidate the mode of action of these plant bioactives.

3.3

Conclusion

In conclusion, this study hypothesis was rejected as there were no differences according to two dose-timing
regimens of consumption of QGPJ. An acute BP-lowering effect of anthocyanin-rich plum juice was similarly
observed for both dose-timing regimens, while no cognitive effects were observed for either dose, nor were
differences in anthocyanin metabolite excretion evident between younger and older adults. Anthocyanin
metabolites were bioavailable in the urine following consumption, but no differences were observed in the
absorption rate and metabolism of anthocyanins between young and older adults, as assessed in urinary

89

biomarkers. It is important that the mechanism of action is studied further to better understand how
anthocyanins exert protective effects on BP and how this reduction effect can be sustained over time, as well as
to determine effects on cognition in longer-term consumption studies. The greater BP reduction observed in
older participants indicates that future studies should focus on this age group where elevated BP is more
prevalent, by using a placebo-controlled design. As a first step, an important consideration relates to further
understanding the metabolism and subsequent actions of anthocyanins in the colon. This could shed some light
on the possible association between anthocyanin intake and observed beneficial health effects. With evidence
showing that anthocyanins are further broken down in the colon, it is worth understanding the plausible
mechanism and how this could be incorporated into future trials.
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4 Chapter 4
4.1 A SYSTEMATIC LITERATURE REVIEW ON THE EFFECT OF
ANTHOCYANINS ON GUT MICROBIOTA AND METHODS OF
MICROBIOTA DETERMINATION
In order to further the understanding of anthocyanin metabolism and absorption, the role of gut microbiota needs
to be examined. The gut microbiota plays a significant role in anthocyanin metabolism. Evidence has shown that
in the gut, anthocyanins are metabolised and, in the process, modulate bacterial species and exert bioactive
effects through this interaction. A systematic literature review was undertaken to determine the level of current
evidence for the association between anthocyanin intake and changes in gut microbiota. Findings from this
review showed that anthocyanins induced a significant proliferative effect on Bifidobacterium spp., known for
their wide use in probiotics and for the treatment of Irritable Bowel Syndrome (IBS). There was also an
observed inhibition of Clostridium histolyticum, which have been shown to be pathogenic in humans.
Nonetheless, very limited research has been carried out in the area of anthocyanins and gut microbiota and
further clinical trials in humans are needed to confirm changes to gut microbes.

The majority of this chapter is the substantive content of the published article: (Appendix F)

Igwe E.O., Charlton K.E., Probst Y.C., Kent K., Netzel M.E. (2018) A systematic literature review of the effect
of anthocyanins on gut microbiota populations. J Hum Nutr Diet. https://doi.org/10.1111/jhn.12582

Specific role/authorship of all the authors: EI, KC and YP designed the study. EI and MN contributed to the
literature search. EI produced the summary tables and EI and KK produced the first draft of the manuscript. All
Authors contributed to writing and editing the manuscript and approved of the ﬁnal version of the paper
submitted for publication
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4.1.1 Introduction

The metabolism of anthocyanins has been well reviewed [48]. Briefly, anthocyanins consumed through the diet
have shown to be poorly absorbed by the body, with only a small proportion of intact anthocyanins able to pass
through the gastrointestinal wall using active transporters like the sodium-dependent glucose transporter 1
(SGLT1) and facilitative glucose transporter 2 (GLUT 2) [251]. Anthocyanins that are absorbed in the GI tract
are mainly found as methylated, sulphated or glucuronidated forms but also as intact glycosides in very low
concentrations in biological fluids such as blood (plasma) and urine (10 to 2000 nM) [48]. Even though
bioavailability of intact anthocyanins in the body is reportedly low, a considerable amount of (food) matrixbound anthocyanins can reach the large intestine and the colon. Here they undergo further intensive metabolism
and degradation and are absorbed into the blood stream, with some of the subsequent metabolites showing
potential to be more biologically active than the intact anthocyanins [48, 252]. The recent interest in the gut
microbiota and its role in human health has implications for furthering the understanding of the effect of
anthocyanins on gut microbiota, and subsequent health benefits [253].

The gut microbiota, which is the microbe population living in the intestine, contain tens of trillions of
microorganisms, and is made up of at least 1000 different species of identified bacteria [254]. The majority of
the bacteria in the gut are categorised under seven phyla, namely Firmicutes, Bacteroidetes, Proteobacteria,
Fusobacteria, Verrucomicrobia, Cyanobacteria and Actinobacteria with the Firmicutes and Bacteroidetes phyla
making up over 90% of the human gut microbiota [255, 256]. Some of the essential functions of the gut
microbiota include vitamin production, regulation of lipid metabolism, short chain fatty acid production as fuel
for epithelial cells and regulation of gene expression [257] as well as an important functional role in the gutbrain axis relationship [258]. A heathy gut, which comprises of effective digestion and absorption of food,
absence of GI illness, normal and stable intestinal microbiota, and effective immune status, is required in order
to sustain a host homeostasis [259]. Irregularities and imbalances in the microbiota at different ages have been
linked to different diseases and metabolic conditions across the lifespan, ranging from allergies in young infants
to Inflammatory Bowel Disease in young adults [260]. Research on the gut microbiota continues to shed light on
the health effects of changes to the gut microbiota modulated by diet.
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Different techniques have been described for the determination of gut microbiota. Advancement in the
taxonomical composition of the gut microbiota was limited until the 21 st century due to bacteriological culture
being the only method available to determine its composition. Even to date, only about 30% of the gut
microbiota has been cultured [255]. Further understanding of the human gut has been improved by advanced
techniques independent of bacteriological culture. Prior to these advancements, culture and biochemical typing
were the gold standards for identification of bacteria species but have now been overtaken by methods that are
able to produce a more representative information of the overall microbiota [261]. Examples of some of these
techniques are sequencing of the 16S rRNA gene or its amplicons, fluorescence in situ hybridization (FISH),
quantitative polymerase chain reaction (qPCR), denaturing gradient gel electrophoresis (DGGE) and terminal
restriction fragment length polymorphism (T-RFLP). With these methods researchers are able to obtain
qualitative and quantitative information on the diversity of the gut microbiota, as well as detect changes in the
gut microbiota in relation to an intervention or disease [262]. Improved scientific methods of gut microbiota
determination have also presented the issue of suitability of the different techniques used, and how the results
can be compared to one another.

Alterations of the gut microbiota have been shown to induce and promote or reduce the risk of chronic diseases.
This hypothetical mechanism has been applied to the field of obesity and obesity-related non-alcoholic fatty
liver disease in relation to both prebiotics / probiotics [263, 264] and anthocyanins [265] as gut modifiers. With
this question in mind, given this rapidly advancing area of research in gut health, a systematic literature review
has been undertaken to summarise the current evidence on the effect of anthocyanins on the gut microbiota. The
included studies are also assessed for the different techniques used in microbiota determination. It is
hypothesised that supplementation of the diet with anthocyanin rich foods promotes the proliferation of healthy
anaerobic bacterial populations, while inhibiting the pathogenic species, as evidenced using a range of gut
microbiota determination techniques.

4.1.2 Methods

A systematic literature review was conducted according to recommendations of the PRISMA (Preferred
Reporting Items for Systematic Reviews and Meta-Analyses) statement and checklist [110] (Figure 4-1).
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Scientific databases including Scopus, PubMed, ScienceDirect, Web of Science, and MEDLINE were searched
up to June 2017. A combination of search terms with truncations included the following keywords:
anthocyanins and gut microbiota or colon microbiota (see Appendix B for search strategy). The review was
registered on PROSPERO (International prospective register of systematic reviews) as CRD42017073750 [266].
Eligibility criteria for included studies (Table 4-2):
1.

carried out either in vitro, on animal or conducted in human subjects;

2.

quantified the effect of anthocyanin on gut microbial population and described the method used;

3.

utilised anthocyanin extracts or anthocyanin-rich foods with anthocyanin (individual compounds or
total) content measured and stated;

4.

assessed changes in gut microbiota associated to anthocyanin metabolism in the gut;

5.

reported in the English language for reasons of time efficiency and cost of translation not being feasible
for this review.

Exclusion criteria
Studies were excluded if:
1.

they measured the stability of anthocyanins in the gut without quantifying effects on gut microbial
population;

2.

there was no measure of anthocyanin content in food/beverage source. One study [267] met this criteria
but was included because anthocyanin content was measured indirectly through the use of anthocyanin
metabolites in the urine and was the only included clinical trial;

3.

they measured total polyphenols or flavonoids in general and not specifically the subclass of
anthocyanins.

Review articles were excluded from the search but were considered for hand searching. Hand searching of
reference lists was undertaken for all included studies and review articles. All selected abstracts and citations
were exported from the scientific databases to the reference management software ENDNOTE X7 (Thompson
Reuters, New York, NY, USA). Following extraction and selection of publications according to the above
eligibility criteria a tabular summary was developed for this review which included the population, design,
intervention, anthocyanin dosage, health outcomes and results.
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Identification

Figure 4-1 PRISMA flowchart for study selection

Records identified through database
searching
(n = 542)

Additional records identified through
other sources
(n =1)

Screening

Duplicate records removed
(n = 6)

Eligibility

Records screened
(n =537)

Abstracts assessed for
eligibility
(n =48)

Included

Full text assessed
(n=28)

Records excluded
(n = 489)

Abstracts excluded; Review
articles (n = 16) Studies on
polyphenols in general (n =
4)

Full-text articles excluded;
No measure of Anthocyanin
(n =12) Studies on
microbiota activities (n = 5)
Studies on faecal weight
(n=5)

Studies included in
qualitative synthesis
(n =6)
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4.1.3 Results

The database searches returned 542 articles and one additional study was identified through hand searching of
reference lists. Following removal of duplicates and screening of records, 28 full text articles were evaluated
and only six studies were eligible and therefore included in the review using the PICOS criteria [268] (Figure 41). The included studies are summarised in Table 4-3 and briefly described below.

4.1.3.1 In vitro studies
Three in vitro studies were included in this review. Anthocyanins were tested individually or in a mixture, in the
case of enocianin, a commercial food colouring from Vitis Vinifera grape peel which contains a mixture of
anthocyanins including malvidin-3-glucoside (200 mg/L and 20 mg/L respectively), delphinidin-3-glucoside (60
mg/L and 6mg/L respectively), petunidin-3-glucoside (85 mg/L and 8.5 mg/L respectively), peonidin-3glucoside (traces), and cyanidin-3-glucoside (traces). With high and low concentrations reflecting different
levels of intake, anthocyanins showed proliferative effects on beneficial bacterial populations and inhibitory
effects on pathogenic species. Incubation of malvidin-3-glucoside with human faecal slurry at 0 (control), 5, 10
and 24 h, showed a significant, (p<0.05), increase in total bacteria at 24h. Significant proliferative effects were
also observed in the bacteria species with beneficial effects such as Bifidobacterium spp. and Lactobacillus spp.
known for their wide use in probiotics and for the treatment of ulcerative colitis, Irritable Bowel Syndrome
(IBS) and constipation [269]. A reduction, although not statistically significant, was observed in the potentially
harmful Clostridium histolyticum following 24 h incubation. For enocianin, a statistically significant increase
(p<0.05) was observed in Lactobacillus spp. and Bifidobacterium spp. following all incubation durations.
Bacterial levels were significantly higher than those observed with maldivin-3-glucoside, however, no
significant change was observed in C.coccoides- Eubacterium rectale group which are known for the critical
roles they play in immune homeostasis [270] or the pathogenic C. histolycum group [271].
Similar effects have also been observed with purple sweet potato anthocyanin extracts (cyanidins and
pelargonidin based anthocyanins) using faecal samples. Following fermentation at 0, 6, 12, and 24 h, a
significant increase (p<0.05) was observed for the total bacterial count. In comparison to the control medium, a
steady increase was observed in the numbers of the Bifidobacterium spp. following incubation with purple sweet
potato anthocyanins while a significant increase was observed in the bacterial population of
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Lactobacillus/Enterococcus spp. On the contrary, the control media had a steady increase in the BacteroidesPrevotella and Clostridium histolycum during fermentation, whereas in the media containing anthocyanins,
levels were significantly reduced (p<0.05).[272]
On the release, metabolism, and effect on gut microbial growth of cyclodextrin encapsulated anthocyanins
(cyanidin-3-glucoside, delphinidin-3-glucoside and malvidin-3-glucoside) on faecal slurry, between 0 and 24h,
malvidin-3-glucoside showed no significant effect on the population of Bifidobacterium spp., Clostridium
coccoides/Eubacterium rectale group, Lactobacillus/Enterococcus spp., C. histolycum group, bacteroides spp.,
or Clostridium cluster IX. However, a significant increase was observed for the members of the domain
Bacteria (EUBmix probe). Cyanidin-3-glucoside and delphinidin-3-glucoside on the other hand showed a
significant (p<0.05) inhibition of the C. histolycum group [273].
All three in vitro studies utilised the FISH technique for enumeration of bacterial populations.

4.1.3.2 Animal studies

Using six different berries (blackberry, blackcurrant, black raspberry, blueberry, Concord grape, and maqui
berry) with structurally diverse anthocyanin profiles, Overall et. al. (2017) [274] supplemented the diets in a
mouse model of polygenic obesity. Anthocyanins from these individual berries was normalised to 400µg/g food
of total anthocyanins and supplemented with animal chow for each berry category. Six-week old mice were fed
LFD (Low-fat diet) or HFD (High-fat diet) for six weeks to initiate the development of obesity in the HFD
animals. Thereafter, the HFD animal group were randomised to different berry supplemented diets for a further
12 weeks. Faecal samples were collected from the cages, weighed, and pooled at different time points (weeks 4,
8, 9 and 12) and analysed at the end of the study. Using quantitative real-time PCR, analysis of the bacterial
phyla relative abundance in the faecal samples showed that berry supplementation with blackberry and black
raspberry did not change the gut microbial population shift that was observed with either LFD or HFD.
Supplementation with Concord grape showed a significant increase of the Actinobacterial populations from 2%
to 8% in comparison to HFD controls which were similar in kcal/g but without anthocyanin supplementation.
Blueberry and blackcurrant supplementation also showed a significant increase in the populations of obligate
anaerobes Bacteroidetes from 7% to 10%-12% and Actinobacteria from 2% to 9%-15% which are some of the
bacteria species beneficial to humans. Translating the anthocyanin consumption in these animal studies to the
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human context , the authors suggested it was equivalent to consuming 2.4 mg/kg/day or 145 mg/day of total
anthocyanins for an average adult [275] which could be achieved by daily consumption of 1–2 servings of fresh
anthocyanin-rich berries [276].
Similarly, Lacombe et. al. (2013) [277] examined the effect of dietary supplementation of lowbush wild
blueberries (LWB) on the colonic microbial population of Sprague Dawley rats. Following control diets or
LWB-supplemented diets for six weeks, analysis of the colon contents of the rats using shotgun sequencing
showed a significant reduction in the relative abundance of the genera Lactobacillus and Enterococcus
associated with the berry intervention. There was also a significant (p<0.05) two-fold increase in the relative
abundance of Bifidobacteriaceae and Coriobacteriacaea and the phylum to which they belong, Actinobacteria, in
the LWB-supplemented group.

4.1.3.3 Human clinical trials

A randomised crossover clinical trial tested the association between changes in faecal microbiota following
wine interventions. Nine male participants were randomized to receive daily 275 mL of alcoholised red wine or
dealcoholized red wine or 100mL of gin for 20 days. Participants’ usual baseline dietary habits and pattern and
lifestyle were maintained, and additional alcoholic beverages were avoided for the duration of the study. At
baseline, and following each intervention period, faecal samples were collected from participants. No significant
differences in daily energy and dietary intake were observed between baseline and after each intervention.
Quantification of the microbial content of faecal samples was done using quantitative real-time PCR. Results
showed that in comparison to gin, both red wine and dealcoholized red wine significantly (p = 0.001) increased
the faecal concentration of Bifidobacterium, Enterococcus and Eggerthella lenta. Although the anthocyanin
content of the red wine intervention used in this study was not measured prior, results showed that the lowest to
the highest changes in Bifidobacteria tertiles was associated with a higher excretion of four phenolic metabolites
related to anthocyanin metabolism in participants[267].
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Table 4-1: PICOS criteria for inclusion and exclusion of studies

Parameter

Inclusion

Exclusion

Participants

Humans, animals and cell
cultures (In vitro)

None

Intervention

Quantified anthocyanins

Other polyphenols or flavonoids

Comparator

Negative controls or different
foods/diets/nutrients

Outcomes

Changes in gut microbiota

Study design

Randomised and nonrandomised experiments

None

Stability of anthocyanins in the
gut
None
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Table 4-2: Summary of studies included in the systematic review

Reference

Population/ Sample

In vitro / in
vivo

Design
(Intervention/control)

Anthocyanin Dosage
mg/100g of food
(reported dosage)

Method of
microbiota
determination

Result

Hidalgo, et al
(2012) [271]

pH-controlled, stirred,
batch-culture
fermentation system
reflective or
mimicking of the
distal human large
intestine conditions

In vitro

Enocianin- commercial
food colouring from Vitis
Vinifera grape peel
anthocyanin-rich extract /
malvidin-3-glucoside
(individual anthocyanin)

34.5 mg (345mg/L)

Fluorescent in
situ
hybridization
(FISH)

Anthocyanins significantly enhanced the
growth of Bifidobacterium spp. and
Lactobacillus-Enterococcus spp. This
increased proliferation was higher after
enocianin treatment. p<0.005

Zhang, et al.
(2016) [272]

Fresh faecal samples
from 8 healthy
volunteers (25-30y)

In vitro

Purple sweet potato
anthocyanins /
Fructooligosaccharide
(FOS) (prebiotic)

706mg (7.06mg/g)
treatment: 1% (w/v)

Fluorescent in
situ
hybridization
(FISH)

Purple sweet potato anthocyanins induced
proliferation of Bifidobacterium and
Lactobacillus/Enterococcus spp. and inhibited
the growth of Bacteroides-Prevotella and
Clostridium histolyticum. They did not affect
the total bacteria count.

Flores, G., et al
(2015) [273]

Fresh faecal samples
from 3 healthy
volunteers

In vitro

Individual anthocyanins /
a negative control (w/out
anthocyanins)

2mg (20mg/L)

Fluorescent in
situ
hybridization
(FISH)

Significant growth of the domain Bacteria
and slight inhibition of the Clostridium
histolyticum group

Seventy-six 6-wk old
male mice/ faecal
sample (cage
collected)

In vivo
(Animal
study)

Berry supplementation /
High fat diet (without
berry supplementation)

0.04mg
(1.14mg/mouse/day)

Quantitative
real-time
PCR

Significant increase in obligate anaerobic
bacterial and Actinobacteria population in
the gut (relative abundance).

Nine males, threeweek old SpragueDawley/ colon content
samples (faeces)

In vivo
(Animal
study).

Blueberry-enriched diet,
(AIN93+8% w/w
Lowbush Wild Blueberry
powder

(24.06 ± 5.2mg/day)

Microbiome
shotgun
sequencing

Significant increase in the relative
abundance of Actinomycetales, and several
novel genera under the family
Bifidobacteriaceae and Coriobacteriaceae
and significant reduction in the relative

In vitro studies

Animal studies
Overall, et al.
(2017) [274]

Lacombe, et al
(2013) [277]
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Reference

Population/ Sample

In vitro / in
vivo

Design
(Intervention/control)

Anthocyanin Dosage
mg/100g of food
(reported dosage)

Method of
microbiota
determination

substituting for dextrose)
/ Control diet (AIN93)
without blueberry
supplementation for 6
weeks
Human clinical
trial
Boto-Ordóñez,
et al (2014)
[267]

9 adult men (45-50y)/
fresh faecal samples

In vivo
(Randomised
crossovercontrolled
trial (3
consecutive
periods of 20
days each))

Randomised crossovercontrolled trial (3
consecutive periods of 20
days each);
Red wine (RW)/
dealcoholized red wine
(d-RW) / gin

Result

abundance of Lactobacillus and
Enterococcus.

9.72mg in RW and dRW/ nd in gin (272mL
(26.44mg
anthocyanin))

Quantitative
real-time
PCR

Significant change in bacteria species
(Bifidobacterium, enterococcus, and
eggerthella lenta) concentration following
RW and d-RW intervention (p<0.001)

RW- Red wine; d-RW-dealcoholized red wine; nd-not detectable
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4.1.4

Discussion

Findings from this systematic review support the hypothesis that consumption of foods high in
anthocyanins promotes the proliferation of healthy anaerobic bacterial populations, while inhibiting the
pathogenic species. Specifically, the presence of anthocyanins significantly increased the microbial
population of Bifidobacterium spp. and Lactobacillus-Enterococcus spp. This observation was consistent in
in vitro, animal and human studies [267, 271, 272, 277]. These gram-positive bacteria species have been
shown to exert beneficial effects in the treatment of diarrhoea and other specific diseases including
inflammatory bowel disease (IBD), necrotizing enterocolitis and colorectal cancer [278].

A number of factors including diet, age and antibiotics are important determinants of the gut microbiota
profile, and the influence of these factors continue to change throughout the lifetime [279]. The most
significant of these factors is diet. In relation to anthocyanin consumption, a diet rich in fruit and
vegetables has been shown to significantly alter the gut microbiota. Included studies showed that
anthocyanins have proliferative and inhibitory effects on bacteria species. However, some studies have not
observed increases in total microbial populations when samples were incubated with anthocyanins. Zhang,
et al. (2016) [272] suggested that anthocyanins contained in purple sweet potatoes, including anthocyanin
monomers, may enhance both inhibition and proliferation of different bacteria species at similar rates and
thereby not affect total overall bacteria count. In addition Flores et al (2015) [273] attributed this to the
amount of anthocyanin used in their intervention study (20mg/L of batch culture) which could have been
too low to exert any significant effects. Contrary to these observations, with higher concentration
(200mg/L) of anthocyanins, Hidalgo et. al. (2012) [271] observed a significant (p<0.05) proliferative and
inhibitive effect in microbiota population which was more evident in samples that were supplemented with
a mixture of anthocyanins showing the synergistic effect of anthocyanin subclasses. Another possibility is
that the observed simultaneous proliferative effect on the beneficial bacteria and inhibitory effect on
harmful bacteria by anthocyanins could explain the absence of any significant change in total bacterial
population as there exists a natural balance between beneficial and harmful bacteria in the gut [280].
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Even though observations in in vitro models may not be extrapolated to in vivo systems, comparison of
composition and concentration of anthocyanins across studies which had a significant effect on gut
microbiota showed that lower concentrations with a variety of anthocyanins (Malvidin-, delphinidin-,
petunidin-, peonidin- and cyanidin-glycosides) [271] had as much effect as higher concentration with only
one class of anthocyanins (cyanidins glycosides) [272]. Although anthocyanins were not the highest
concentration of flavonoids or polyphenols in wine [267], it is important to note that anthocyanins, not
other polyphenols, was associated with the increased level of Bifidobacteria in faecal samples. This was
due to the observed increase in microbial metabolites in urine presumably derived from anthocyanins. The
anthocyanin content of all interventions used in the included studies was determined using High
Performance Liquid chromatography (HPLC) coupled to different detectors. HPLC has been identified as
the most reliable method of measuring total anthocyanin content as well as individual anthocyanins in
foods and biological matrices in comparison to the colorimetric method that measures only total
anthocyanins [281].

With these observed beneficial effects, the exact mechanism of action of anthocyanins in the gut remains
unclear. Overall et. al., (2017) [274] observed an increased oxygen tension in all gut compartments
associated with high-fat diets which was attenuated by supplementing the diet with berries and berry
anthocyanins. As a result, they suggested anthocyanins may reduce oxygen tension in the gut lumen and
therefore promote the proliferation of oxygen-sensitive bacterial population. However, in the small
intestine, there exists high level of oxygen which limits bacterial growth, such that only fast growing,
facultative anaerobes with the ability to bind to epithelial/mucus are believed to survive [282]. This
highlights the difference in microbiota composition along the lower GI tract and an important consideration
in sampling.

On the issue of sampling, all the studies, but one, included in this review utilised faecal samples for the
quantification of anthocyanin effects on gut microbiota. In place of faecal samples, rectal mucosal biopsy
has been proposed as a better alternative in gut microbiota research in terms of assessment but not
participant burden [283]. Durbán et al. (2011) [284] did a comparative study on the bacterial community
composition between faecal samples and rectal mucosal biopsies. Samples were collected from an unprepped healthy population. Comparison of the two samples showed a significant difference in the bacterial
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diversity between faecal and rectal mucosal samples from the same participant. Another study compared
healthy subjects to IBS subjects, where they observed that there was a reduction in bacterial abundance and
diversity in mucosal samples in comparison to stool samples from the same participants [285]. There is a
possibility that significant differences exist in the microbial community across the six major subdivisions
of the human colon (cecum, ascending colon, transverse colon, descending colon, sigmoid colon, and
rectum). However, the degree to which composition and functions differ remain unclear. Studying the
microbial diversity of the human colon, Eckburg et. al. (2005) [255] observed significant inter-individual
variability and differences between faecal and mucosa community composition. This discrepancy
highlights the importance of sampling sites and raises the suggestion that rectal mucosal biopsy samples
are more appropriate than faecal samples and should be used instead or together with faecal samples [262].
Regardless, faecal samples are still preferred over rectal mucosa biopsy due to ease of collection and being
less invasive.

Another important consideration in gut microbiota research is the methods of determination and
quantification. Although bacterial culture, which was the gold standard in the past, is inexpensive, it
produces a limited representation of the gut microbiota diversity and results in undervaluation of real
changes. Culture independent techniques have become popular and are now the most commonly used
techniques [286]. Most of the different culture independent techniques are based on the analysis of the
16rRNA gene. The 16rRNA genes are highly protected across bacterial species. They also have distinctive
characteristics that allows for identification of different species. [262]. Studies included in this review
employed different techniques including the Fluorescence in situ hybridization (FISH), quantitative
polymerase chain reaction (qPCR) and shotgun sequencing in the determination and quantification of the
gut microbiota. These techniques have different pros and cons. The qPCR for example, although fast, is
unable to identify unknown species and has an amplification bias in that the primer set used in multitemplate PCR is required to have a shared sequence across the targets. As often is the case, this shared
sequence is absent in the targets. When a primer has one incongruity with some targets, the amplification
efficiency is significantly reduced and as a result, a large bias in the amplification will occur [287]. Even
though the FISH technique has no PCR bias, it is dependent on probe sequences which mean that it is also
unable to identify unknown species. The shotgun sequencing on the other hand, although more adequate
than the aforementioned techniques, is expensive and analysis of data involves a complex software [262].
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The major limitation of the PCR and FISH methods in comparison to the shotgun sequencing is their
inability to identify unknown species. This limitation does not seem to have affected study results as
changes in bacteria species were measured with already known species, hence addressing this limitation.
The availability of various methods requires deciding the suitability of a given methodology in gut
microbiota research. This decision will be dependent on the depth of analysis. So far, the shotgun
sequencing techniques produces the most potent data including projections of microbiota function [262].
Although a comparative study of 16S amplicon and shotgun sequencing on water samples found that less
than 50% of phyla identified via 16S amplicon sequencing were recovered from shotgun sequencing while
also identifying ~27% more families [288].

A notable strength of this systematic review is the side by side comparison of different methods of
microbiota determination as well as effects of anthocyanins. At the time of writing this article, to our
knowledge, this systematic review is the first to determine the effect of anthocyanins on gut microbiota,
while comparing different methods of microbiota determination. Another possible strength is the specific
focus on anthocyanins and their effect on gut microbiota. The synergistic effect of compounds in food
(nutrients) presents some difficulty in clearly defining causal association in epidemiological research. It is
important to note that the presence of procyanidin polymers in anthocyanin containing foods such as
berries and some nuts may also contribute to some of the reported microbiome activity [289]. Procyanidin
polymers act as microbial substrates similar to anthocyanins; as a result, synergy might explain some of the
observed effects. However, there is limited evidence on the absorption and metabolism of procyanidins due
to their polymeric nature and high structural complexity which further limit the plausible explanation of
their mechanism of action in health [289]. Although nutrients are not consumed in isolation, determining
the specific effects of particular nutrients is an important aspect of nutrition research.

As an emerging area of research in the last decade, there are very few in vitro and animal studies and even
fewer clinical trials that have been carried out. Consequently, there are limitations in the comparison of
results and generalisation of conclusions due in part to the diverse sources of anthocyanins, methods of gut
microbiota determination and quantification as well as the possibility of synergistic effects of anthocyanins
and/with other phytochemicals and nutrients present in the food sources resulting in the observed benefits.
Another notable limitation of this review is the different control diets/samples used which restricts the
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generalisation of results. Although a limitation, it is important to note that these controlled samples/diets all
had in common the absence of anthocyanins demonstrating the modulatory effects of these natural plant
pigments.

4.1.5

Conclusion

In conclusion, research on the gut (microbiota) as a metabolic organ is still emerging and characterisation
of bacteria species present in the gut is ongoing. Results from this review observed beneficial effects such
as significant proliferative effect on Bifidobacterium spp., known for their wide use in probiotics and for
the treatment of Irritable Bowel Syndrome and inhibition of Clostridium histolyticum, which have been
shown to be pathogenic in humans. Research on the possible effect of anthocyanins on gut microbiota
population is still in its early stages and conclusions and generalisations cannot be made due to the limited
evidence base and varied techniques employed in studies. This is also due to differences in anthocyanin
sources, composition, digestive stability, metabolism and biotransformation of anthocyanins in either a
food matrix or supplement isolated. This also makes it difficult to understand or elucidate the exact
mechanism by which anthocyanins may exert these effects. Therefore, the complete effect and exact mode
of action of anthocyanins on gut microbiota needs more research clarification through well-designed
human clinical trials. Further research is required to reach a consensus on anthocyanin dose and form, as
well as using a uniform approach to control intervention and background diets. In addition, it is imperative
to advance the understanding of the direct or indirect beneficial effects of anthocyanins on bacterial growth
through research. An important consideration would be to measure concurrently these observed effects on
gut microbiota, as well as other health effects, for example vascular function (BP) and cognition to further
understand complex in vivo processes such as the gut-brain axis relationship. Determination of key
techniques to measure [290] and confirm these findings is also vital in this field.
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5 CHAPTER 5

5.1 EFFECT OF CONSUMPTION OF FRUIT ANTHOCYANINS ON
BLOOD PRESSURE, COGNITION AND GUT MICROBIOTA
POPULATION IN OLDER ADULTS OVER 8 WEEKS

This chapter describes an 8-week randomised clinical crossover trial that was conducted to determine the
effect and within subject variance on cognition and 24hr ambulatory blood pressure in older adults without
cognitive impairment (55+ years) following daily consumption of 200mL QGPJ (approx. 50mg/L
anthocyanin/day) or raspberry cordial (control). Secondary outcomes included inflammatory markers (Creactive protein), Brain derived neurotrophic factor (BDNF), changes in anthropometrics and physical
function, and gut microbiota (16S rRNA gene sequencing). Twenty-eight participants (55+ years) were
recruited and over 5 clinic visits, data were collected on all outlined parameters. Each study arm lasted for
8 weeks with a 4-week washout period. Order of assignment to intervention arm was randomly allocated.
Cognition, BP and urine samples were measured at every visit while blood samples and faecal samples
were collected at baseline, end of 1st arm and end of 2nd arm. Across treatment periods, no significant
difference was observed on the different domains of cognition measured, blood pressure nor antiinflammatory biomarkers. No intervention effect was found for genera or classes of gut microbes, but there
was a trend towards significance in total bacterial count between the control arm and the intervention arm
(P= 0.06). In this group of healthy older adults, anthocyanins provided from QGPJ did not have any
significant effects on cognition, blood pressure and other measured parameters but may have an effect on
gut microbiota population. Although results from the acute study (Chapter 3) are not comparable to this
study based on experimental design (acute vs chronic intervention), it is important to note that the
anthocyanin concentration of the QGPJ utilised for this study was considerably lower than that used for the
acute study (263mg/100mL vs 50mg/L). This could have been due to seasonal variations, as well as
processing and storage conditions.
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5.1.1

Introduction

As scientific evidence emerges showing that anthocyanins are more bioavailable than originally perceived
[243], the colon has become an emerging area of research as an active site for further metabolism of
ingested anthocyanins [253]. Some of the subsequent anthocyanin metabolites are believed to be more
biologically active than intact anthocyanins [48, 252] and are possibly responsible for some of the observed
beneficial effects on cognition (gut-brain axis) and vascular function (blood pressure). Research on the
colonic metabolism of anthocyanins has been faced with limitations, including the wide inter-individual
variability in the metabolic fate of anthocyanins. This poses the largest methodological challenge thus far
in determining the health effects associated with anthocyanin consumption [207]. Absorption of
anthocyanins in the upper gastrointestinal tract is very low, possibly due to their digestive stability and
binding interaction within the food-matrix [291]. As a result, a considerable amount of intact anthocyanins
can reach the intestinal microbiota which cleave conjugated moieties, resulting in aglycones. These
aglycones undergo ring fission to produce low molecular metabolites including phenolic acids and
hydroxycinnamates which are then reabsorbed into the bloodstream where they are biologically active [44,
292]. Evidence from in vitro studies suggest that bacterial metabolism of anthocyanins in the colon
involves the cleavage of glycosidic linkages and the breakdown of the anthocyanidin heterocycle [252,
293].

The field of research related to the influence of the gut microbiota on a large array of chronic diseases
including obesity and type 2 diabetes mellitus [294], IBD [295], IBS [296] and allergies [297], has
increased exponentially in recent years. The gut microbiota profile is also known to possess an important
functional role in metabolism, immunity and maintenance of a healthy human gut [298] as well as in
regulating the gut-brain axis [258]. The gut-brain axis (GBA) involves a two-way communication between
the central and the enteric nervous system that links emotional and cognitive centres of the brain, with
peripheral intestinal functions. It has been shown that even though intact anthocyanins possess protective
health effects, their further metabolism and absorption in the colon leads to the generation of bioactive
metabolites. In turn, these metabolites also regulate the growth of specific beneficial bacteria in the
intestinal microbiota. An example is an observed increase in the concentration of faecal Bifidobacterium as
a result of anthocyanin microbial metabolites following anthocyanin supplementation [267]. Bifidobacteria
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are gram-positive, polymorphic rod-shaped bacteria normally found in the gastro-intestinal tract of humans
and animals [299]. In healthy breastfed babies these bacteria are the dominant microbial group and their
levels remain relatively stable, tending to decrease with advancing age when bacteria belonging to
Bacteroidetes and Firmicutes phyla are more dominant in adulthood [300]. In recent years, this microbial
genus has been studied extensively due to both its important role within the human intestinal microbiota
and the widespread use of Bifidobacterium strains in probiotic food products.

With the gut now considered as an important metabolic site for anthocyanins, as well as other nutrients,
there is a better understanding of the potential mechanism of action of anthocyanins and the significant role
of the gut microbiota in this process. In acute and longer term studies, anthocyanins have been shown to
have significant clinical benefits on different domains of cognition [201] and blood pressure [61, 301].
These effects have been observed in studies using different dietary sources of anthocyanins [201], and in
individuals with mild to moderate cognitive impairment [201] and hypertension [248]. However,
information in non-cognitively impaired older adults is limited and the current 8-week randomised
controlled trial was designed to address this gap.

The design of this trial was informed by the synthesis of current evidence as reported in the systematic
literature reviews (Chapters 2 and 4) in this thesis, as well as results from our acute dose-timing trial
(Chapter 3). There was limited evidence on the longer-term clinical effects of anthocyanins in healthy older
adults and even less clinical trial evidence on anthocyanin effect on gut microbiota. As a result, the aim of
this trial was to determine the effect, and within subject variance, on primary measures of cognition and
ambulatory blood pressure in healthy older adults following a daily consumption of QGPJ or a control
beverage. Changes in the gut microbiota during the trial were also measured, in order to better understand
the mechanism of clinical effects. This study hypothesised that consumption of QGPJ for 8 weeks would
have significant positive effects on cognitive function and BP, compared to a control cordial.
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5.1.2

Methods

This study was conducted according to the guidelines laid down in the Declaration of Helsinki, and all
procedures involving human subjects were approved by the University of Wollongong (UOW) Human
Research Ethics Committee, New South Wales, Australia (HE16/278). This study was registered with the
Australian New Zealand Clinical Trials Registry (ACTRN12617000220369). Written informed consent
was obtained from all eligible participants.

Study design
A randomised, crossover clinical trial ran for a period of twenty weeks. Participants were randomly
allocated to one of two arms (8 weeks on each with a washout period of 4 weeks). The intervention arm
received QGPJ and the control arm received Raspberry cordial, with similar vitamin C content (Table 5-1).
Participants were advised to consume 200mL per day (1 bottle) of the provided beverage for the duration
of the study. The duration of the trial was based on a previous trial by members of the research team using
high anthocyanin cherry juice [61] which detected changes in measured variables as early as 6 weeks.

In comparison to the acute study where a single dose of 300mL was administered, a dose of 200mL was
used in this longer term crossover study as consumption was for 8 weeks and 200mL per day was deemed
to be a feasible amount that would encourage compliance for the intervention period [61, 302]. A smaller
quantity of anthocyanins provided in the reduced quantity of juice will potentially allow translation to
habitual dietary intakes and facilitate practical dietary messaging.

Sample size and inclusion criteria
The sample size for this study was calculated using GPower [303]. Our pilot study as well as a similar
previous study [61] found effects of anthocyanin supplementation on blood pressure and memory of a
moderate size therefore the aim of this study was to detect a moderate effect of 0.3. To obtain a power of
0.90, n = 30 participants are needed, which includes 10% expected dropout. The cross-over design allows
each participant to act as their own control, thus improving power of the study.
Based on sample size calculation, participants aged 55 years and above were recruited. Exclusion criteria
included individuals with:
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1.

Uncontrolled hypertension;

2.

Type 2 diabetes mellitus;

3.

Any unstable physical or mental health condition including dementia that might confound results;

4.

Inability to provide informed consent;

5.

Inability to communicate in the English language.

Uncontrolled hypertension, Type II diabetes miletus and any unstable physical or mental health condition
were not directly assessed at pre-screening interview, but participants were asked about their last regular
medical check-up sessions and whether they had been diagnosed with any of the above prior to enrolment.

Table 5-1: Nutrient composition of the two study beverages

QGPJ (per 100mL)a

Raspberry cordial (per 100mL)c

Anthocyanins

5b

-

Energy (kj)

213

115

Protein (g)

1.1

0

Total fat (g)

0.1

0

Total carbohydrate (g)

6.4

6.5

Sugars (g)

8.7

6.5

Dietary fibre (g)

<0.1

<0.1a

Sodium (mg)

4.8

4

Vitamin C (µg)

<0.05

<0.05a

a

Data from Santhakumar et. al. (2015)[85]; bAnalysed by University of Wollongong and University of
Queensland Chemistry laboratories; cNutrient content from label.

Study Procedure
The QGPJ was donated by Nutrafruit Pty Ltd., while the cordial control beverage (Golden Circle
Raspberry cordial) was purchased from a major supermarket chain at a single time-point. The QGPJ was
supplied in 20L containers frozen at -20oC. It was stored frozen in -20oC freezer for about 8 months prior to
the start of the study. At the start of the trial, the plum juice was thawed (in the refrigerator), bottled in
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unmarked 200mL plastic containers and frozen again at -20oC to be delivered to participants. The juice was
obtained from two seasonal batches of processing and combined to provide uniform anthocyanin
composition for all participants. The juice variant was analysed by two laboratories for anthocyanin content
using the colorimetric analysis method (University of Wollongong) and the HPLC method (University of
Queensland).

A random allocation schedule prepared by an independent statistician was used to assign participants to
either arm. Researchers were blinded to the allocation but due to taste and physical differences, participants
were able to determine that there was a difference between the beverages. Participants were required to
consume one 200mL bottle of juice daily (approx. 50mg/L) and compliance was recorded from
unconsumed returned juice bottles every fortnight. An independent research assistant packed the
appropriate beverage in a labelled sealable cooler bag to be delivered to participants’ home on a fortnightly
basis. No change to regular diet was advised and dietary intake was assessed using estimated 3-day food
diaries and 24-h diet recall questionnaires.
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Figure 5-1: Study design
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Data collection
The primary outcome measure was change from baseline in blood pressure parameters (SBP, DBP, MAP,
HR and PP) and cognition measured by 5 different cognitive tasks. Secondary outcome measures included
change from baseline in inflammatory biomarkers in blood samples (BDNF and CRP) and gut microbiota.
Data collection was performed over 5 visits to the clinical trials research facility: baseline, 4 weeks, 8
weeks which was the end of arm 1 as well as 4 weeks and 8 weeks of arm 2 after crossover. (Figure 5-2).
Participants were required to arrive at the research facility after fasting for 10-12 hours for baseline and 8week data collection visits which involved collection of fasting blood samples. On clinic days, participants
were provided with a standardised breakfast (cereal, milk, muffin, and tea/coffee) after blood sample
collection and before the administration of the battery of cognitive tasks. For the 4-week visits, participants
had their usual breakfast at home prior to attending the testing facility.
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At the baseline interview, demographic and lifestyle questionnaires were completed by participants. The
International Physical Activity Questionnaire validated by Hagströmer et al. (2006) [213] was used to
determine habitual level of physical activity. For dietary data, participants were required to complete a 24-h
dietary recall questionnaire, as well as a 3-day estimated food record all food and beverages consumed over
2 weekdays and 1 weekend day. For baseline and follow-up appointments, anthropometric measures
including weight, height, waist and hip circumference, as well as physical measure (30-second sit-to-stand,
and grip-strength) were collected.

A battery of five cognitive tests, including The Rey Auditory Verbal Learning test (RAVLT), the verbal
fluency task, Digit-span backwards task, the Stroop task, and counting span, was carried out to assess
mental functioning of participants as shown in the table 5-1 below. For each cognitive task, accuracy and
response time were recorded. Evidence shows that anthocyanins may have protective effects on cognition
in both acute and chronic conditions. Different studies have utilised different measures to assess these
effects [201]. Some of these protective effects on cognition have been shown to be more sensitive on
specific domains of cognition including verbal learning and memory, speed of processing and executive
function. As a result, specific cognitive tasks targeting these domains were chosen as study instruments
[236].

Enrolment, randomisation and retention of participants are described in Figure 5.2 below. Following
dropouts, data for one participant was excluded from ambulatory blood pressure analysis due to significant
changes in blood pressure medication and physical activity after completing the first arm of the trial.

Two blood pressure measurements (24h and office) were taken. Twenty-four-hour ambulatory blood
pressure was taken using Welch Allyn ABPM (Welch Allyn, NSW, Australia; Model 7100) and office BP
measured according to standard protocols [304] using Welch Allyn Spot Vital Signs LXi DXEmed Com.
The blood samples collected were spun in a normal centrifuge for 15min at 3000rpm and the serum
collected in 2mL sterile tubes and stored at -80oC for batch analysis by an independent laboratory (Cardinal
Bioresearch Pty Ltd.) for BDNF (Brain-derived neurotrophic factor) and CRP levels. Serum BDNF was
analysed using an R&D Systems Duo ELISA kit. (Intra assay CV 3% and Inter assay CV 4%, Lowest
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Detectable Dose 5ng/mL) and serum hsCRP was analysed using a BioBase immunoturbidimetric assay.
The assay was run on a BioBase BK400 chemistry analyser. (Intra assay CV 3.5% and Inter assay CV 5%,
Lowest Detectable Dose 0.2 ng/mL).

Faecal samples were collected using commercial uBiome™ (San Francisco, USA) gut kits. The uBiome gut
analysis uses 16S-sequencing on the Illumina Next Generation Sequencing platform that delivers sequence
data [262]. 16S is a ribosomal gene present in bacterial DNA that enables classification of bacteria at the
genus level and in addition filters out genetic material from humans and other organisms. Of the three
bacterial rRNA genes (16S, 5S and 23S), the 16S rRNA gene provides the most tractable combination of
conserved sites for PCR primers and is therefore preferable to the other rRNA genes for phylogenetic
identification [262]. This method of sequencing is commonly employed in gut microbiota studies creating
less heterogeneity in studies for comparison. Trained assessors measured grip strength using a digital Jama
handgrip dynamometer (Lafayette Instruments, Indiana USA). Participants were seated with their elbow
bent at 90oC. With a neutral wrist position, the dynamometer handle was held at position II, with the
dynamometer supported underneath [305] and grip strength recorded for both left and right hands, and
hand dominance noted.

Urine analysis was conducted in a similar manner as the pilot study (Chapter 3) using a solid-phase
extraction (SPE) cartridge (Sep-Pak C18, Waters Corporation, Milford, MA, USA) according to Felgines et
al. (2003) [46] and Netzel et al. (2012) [187]. Briefly, acidified urine samples were thawed and maintained
for 60 min at room temperature before SPE extraction to obtain the maximal yield of the coloured
flavylium cations. The SPE cartridge was activated with 10 mL of methanol and equilibrated with 10 mL
of 12 mM aqueous HCl before use. Subsequently, 5 mL of acidified urine was applied to the equilibrated
cartridge. The cartridge was then washed with 10 mL of 12 mM aqueous HCl, and anthocyanins were
eluted with 2 mL of 12 mM HCl in methanol. The extracts were filtered (0.2 µm syringe filters; Palls,
Cheltenham, VIC, Australia) before UHPLC-PDA-ESI-MS/MS analysis.
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Figure 5-2: Enrolment, Randomization, and Retention of Study Participants.
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Table 5-2: Cognitive tasks description

Measurements

Application

Scoring

The Rey Auditory Verbal
Learning test (RAVLT) [219]

This test measures verbal
learning and memory. It
requires the participant to learn
a list of words over 5
presentation-test trial
sequences.

Each correct word that is
identified is associated with a
score. This score is added, with
a higher score indicating
greater memory capabilities.

The verbal fluency task [306]

This task is a sensitive measure
of executive dysfunction and
control processes. The task
requires the participant to
produce as many words
starting with a particular letter
or category as possible in one
minute.

This task assigns each word
that is produced a score of 1.
This score is added, where a
higher score indicates high
executive function.

Digit-span
[307]

This task requires the
participant to recall a small set
of digits in reverse order and
assesses short-term memory
storage and executive control
processes.

The longer the set of digits that
are
successfully
recalled
implies
better
memory
processes.

Stroop task [222]

Participants are provided with
a sheet on which the
words green, yellow, red,
and blue are printed (20 in
total). Each word is shown in
either congruent or incongruent
ink colours (e.g., the word
“blue” printed in red).
Participants are instructed to
read out the actual colour and
not the printed word as quickly
as possible. This task assesses
executive function.

The amount of time taken
(seconds) to complete each set
of words was recorded.

Counting span [308]

Participants are presented
slides with grey and blue
shapes (squares and circles)
and are asked to count the
number of blue circles on each
slide. After a certain number of
slides (starting with a span size
of 2 and going up to 6),
participants are asked to
remember the number of
circles they counted for each
card, starting with the first card
and going in order.

The responses are typed into
free recall boxes.

backwards

task
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5.1.2.1 Data analysis

Statistical analysis was carried out using Statistical Package for the Social Sciences (SPSS) software
(version 22.0, Chicago IL, USA). Normal distribution of the continuous variables was assessed using the
Shapiro-Wilk test, histogram, Q-Q plot and skewness and kurtosis. Continuous data are presented as mean
± SD. Differences between baseline and 4 and 8 weeks of each study arm were analysed using paired
sample t-tests for continuous variables and Chi-square for categorical variables.

Repeated measures ANOVA was used to determine the effect of time, treatment and time*treatment
interactions for cognition and blood pressure measurements at 4 and 8 weeks, and markers of inflammation
at baseline and 8 weeks. Alpha was set at 0.05 for statistical significance. Eta-squared (η2) values were also
calculated to quantify the difference between the interventions. The Cohen’s f effect size estimates were
characterised as small (0.10), medium (0.25) and large (0.40) [309]. The statistical analysis controlled for
potential cofounders, including age and gender, physical activity and use of blood pressure medication.
Treatment order was also included as the between subject factor.
Dietary anthocyanin intake was determined from the dietary assessments using an Australian anthocyanin
database [310] available within the dietary analysis FoodWorks software system (Version 8, 2009, Xyris
pty ltd, Spring Hill, QLD, Australia) (See Chapter 6.1 for description of database). All participants were
included in the final data analysis (i.e. intention-to-treat). Linear discriminant analysis effect size (LEfSe)
tool [311] was used to analyse gut microbiota data.

Analysis of urine samples by UHPLC-PDA-ESI-MS/MS
Analysis were carried out on a Shimadzu Nexera X2 UHPLC-PDA-ESI-MS/MS system (Shimadzu,
Rydalmere, NSW, Australia). The system consisted of a system controller (CBM-30A), three pumps (LC30AD), an autosampler (SIL-30AC), column heater (CTO-20AC), photodiode-array (PDA) detector (SPDM30A) and two degassers (DGU-20A3R and DGU-20A5R). Chromatographic separation was carried out on
a Waters Acquity UPLC BEH C18 column (100 x 2.1 mm i.d., 1.7 µm) at a column temperature of 60°C
and flow rate of 0.25 mL/min. PDA spectrum was scanned from 200-800 nm and anthocyanin compounds
were monitored at 520 nm. LC mobile phase A consisted of acetonitrile, deionized water and formic acid
(92:7:1, v/v/v) and B of 1% formic acid in acetonitrile. The elution was programmed with 0% A as initial
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isocratic hold for 1 min followed by a linear gradient from 0-8% B for 12 min, then increasing to 50% in 5
min followed by a cleaning and equilibration step before the next injection. The Nexera X2 UHPLC system
was coupled with a Shimadzu LCMS-8050 triple quadrupole mass spectrometer. The ESI source was
operated with nitrogen as nebulizer gas at a flow of 2 L/min and drying gas at a flow of 10 L/min,
respectively. Desolvation line (DL) temperature was 250 C and heat block temperature was set at 400 C.
Selected ion monitoring (SIM) and product ion monitoring at a collision energy of -20V and full MS scans
in positive mode were in the range of m/z 100-1200.

5.1.3

Results

Thirty-one participants (14 males and 17 females) were recruited, 28 (90.3%) of whom completed the trial.
Three participants withdrew; two, due to illness and one due to involvement in an accident (see Figure 52). The average washout period for participants was 5 weeks (4-7 weeks), a deviation from the original 4week washout period due to schedule clashes and illnesses. Four weeks was chosen according to
recommendations for crossover trials to have a washout period at least five times the half-life of the
treatment with the maximum half-life in the study [312]. Even though the half-life of the main anthocyanin
(cyanidin-3-glucoside) present in QGPJ [85, 107] has been shown to range between 12 and 51h [49], 4
weeks was chosen in order to allow enough time for dissipation of treatment effects.

Baseline
Baseline characteristics of participants are summarised in Table 5-2 below, with no significant differences
in any variables according to order of randomisation.
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Table 5-3: Baseline characteristics of the study population

Baseline characteristics

Full group n=31(%)

a

IC sequence (n=16)

b

CI sequence (n=15)

pvalue

Gender
Male
Female

14 (45)
17 (55)

6 (37)
10 (63)

8 (53)
7 (47)

ns

Age (mean ± SD)

70 ± 10

69 ± 10

70 ± 10

ns

BMI (mean ± SD)

26 ± 4

25 ± 4

27 ± 4

ns

0.88 ± 0.09

0.86 ± 0.09

0.89 ± 0.10

ns

Level of education
Secondary
TAFE/Diploma
University degree
Post-grad

4 (13)
9 (29)
4 (13)
14 (45)

1 (6)
4 (25)
4 (25)
7 (44)

3 (20)
5 (33)
0 (0)
7 (47)

Marital status
Married
Divorced
Widowed

22 (71)
5 (16)
4 (13)

14 (88)
2 (12)
0 (0)

8 (53)
3 (20)
4 (27)

Physical activity
High
Medium
Low

14 (45)
12 (39)
5 (16)

7 (44)
4 (25)
5 (31)

7 (47)
8 (53)
0 (0)

BP medication
Yes
No

7 (23)
24 (77)

1 (6)
15 (94)

6 (40)
9 (60)

24 ABPM (mean ± SD)
SBP
DBP
MAP
HR
PP

129 ± 12
80 ± 8
102 ± 9
72 ± 9
49 ± 9

126 ± 11
79 ± 7
100 ± 8
72 ± 10
47 ± 10

132 ±12
81 ± 9
104 ± 9
72 ± 8
51 ± 8

Spot Blood Pressure
SBP
DBP
PR

131 ± 19
75 ± 9
74 ± 14

127 ±20
74 ± 9
79 ±16

136 ± 18
77 ± 9
69 ± 9

Hand grip strength (mean
± SD)
Right
Left

30.1 ± 10.3
26.8 ± 10.6

29.3 ± 9.6
25.1 ± 9.8

30.9 ± 11.2
28.6 ± 11.5

Sit-to-stand (mean ± SD)

19 ± 7

19 ± 8

18 ± 5

Waist-Hip ratio (mean±SD)

Cognitive Assessment
(mean ± SD)
RAVLT total (I-V)
RAVLT delayed recall

ns

ns

ns

ns

ns
ns

43 ± 12
8±4

44 ± 11
8±3

41 ± 14
8±4
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Baseline characteristics

Full group n=31(%)

RAVLT 20m delayed
recall

a

IC sequence (n=16)

b

CI sequence (n=15)

pvalue

8±4

9±4

8±5

Digit Span (mean ± SD)

7±3

7±3

7±3

ns

Letter fluency (mean±SD)

14 ± 6

14 ± 6

14 ± 7

ns

Category fluency
(mean±SD)

17 ± 6

18 ± 6

15 ± 6

ns

Counting span (mean±SD)

9±4

8±4

10 ± 3

ns

Stroop (secs) (mean±SD)

12 ± 6

14 ± 7

10 ± 4

ns

Inflammatory biomarkers/
nerve growth factor
hsCRP
BDNF

ns
1.56 ± 1.67
37.67 ± 10.44

1.44 ± 1.22
35.44 ± 12.54

1.70 ± 2.11
40.21 ± 6.99

IC- intervention- then control order; bCI- control then intervention order; RAVLT-Rey auditory verbal learning test; 24-ABPM – 24-

a

h Ambulatory Blood Pressure Monitor; SBP-systolic blood pressure; DBP-diastolic blood pressure; MAP-mean arterial pressure; HRheart rate; PP-pulse pressure; PR-pulse rate; hsCRP- high sensitivity c- reactive protein; BDNF- Brain-derived neurotrophic factor

Cognition and physical measurements
There was no observed significant difference from baseline or between groups in cognition or physical
tests (Table 5-3). Calculated p values were greater than 0.05 (Table 5-4). In addition, calculated eta squared
(η2) for effect sizes for the different cognitive tasks were as follows: RAVLT total (I-V) = 0.024; RAVLT
delayed recall =0.012; RAVLT 20m delayed recall = 0.018; Digit Span = 0.019; Letter fluency = 0.00;
Category fluency= 0.065; Counting span = 0.00 and; Stroop (secs) = 0.06.

122

Table 5-4: Crossover analysis of cognitive and physical function variables

Mean (SD)
4-weeks

RAVLT total (I-V)
Baseline
Plum juice
Cordial
RAVLT delayed
recall
Baseline
Plum juice
Cordial
RAVLT 20m
delayed recall
Baseline
Plum juice
Cordial
Digit Span
Baseline
Plum juice
Cordial
Letter fluency
Baseline
Plum juice
Cordial
Category fluency
Baseline
Plum juice
Cordial
Counting span
Baseline
Plum juice
Cordial
Stroop (secs)
Baseline
Plum juice
Cordial
Hand grip
strength
Right
Baseline
Plum juice
Cordial
Left
Baseline
Plum juice
Cordial
Sit-to-stand
Baseline
Plum juice
Cordial

43(12)
48 (11)
48 (13)

8 (4)
9 (4)
9 (4)

8 (4)
9 (3)
9 (5)

8-weeks

p-values of associated ANOVA analysis
Treatment
effect

Time effect

Treatment*
time effect

0.69

0.74

0.44

0.49

1.0

0.43

0.41

0.77

0.72

0.23

0.14

0.49

0.73

0.63

0.94

0.58

0.47

0.20

0.35

0.90

0.96

0.08

0.72

0.08

0.90

0.59

0.88

0.53

0.81

0.30

0.34

0.12

0.12

49 (11)
49 (12)

9 (4)
9 (4)

9 (4)
9 (4)

7 (3)
8 (2)
8 (3)

8 (2)
8 (2)

14 (6)
15 (6)
16 (7)

16 (6)
15 (6)

17 (6)
15 (5)
19 (7)

16 (6)
18 (7)

9 (4)
9 (3)
10 (3)

10 (3)
10 (3)

12 (6)
11 (5)
10 (6)

10 (5)
9 (5)

30.1 (10.3)
32.4 (11.0)
31.3 (10.6)

31.9 (11.1)
31.7 (11.0)

26.8 (10.6)
29.3 (10.7)
28.6 (11.3)

29.2 (11.3)
27.6 (10.1)

19 (7)
21 (8)
21 (9)

21 (7)
22 (9)
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Ambulatory blood pressure and anti-inflammatory biomarkers
Similar to cognitive outcomes, there was no observed significant effect observed in 24-h
ambulatory blood pressure (Table 5-4) or anti-inflammatory biomarkers (Table 5-5).

Table 5-5: Crossover analysis of 24-h Ambulatory blood pressure data

Mean (SD)
4-weeks
SBP
Baseline
Plum juice
Cordial

129 (12)
125.9(10.0)
124.2 (11.3)

DBP
Baseline
Plum juice
Cordial

80 (8)
78.5 (7.8)
76.1 (7.0)

MAP
Baseline
Plum juice
Cordial

102 (9)
100.1 (7.9)
98.1 (8.1)

Heart rate
Baseline
Plum juice
Cordial

72 (9)
70.7 (10.4)
69.0 (8.8)

Pulse pressure
Baseline
Plum juice
Cordial

49 (9)
47.6 (8.0)
48.0 (8.5)

8-weeks

p-values of associated ANOVA analysis
Treatment
effect

Time
effect

Treatment by
time effect

0.73

0.97

0.44

0.41

0.92

0.86

0.75

0.93

0.71

0.37

0.06

0.62

0.77

0.97

0.39

127.3(9.5)
122.5 (7.7)

77.9 (7.8)
76.1 (7.0)

100.5 (7.6)
97.4 (6.3)

70.9 (8.3)
70.5 (8.7)

49.5 (9.7)
46.4(7.5)
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Table 5-6: Crossover analysis of nerve growth factor / inflammatory biomarkers (BDNF and CRP)

Mean (SD)
8-weeks

BDNF (ng/mL)
Baseline
Plum juice
Cordial
CRP (mg/L)
Baseline
Plum juice
Cordial

p-values of associated ANOVA analysis
Treatment effect

Treatment by
baseline

0.70

0.67

0.17

0.16

37.67 (10.44)
33.61 (12.13)
33.71 (11.52)

1.56 (1.67)
2.66 (4.02)
2.19 (2.20)

Gut microbiota
Analysis of gut microbiota data showed that there were no biomarkers associated with QGP juice
consumption over eight weeks. There were no significant differences observed for Bifidobacterium and
Clostridium genera. These bacteria genera have previously been shown to be affected by anthocyanin
supplementation [53]. Analysis of total bacteria count showed a trend towards significance in the
comparison of total bacteria from baseline to week 8 in the control arm. This trend was not observed
between baseline and intervention (Figure 5-3).
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Total Bacteria Count
160000

p = 0.08

p = 0.06

Total Bacteria count
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Control

Intervention

Figure 5-3: Total bacterial count across baseline, and week 8 of intervention and control arms (error bars
are SE) (n=31)

Mean

- - - - - - - - - Median

Figure 5-4: Relative abundance of Bifidobacterium and clostridium genera in gut sample across study arms
(according to linear discriminant analysis effect size; LefSe).
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Urinary analysis
Cyanidin-3-glucoside and cyanidin-3-rutinoside, the main QGP anthocyanins, as well as cyanidin
monoglucuronide, peonidin monoglucuronide and peonidin-3-rutinoside, the most common
methylated/conjugated metabolites of cyanidin-based anthocyanins, were tentatively identified in some
urine samples after QGPJ consumption (Table 5-7). However, further evaluation was not undertaken since
the concentrations of these anthocyanins and metabolites were below the limit of quantification. No other
conjugated or methylated anthocyanin forms could be detected. Furthermore, no intact anthocyanins or
common anthocyanin metabolites could be identified in the control samples (consumption of cordial).

Table 5-7: UHPLC-PDA-ESI-MS/MS characterization of QGP anthocyanins and metabolites detected in
human urine after the consumption of QGP juice

Compounds

Precursor ions (m/z)

Empirical molecular

Proposed identity

[M+H]+

formula

Cyanidin-3-glucoside

449.15

C21H21O11+

287.05

Cyanidin monoglucuronide

463.10

C21H19O12+

287.05

Cyanidin-3-rutinoside

595.15

C27H31O15+

449.10, 287.05

Peonidin monoglucuronide

477.10

C22H21O12+

301.10

Peonidin-3-rutinoside

609.15

C28H33O15+

463.15, 301.10

Fragments

Dietary data
Analysis of participants’ background diet is presented in Table 5-8 below. The mean intake of dietary
anthocyanins was 142.69mg/day with a median of 34.15mg/d (IQR =280.33) and energy intake of
9302kJ/day.
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Table 5-8: Dietary data analysis of participants from estimated 3-day food diary data

Nutrient/day

Full group (n=31)
mean ± SD
(median(IQR))

a

IC sequence (n=16)
mean ± SD
(median(IQR))

b

CI sequence (n=15)
mean ± SD
(median(IQR))

p value+

Anthocyanin (mg)

142.69 ± 217.58
(34.15(280.33))

152.42 ± 264.77
(35.05(149.75))

132.97 ± 167.40
(27.35(287.83))

ns++

Energy (KJ)

9302.9 ± 3035.89
(9065 (3245))

9716.74 ± 3536.54
(9209 (4310.5))

8889.06 ± 2503.24
(9040.95 (3347.4)

ns

Carbohydrate

209.66 ± 62.71
(193.6 (81.93)

201.37 ± 55.45
(185.05 (62.65)

217.96 ± 70.31
(213.65 (86.93))

ns

Protein

94.59 ± 24.87
(87.4 (50.5))

93.49 ± 33.69
(80.50 (59.45))

95.69 ± 24.35
(92.40 (49.5))

ns

Total Fat

94.92 ± 42.92
(86.9 (59.72))

107.77 ± 51.44
(94.45 (59.8))

82.06 ± 28.70
(78.5 (30.93))

ns

Saturated Fat (g)

30.76 ± 10.55
(29.6 (12.85))

30.96 ± 11.38
(31.4 (17.45))

30.56 ± 10.09
(28.05 (8.95))

ns

Dietary fibre (g)

32.23 ± 12.73
(30.25 (20.55))

34.39 ± 15.16
(33.5 (22.2))

30.08 ±9.86
(28.5 (18.1))

ns

Sodium (mg)

2304.36 ± 815.33
(2118.39 (972.22))

2266.09 ± 752.97
(2095.15 (1013.92))

2342.63 ± 900.30
(2150.07 (968.08))

ns

Potassium (mg)

3746.13 ± 1192.90
(3642.36 (1146.08))

3744.75 ± 1372.60
(3478.31 (1171.54))

3747.51 ± 1035.12
(3807.56 (1396.32))

ns

Magnesium (mg)

404.21 ± 189.00
(379.04 (231.79))

418.47 ± 243.15
(354.89 (344.22))

389.94 ± 120.96
(427.91 (237.05))

ns

Calcium (mg)

1056.97 ± 431.95
(912.71 (471.96))

978.89 ± 432.43
(858.26 (395.33))

1135.05 ± 432.89
(977.80 (456.62))

ns

Iron (mg)

13.83 ± 7.00
(11.82 (7.29))

14.14 ± 6.57
(11.82 (10.00))

13.53 ± 7.64
(11.55 (6.72))

ns

Omega 3 (g)

2.45 ± 1.82
(1.83 (1.75))

3.21 ± 2.25
(2.68 (2.72))

1.69 ± 0.77
(1.41 (1.06))

0.024

a

IC- intervention- then control order; bCI- control then intervention order; ns- not significant; +t-test; ++Wilcoxon signed-rank test
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5.1.4

Discussion

This study hypothesised that consumption of anthocyanin-containing plum juice for 8 weeks would have
significant positive effects on cognitive function and BP, compared to a control cordial. However, in a
group of healthy older adults, there were no observed effects on blood pressure, cognition or measured
inflammatory biomarkers. The significance levels measured using p value less than 0.05 and effect size
measured using eta squared (η2) did not show any significant effects of the intervention. Results from this
study add to the evidence that in healthy older adults without cognitive decline, supplementation with fruit
anthocyanins may provide no beneficial effects [313, 314].
Anthocyanins have been shown to exert protective effects on cognition even in the presence of other
polyphenols. Evidence from animal studies continue to show promising results [315] however, clinical trial
evidence have not been in agreement. A randomized, double-blind, placebo-controlled study compared the
safety and efficacy of encapsulated low dose enhanced wild blueberry extract (WBE111) in healthy older
adults (65-80 years). Two doses of wild blueberry powder (500mg and 1000mg) were compared to a
formulated wild blueberry extract, Thinkblue™ wild Blueberry Extract (111mg). The anthocyanin doses
across the three interventions were 1.35, 2.7 and 7mg/dose/day respectively. The authors observed
significantly better episodic memory performance following WBE111 at 3 months and lower SBP
following intervention with WBE111 in comparison to placebo even though one of the doses of wild
blueberry powder (1000mg) contained more total polyphenols than the WBE supplementation
(70mg/dose/day vs 50mg/dose/day) [316]. Other studies using grape or blueberry (87mg of anthocyanins
per 100g and 1920mg/100g respectively) observed significant effects on episodic and working memory
[317, 318] as well as in a study using encapsulated grape and blueberry extract mix [319] and individuals
with mild-moderate cognitive impairment [61]. Similar to the findings of our study, Bensalem et. al. (2018)
did not report benefits of anthocyanin supplementation in healthy older adults. However, memory benefits
were seen following stratification of participants according to baseline cognitive characteristics, with
memory benefits seen in those with poorer function initially [319]. In addition, Different study populations
and anthocyanin sources also limits comparison and generalizability between the two studies.

Our study findings are consistent with similar studies on healthy older adults using a crossover study
design [320, 321] as well as a parallel study design using elderberries [322]. In one of the studies [321]
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80 mg of anthocyanin extract from bilberry (blueberry) (Vaccinium myrtillus) and black currant (Ribes
nigrum) were consumed in capsule form. While it is possible to encapsulate anthocyanins [323], which
may make anthocyanin-consumption easier to control by improving compound stability, the bioactive
benefits of extracting and isolating specific flavonoids via encapsulation has been questioned [324], as this
process may adversely impact bioavailability.

Comparison across studies that report significant positive effects and those that have not found
anthocyanin-related health benefits suggest the following four important differences: longer duration of
intervention (3- 6 months); food source of anthocyanin (usually blueberry anthocyanins); study design
(parallel vs cross over); and cognitive function (individuals with mild cognitive impairment vs no cognitive
decline). Positive studies have tended to use fruits that contain a wide range of anthocyanin sub-classes (i.e.
blueberries and grapes), while the fruit vehicle (plum) in the current study mostly contained cyanidins
[325]. The synergistic effect of multiple anthocyanin sub-groups found in blueberries could also account
for these observed effects. To further demonstrate a synergistic effect of a combination of anthocyanin subgroups, a study that compared enocianin, (a commercial grape extract food colouring that contains a variety
of anthocyanins) with a pure malvidin-3-glucoside extract reported a more significant proliferative effect
on gut bacteria by enocianin [271]. The synergistic effect of both nutrients and bioactive non-nutrient
components within a food matrix has been highlighted by Jacobs and Tapsell (2007) [326]. This is an
important consideration in planning and executing nutrition research that is relevant for translation into
dietary guidance.

A recent meta-analysis on the effect of anthocyanin-rich foods on cardiometabolic biomarkers found that
berries and red grapes/wine significantly reduced BP. These effects were detected in overweight/obese
individuals but not in normal weight individuals [327]. Available evidence suggests that in healthy older
individuals, lower levels of anthocyanin supplementation do not seem to have significant effects over the
short term (≤ 2 months) on either blood pressure or cognition. A study using anthocyanin-rich blood orange
juice (50mg of anthocyanins/500mL) did not observe any effect on blood pressure in healthy people (2584yr) over 4 weeks [320]. On the other hand, a study of dementia patients (69mg of anthocyanins /100mL
of cherry juice) [61] and post myocardial infarction patients [328] reported significantly reduced blood
pressure over 12 weeks. Another important consideration for study design is the differential effects seen in
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acute vs longer-term interventions. In acute settings, positive effects have been observed on cognition and
BP both in children and adults [201, 214, 301] and also in longer-term studies on individuals with mild to
moderate cognitive impairment [61, 201]. However, these acute effects in healthy older adults are not
generally seen chronically [320] except in studies where blueberries have been supplemented over a longer
term (3-6 months). There is no clear explanation for this observation except for the difference in duration,
anthocyanin vehicle, study design and possibly metabolism. Evidence has suggested that chronic intake of
flavonoids do not result in increased levels of metabolites in the tissues compared to single doses, which
shows that brain levels are likely reflective of acute intake and may not accumulate in the long term [329].
There is also a possibility that the amount of anthocyanin in the plum juice used in this study could have
affected study results. Anthocyanin content of the plum juice used in the acute dose-timing study (Chapter
3) was 123mg/100mL but for this current study, the anthocyanin content of the QGPJ was much lower,
approximately 50mg/L. Additionally, the lower concentration of anthocyanins in the QGPJ utilised in this
study could explain the lower concentrations of anthocyanin metabolites observed in the urinary analyses,
which were below the limits of quantification.

In line with the absence of any significant effects on cognition, no changes in the brain derived
neurotrophic growth factor and the inflammatory biomarker, hsCRP were observed following anthocyanin
supplementation. BDNF is an important growth factor for synaptic plasticity and learning and memory
[330, 331] while C-reactive protein (CRP) is a broad marker for presence of inflammation in the body. Our
hypothesis was that anthocyanins would exert protective effects on memory and cognition through a
subsequent increase in BDNF levels, amongst other pathways. In animal models, anthocyanins have been
shown to increase BDNF levels [73] but there is little available evidence from human clinical trials. The
only available evidence is from an acute trial [241] which showed stable BDNF plasma levels following
blueberry anthocyanins supplementation in adults compared to a reduction associated with consuming a
control drink. It is important to note that baseline CRP and BDNF concentrations were within normal
ranges (CRP < 3mg/L) and BDNF generally between 8–46 ng/mL [332]) which may explain the lack of
change in these biomarkers. It has been suggested that anthocyanin-rich interventions tend to exert
beneficial effects on the cardiovascular system in participants with clinically diagnosed diseases compared
to healthy subjects, where no significant effects are observed [322]. A review of anthocyanin effects on
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CRP levels from clinical trials also observed that purified anthocyanins or anthocyanin-rich extract
supplementation did not have any significant impact on CRP levels [333].

In terms of effects of anthocyanins on gut microbiota, anthocyanins may have a significant proliferative
effect on Bifidobacterium spp., known for their wide use in probiotics and for the treatment of Irritable
Bowel Syndrome (IBS) as well as an inhibitory effect on the pathogenic strain Clostridium histolyticum
[53]. Our study did not find an intervention effect on these genera of gut bacteria however, but there was an
observed reduction in total bacteria in the control arm which was borderline significant. A review on the
effects of sweeteners on the gut microbiota showed that some artificial sweeteners reduced bacteria counts
in vivo in animal models [334]. Although the sugar content of the cordial and QGPJ were comparable,
there is a possibility that the consumption of raspberry cordial may affect the gut microbiota population in
a different manner. Studies on the effect of anthocyanins on gut microbiota have observed proliferative and
inhibitory effects on different bacteria species but the effect on total bacteria count has not been consistent
[53] and they may have proliferative and inhibitory effects of a similar magnitude in different species
[272]. There is also the possibility that the observed borderline effect on gut microbiota from this study
could be attributed to a synergistic effect of other significant bioactive phenolic compounds present in the
intervention juice. One of such nutrients is the hydroxycinnamic acids which are present in plums in higher
quantities than anthocyanins [180]. Research on hydroxycinnamic acids shows significant biological
activities, however, the low bioavailability of hydroxycinnamic acids continues to limit research translation
[335]. Evidence from pre-clinical and clinical studies suggest that due to their resistance to substrates in the
small intestine namely Lactase-Phlorizin Hydrolase (LPH) and Cytosolic β-glucosidase (CBG), they cannot
be absorbed in the small intestine but are transported to the colon where the colon microbiota cleave the
conjugating moieties, with resultant beneficial effects on the microbiota [35, 336].

The absence of significant effects on the primary outcome measures could also be associated with
background nutrition. Anthocyanin intake in the Australian population has been estimated at between 1.4 24.17mg/d (Chapter 6.2). However, the mean intake of dietary anthocyanins in the habitual diet of the
current study population was 142mg/d (median (IQR) = 34.15(280.33)). This was higher than intakes
reported in other Australian studies [337, 338]. A higher intake of background dietary anthocyanin may
hinder any possible additional benefits from anthocyanin supplementation as evidence has shown
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significant associations between habitual anthocyanin intake and reduced disease risks in longitudinal
studies [231, 339, 340]. Processing and storage times could have also affected anthocyanin stability in the
intervention juice and, subsequently, the absence of any significant changes in measured variables. In
comparison to the acute dose-timing study (Chapter 3) in which the study beverage was stored for about 2
months (frozen) prior to the start of the trial which lasted for 4 weeks, this study beverage was stored for
about 8 months (refrigerated and frozen) while the study duration was 8 months. Due to the short growing
season of plums in Australia, and the extended period of time typically required in clinical trials to recruit
sufficient numbers of participants, we endeavoured to standardise the provided juice by using two
combined batches that had been processed. This necessitated the juice to be kept in storage under
controlled conditions for a relatively long time. Evidence shows that processing of fruits to juice, especially
in high temperatures significantly degrades anthocyanins [341]. In addition, the thawing and freezing
process involved in bottling the juice could have also caused significant degradation of the plum juice
anthocyanins [342]. This degradation effect together with the low stability of anthocyanins in general could
have significant effects on research findings hence limiting generalisation of research findings [343].

The research team endeavoured to match the study beverages in nutrient content except for anthocyanins.
However, there was considerable difference in the energy content between the beverages. There are no
indications that this observed difference could have affected study results.
One of the main strengths of this study is the crossover design. Participants acted as their own control
which accounted for inter-individual variances and thereby increasing statistical power. In crossover trials,
3 types of baseline measurements have been described: those taken before the start of the first arm, those
taken at the end of the first arm and before the start of the second arm, and those taken at the end of the
second arm. The first type has been described as a true baseline as there is always the possibility that carryover effects may be present in the second and third type [344]. In addition, as comparisons are within each
trial participant, it has been suggested that different baseline measurements are not compulsory. Hence for
this study baseline measurements were recorded only once at the start of the trial.

There were few dropouts in this study and juice consumption compliance was satisfactory. As with food
interventions, blinding of participants was not possible. Other limitations in this study may include the lack
of characterization of microbial metabolites of in the plasma and the relatively short duration of
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intervention. The major consideration in the design of anthocyanin food-based research is related to
preservation of the anthocyanin content in test foods. Losses in anthocyanin content of juice due to the
bottling process (thawing and refreezing) and other storage considerations present real challenges.

5.1.5

Conclusion

In conclusion, anthocyanin supplementation provided in a food matrix of plum juice did not have any
significant effect on cognition, BP, or nerve growth factor/ inflammatory markers (BDNF and CRP) over 8
weeks but may have an effect on the gut microbiota population in healthy older individuals. Future
research may consider stability of anthocyanins while focusing on supplementation with other available
fruits with different anthocyanin profiles in longer-term (3-6 months) crossover studies in order to confirm
the absence of a chronic effect from fruit anthocyanins at this level of concentration.
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6 CHAPTER 6
6.1 DEVELOPMENT OF AN AUSTRALIAN ANTHOCYANIN
DATABASE AND SECONDARY DATA ANALYSIS OF
CURRENT ANTHOCYANIN INTAKE IN THE AUSTRALIAN
POPULATION

To accurately measure nutrient intake in population studies, food composition databases tailored to specific
regions need to be developed. As stated in Chapter 1, the available databases are not region-specific which
limits measurement of anthocyanin intake in epidemiological research. The aim of this section of Chapter 6
was to describe the first stage development of an Australian anthocyanin food composition database
focusing on fruit and vegetables. Development of an anthocyanin food composition database relies on the
availability of analytical food data. In the case of Australian fruits and vegetables, there was limited data
available for their anthocyanin content using a systematic literature review approach. As a result,
imputations (conversion to Australian values using the moisture conversion factor) from other polyphenol
datasets was necessary.

The majority of this section of chapter 6 is the substantive content of the published articles: (Appendix D)

Igwe, E., Neale, E., Charlton, K.E., Morton, K. and Probst, Y.C., 2017. First stage development of an
Australian anthocyanin food composition database for dietary studies–A systematic process and its
challenges. Journal of Food Composition and Analysis, 64, pp.33-38.

Specific role/authorship of all the authors: All authors were involved in the development of the
Australian anthocyanin database. All authors were involved in the planning the project. EI and KM
conducted the systematic literature reviews for the anthocyanin content of Australian foods. EN, KC and
YP advised on methods for data merging (USDA and Phenol-Explorer) and entry into a single database.
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All Authors contributed to writing and editing the manuscript and approved of the ﬁnal version of the paper
submitted for publication

Following the first stage development of the Australian anthocyanin database, the database was
incorporated into the commercially available FoodWorks software for nutritional analyses (version 9).
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6.1.1

Part 1: First stage development of an Australian anthocyanin food
composition database for dietary studies – A systematic process

6.1.1.1 Introduction

In order to translate clinical trial findings to dietary messages, it is important that the amount of
anthocyanin intake is accurately measured in both epidemiological and experimental studies. This would
allow translation of this evidence into dietary messages for overall health improvement. For this purpose, a
number of specific and general polyphenol databases, including the USDA Database for the Flavonoid
Content of Selected Foods and the European Phenol-Explorer, exist for the measurement of polyphenol
(anthocyanin) intake [345, 346]. Comparing these two databases for the estimation of dietary polyphenol
intake in Polish adults, significant discrepancies were demonstrated in the amount of flavonoid intake
between the USDA and Phenol-Explorer databases (525 mg/day vs 403.5 mg/day, respectively p<0.001)
[347]. Epidemiological studies commonly utilise either of these databases for the measurement of
polyphenol intakes. Such discrepancies between databases may lead to differing conclusions regarding the
amount of anthocyanins in the human diet and potential dose responses [338, 347, 348].

Within the USDA and Phenol Explorer databases, analytical data are not country or region specific but are
reported as mean values for all available data for a particular food. As a result, there is the possibility that
this can lead to inaccurate measurement of polyphenol intakes in specific populations. Evidence has shown
that differences in climate, soil conditions and methods of plant harvesting among other factors are major
determinants of natural variation in the amounts of nutrients contained in foods [89, 90]. For example, the
levels of anthocyanin in fruit may be directly proportional to the amount of sunlight exposure. Anthocyanin
levels in grapes have been observed to substantially increase with grape bunch exposure to sunlight in
comparison to shading [349]. Average monthly hours of sunshine over the year has been shown to be
significantly different in various fruit producing regions of the world [350]. Focusing on this difference in
climate and harvesting practices as an example, the amount of micronutrients in apples are found to differ
substantially between the USDA [351] and the Australian Food, Supplement and Nutrient Database
(AUSNUT) [352] (Table 6-1). For these reasons, it is important that databases tailored to specific regions
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of the world are developed to facilitate better measurement of anthocyanin intakes in population level
studies.

In utilising the available databases for epidemiological studies, another drawback is the
underrepresentation of native fruit and fruit hybrids specific to particular regions. For example, there is
limited data for some common Australian native fruit including quandong, riberry and fingerlimes which
are known to have high levels of anthocyanins [353].
In summary, the underrepresentation of fruit specific to particular regions in existing databases, as well as
the differences in climate and harvesting practices between regions warrants the development of an
anthocyanin food composition database specific to different regions.
The aim of this study was, therefore, to describe the first stages of the development of an Australian
anthocyanin food composition database using fruit and vegetables as a preliminary step in the systematic
development process.

6.1.1.2

Methods

The development of an Australian anthocyanin database involved an expansion of the existing Australian
Food and Nutrient database (AUSNUT) 2011-13 database to include anthocyanin content. The AUSNUT
2011-13 database contains over 5,700 foods and beverages reported by Australians and was developed for
use in the 2011-13 Australian Health Survey [354].
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Table 6-1: Micronutrient comparison between USDA and AUSNUT food composition database values of
apple
AUSNUT* values

USDA+ values

Preformed vitamin A (retinol) (µg)

0

3

Beta-carotene (µg)

10

27

Provitamin A (b-carotene equivalents) (µg)

13

Vitamin A retinol equivalents (µg)

2

0

Thiamin (mg)

0.022

0.017

Riboflavin (mg)

0.013

0.026

4
13

4.6
3

Vitamin C (mg)
Dietary folate equivalents (µg)

*AUSNUT – Australian Food and Nutrient Database +USDA – U.S Department of Agriculture
Source: [351, 355].

As a first stage development, the main focus was fruit and vegetables as these are the major food groups
with high levels of anthocyanins. The most reliable method to measure anthocyanin content in foods has
been identified as High-Performance Liquid Chromatography (HPLC). When evaluating
spectrophotometric methods for antioxidant compound measurement, the colorimetric methods were found
to be unreliable as reactions could be different for individual compounds within a sub-group (anthocyanins,
flavonols or flavan-3-ols) and were not specific to one family [281]. For this reason, only data generated
using HPLC methods of analysis were included.

The proposed methodology for estimating the anthocyanin content of Australian foods was adapted from a
systematic approach that was developed and used for the estimation of added sugar content in Australian
foods via an expansion of the AUSNUT database [356].

Step by step systematic approach to estimating anthocyanins in foods

A step by step process was developed for estimating the anthocyanin content of Australian fruit and
vegetables. The first four steps were objective while the rest were considered subjective.
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Step 1: Classification of food groups: Food groups were coded into three different categories; plant-based
foods, non-plant-based foods and composite foods (made up of plant-based and non-plant-based foods).
The difference between the non-plant-based food and the composite food group is that the majority of the
former were assigned zero values while in the latter; fewer foods were assigned a zero value (Table 6-2).
The grouping system developed for the AUSNUT 2011-13 database classifies foods according to a major
(2-digit) based on key ingredients, followed by sub-major (3-digit) and minor food (5-digit) groups. Using
this classification system, there are 24 major food groups covering all the reported foods eaten by
Australians, as shown in Table 6-2.

Step 2: Assignment of zero values: Zero values were assigned to non-plant-based food and composite food
groups with careful attention being paid not to assign 0 values to foods that contained ingredients from the
plant-based food groups.

Step 3: Conduct a systematic literature search for analytical data: A systematic literature search of
electronic databases was conducted (Scopus, Web of Science, Medline, PubMed central, ProQuest, and
Science Direct) using a combination of search terms; “anthocyanin*”, “Australia*”, “Fruit*”, “vege*”, and
“analy*”. Studies were included if they had analysed the anthocyanin content in Australian fruit and
vegetables. Additional literature searches using USDA and Phenol-Explorer databases were conducted to
identify fruits and vegetables with available anthocyanin analytical values. Searches used scientific and
common names to identify all relevant foods in the USDA and Phenol-Explorer databases.
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Table 6-2: Major food groups in the Australian Food and Nutrient Database (AUSNUT)

Plant based food groups

Non-Plant based food groups

Composite food groups

16. Fruit products and dishes

14. Fats and oils

11.Non-alcoholic beverages

22. Seed and nut product and
dishes

15. Fish and seafood products

12.Cereals and cereal products

24. Vegetable products and
dishes

17. Egg products and dishes

13.Cereal based products and
dishes

25. Legume and pulse products
and dishes

18. Meat, poultry and game
products and dishes

20. Dairy & meat substitutes

19. Milk products and dishes

21. Soup

30. Special dietary foods

23. Savoury sauces and
condiments

34. Reptiles, amphibia and
insects

26. Snack foods
27. Sugar products and dishes
28. Confectionery and
cereal/nut/fruit/seed bars
29. Alcoholic beverages
31. Miscellaneous
32. Infant formulae and foods
33. Dietary supplements

Step 4: Contact local researchers and organisations: Experts in the field of anthocyanin research were
identified from the systematic literature search as well as web searches of organisations, groups, and
individuals to identify where further sources of analytical anthocyanin data may be located. These sources
were contacted to enquire about the existence of any unpublished data for the anthocyanin content of
Australian fruits and vegetables.
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Step 5: Using borrowed values: Having exhausted steps 1-4, where Australian data was not identified for
fruit and vegetables, data will be obtained for similar foods from international databases, including the
USDA Database for the Flavonoid Content of Selected Foods and Phenol-Explorer. To assist with the
choice of the most appropriate foods from those databases, estimations were made by calculating a
conversion factor to apply to the borrowed values in the Australian food anthocyanin database, considering
deviation from average moisture content as shown below: [357]
The conversion factor F is calculated using the following formula:

𝐹=

100 − 𝑎𝑐𝑡𝑢𝑎𝑙 𝑚𝑜𝑖𝑠𝑡𝑢𝑟𝑒 𝑐𝑜𝑛𝑡𝑒𝑛𝑡 (𝐴𝑢𝑠𝑡𝑟𝑎𝑙𝑖𝑎𝑛 𝑓𝑜𝑜𝑑 𝑐𝑜𝑚𝑝𝑜𝑠𝑖𝑡𝑖𝑜𝑛 𝑡𝑎𝑏𝑙𝑒)
100 − 𝑚𝑜𝑖𝑠𝑡𝑢𝑟𝑒 𝑐𝑜𝑛𝑡𝑒𝑛𝑡 𝑎𝑠 𝑠ℎ𝑜𝑤𝑛 𝑖𝑛 𝑡ℎ𝑒 𝑈𝑆𝐷𝐴 𝑜𝑟 𝑃ℎ𝑒𝑛𝑜𝑙 − 𝐸𝑥𝑝𝑙𝑜𝑟𝑒𝑟 𝑓𝑜𝑜𝑑 𝑐𝑜𝑚𝑝. 𝑡𝑎𝑏𝑙𝑒

Moisture content of the foods in the USDA flavonoid database was obtained from the USDA National
Nutrient Database for Standard Reference [351] and those of the Phenol-Explorer will be obtained from the
Danish Food Composition Databank the data source indicated in the Phenol-Explorer database [358].
Having calculated the conversion factor, the corresponding Australian nutrient value were computed by
multiplying specific nutrient value by the conversion factor (F). Following this computation, data from the
USDA flavonoid database and Phenol-Explorer were mapped to determine whether to make decisions
based on the calculated values from both databases or if further analysis is required. The choice of the
international database from which to borrow analytical values was dependent on the similarity of the foods
in their macronutrient content and the similarity of the food supply between Australia and the source
country including production and processing techniques.

Step 6: Compression of anthocyanin glycosides to main classes:
In the overseas databases, anthocyanin content was listed by specific glycosides. In order to facilitate
adequate merging of the anthocyanin values, the anthocyanin glycosides were compressed to the main
classes of anthocyanins. For example, cyanidin 3-glucoside was classified under cyanidin.

Step 7: Match values for similar foods: Following compression of anthocyanin glycosides to the main
classes, similar species of foods were matched in anthocyanin values. For example, Fuji apple and green
apple were matched for values. In the case whereby fresh/raw version of a particular food had a zero value,
same value was also assigned to the cooked or processed version of same food.
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Records identified through database

Identification

searching: 2463
Additional records identified through
personal communication (n= 2)

Screening

Scopus (n=18)
Web of Science (n=6)
PubMed central (n= 101)
ProQuest (n=938)
Medline (n=36)
Science Direct (n=1364)

Records screened: 2465
Records excluded:
Reason: duplicates and
relevance to review topic
n= 2187
Articles assessed for eligibility based

Eligibility

on title: n= 278

Scopus (n=10)

Web of Science
(n=6)

PubMed
Central
(n=12)

ProQuest
(n=50)

Medline
(n=22)

Science
Direct
(n=178)

Included

Articles excluded: 269
Total number of articles
included: n= 9
fruits (n=5)
Native fruits (2)
vegetables (n=2)

Studies where methods of analysis was not HPLC
(n=4)
Articles analysing non-Australian grown produce
(n=200)
Articles analysing total phenolic content (n=50)
Articles using
products (n=15)

non-commercially

available

Figure 6-1: PRISMA flow diagram for analytical article selection process
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6.1.1.3 Results

Following the four objective steps outlined above, the existing AUSNUT 2011-13 database was expanded
to include anthocyanin content. The foods contained in the database are classified under 24 food groups
(Table 6-2). Of these, four were grouped as plant-based foods, seven under the non-plant-based food group
and 13 under the composite food group. There was a total of 58 individual fruits and 62 vegetables in the
database following this method of categorisation.

The systematic literature search (Figure 6-1) for analytical values of Australian fruits and vegetables
yielded analytical values for only five Australian fruit (Table 6-3), including berries [359, 360] plums [13,
361], apple [362], grape [363] as well as ten native Australian fruit [360, 364] and two Australian
vegetables, namely purple dragon carrots [365] and red cabbage [366]. Unpublished analytical data from
local researchers at the Queensland Alliance for Agriculture and Food Innovation, University of
Queensland, Australia were obtained for commercially available pomegranate juice, pomegranate and
cranberry juice mix, pomegranate and blueberry juice mix, Dr Red products (Purple Shiraz and Purple
Carrot Blend; Purple carrot blueberry punch; Blueberry punch), Nature’s Goodness (Joint Formula: Cherry
juice concentrate with anthocyanin complex) and Sunraysia (100% Prune juice (from concentrate)).

6.1.1.4 Discussion

Using a systematic approach, for the first time, attempts have been made to bring together in a database the
analytical data for the anthocyanin content of Australian foods (fruit and vegetables). The first four
objective steps were unambiguous as the food groupings based on major ingredients were readily available;
hence classification as plant-based or non-plant-based foods was a straightforward process.
Even though there is currently very limited analytical data on the anthocyanin content of Australian foods
which was evident in the few studies identified during the systematic literature search, preliminary
comparisons of the available data on fruit with the existing polyphenol databases shows a substantial
difference in the reported anthocyanin content (Table 6-4). It is expected that more data will become
available as this area of research advances, allowing for continuous sourcing of unpublished data.
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Expansion of the dataset will enable more precise and consistent estimation of anthocyanin intakes in
future studies.

Currently, the major focus has been on raw fruit and vegetables but as this project progresses, a number of
considerations will be made in gathering analytical values. Food processing, for example, will be a major
consideration as it has been shown to affect the nutritional content of foods with more effect on
micronutrients. Blanching for example was observed to decrease the tannins and anti-radical efficiency of
plums but increased the total polyphenol content, while osmotic dehydration had no effect on the total
polyphenol and ferric reducing power [181]. On drying, it has been observed that some anthocyanin and
flavonol content of plums significantly decreased [180]. In line with this observation, the free radical
scavenging capacity and antioxidant activity of both fresh and dried fruit samples (plum) have been
studied. Results showed that the fresh samples had more oxygen free radical (superoxide and peroxy
radicals) scavenging capacity than the dried samples [183].

Some of the strengths of the proposed methodology are its systematic approach and the fact that local
researchers were contacted for unpublished data in order to gather additional analytical data.
Furthermore, upon completion of the proposed database, there is the possibility of improved study results
based on better measurement of anthocyanin consumption. In estimating anthocyanin intake in population
studies, a major limitation has been the significant differences in the estimated amount of anthocyanin
intake depending on the database used to measure anthocyanin [347]. There is a possibility that the
combination of available databases can have a significant effect on accurate measurement of anthocyanin
intake. Considering this, a major strength of this proposed methodology will be the combination of
analytical data from Australian foods and borrowed data from international databases based on micro and
macro nutrient similarity which will provide more accurate estimation [347].

A major limitation of this project was the limited availability of analytical data for Australian foods and
thus the need to borrow international data. Some of the published analytical values only reported total
anthocyanin content, rather than individual anthocyanins [13, 362, 363, 365, 366]. This could be seen as a
limitation as evidence shows that specific anthocyanins vary substantially in their bioavailability [367]. In
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addition, even though some foods were assigned a zero value on the assumption that they do not contain
any anthocyanins, it will be important to confirm this from analytical data.
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Table 6-3: Anthocyanin content of raw Australian fruit, sourced using a systematic literature review approach

Reference

Food name

Food group

Method of analysisa

Fredericks et al., (2013)
[359]

Strawberry

Fruit products and
dishes

HPLC

Total anthocyanin (SD)
mg/100g fresh weight
2.02 (0.04)

Netzel et al., (2006) [360]

Blueberry

Fruit products and
dishes

HPLC/ESI-MS-MS

381.75 (6.23)

Yes

Bobrich, A., et al. (2014)
[361]

Black diamond
plum

Fruit products and
dishes

HPLC

89.8mg

Yes

Fanning et al., (2014) [13]

Queen Garnet
plum

Fruit products and
dishes

HPLC

195

No

Takos et al., (2006) [362]

Apple skin
(red)

Fruit products and
dishes

HPLC

9mg/100g fruit skin

No

Bidon et al., (2013) [363]

Shiraz grape

Fruit products and
dishes

HPLC

159 (5)

Zabaras et al., (2013) [366]

Red Cabbage

Vegetables

HPLC/ESI-LC/MS

57.4

No

Singh et al., (2012) [365]

Purple dragon
Carrot

Vegetables

HPLC

5 (0.2)

No

Netzel et al., (2006) [360]

Muntries

(Native) fruit
products and dishes

HPLC/ESI-MS-MS

25.26 (1.24)

Yes

Netzel et al., (2006) [360]

Tasmanian
pepper

(Native) fruit
products and dishes

HPLC/ESI-MS-MS

607 (52)

Yes

Individual anthocyanins
reported
Yes

No
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Reference

Food name

Food group

Method of analysisa

Netzel et al., (2006) [360]

Molucca
raspberry

(Native) fruit
products and dishes

HPLC/ESI-MS-MS

Total anthocyanin (SD)
mg/100g fresh weight
73.64 (0.41)

Netzel et al., (2006) [360]

Davidson's
plum

(Native) fruit
products and dishes

HPLC/ESI-MS-MS

38.42 (0.83)

Yes

Netzel et al., (2006) [360]

Illawarra plum

(Native) fruit
products and dishes

HPLC/ESI-MS-MS

556.82 (20.73)

Yes

Netzel et al., (2006) [360]

Cedar bay
cherry

(Native) fruit
products and dishes

HPLC/ESI-MS-MS

27.77 (0.54)

Yes

Netzel et al., (2006) [360]

Burdekin plum

(Native) fruit
products and dishes

HPLC/ESI-MS-MS

174.55(10.63)

Yes

Netzel et al., (2007) [364]

Riberry

Yes

Bush Cherry

HPLC-DAD/ESI/MSMS
HPLC-DAD/ESI/MSMS

72.39 (1.45 )

Netzel et al., (2007) [364]

(Native) fruit
products and dishes
(Native) fruit
products and dishes

105.79(1.24)

Yes

Netzel et al., (2007) [364]

Finger lime

(Native) fruit
products and dishes

HPLC-DAD/ESI/MSMS

11.09 (0.83)

Yes

Unpublished data from
source

pomegranate
juice

fruit products and
dishes

HPLC

13b

No

Unpublished data from
source

pomegranate
cranberry juice

fruit products and
dishes

HPLC

12b

No

Unpublished data from
source

pomegranate
blueberry juice

fruit products and
dishes

HPLC

12b

No

Individual anthocyanins
reported
Yes
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Reference

Food name

Food group

Method of analysisa

Unpublished data from
Source

Dr Red
(Purple Shiraz
and Purple
Carrot Blend)

fruit products and
dishes

HPLC

Total anthocyanin (SD)
mg/100g fresh weight
9b

Unpublished data from
source

Dr Red (Purple
carrot
blueberry
punch)

fruit products and
dishes

HPLC

40b

No

Unpublished data from
source

Dr Red
(Blueberry
punch)

fruit products and
dishes

HPLC

610b

No

Unpublished data from
source

Nature’s
Goodness
(Joint Formula:
Cherry juice
concentrate
with
anthocyanin
complex)

fruit products and
dishes

HPLC

14b

No

Unpublished data from
source

Sunraysia
(100% Prune
juice (from
concentrate))

fruit products and
dishes

HPLC

<<1b

No

Individual anthocyanins
reported
No

a

HPLC- High Performance Liquid Chromatography, HPLC/ESI-MS-MS High-Performance Liquid Chromatography/Electrospray Ionization Tandem Mass Spectrometry, HPLC/ESI-LC/MS - High-Performance
Liquid Chromatography/Electrospray Ionization Liquid Chromatography/Mass Spectrometry, HPLC-DAD/ESI/MS-MS - High-Performance Liquid Chromatography- Diode Array Detection /Electrospray
Ionization Tandem Mass Spectrometry
b
Single item analysis
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Table 6-4: Differences in anthocyanin content of similar fruit vegetables from different databases and sources

Fruit/vegetable

USDA database (mg/100g)

Australian dataa (mg/100g)

Strawberry

2.42

Phenol-Explorer database
(mg/100g)
73.01

Blueberry

163.3

133.99

381.75

Plum

56.05

47.79

89.8

Red cabbage

209.95

-*

57.4

2.02

a

Australian data from systematic literature review [310]; *- not reported
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6.1.1.5 Conclusion

In conclusion, this proposed methodology provides insight for the compilation of analytical data for an
Australian anthocyanin database for fruit and vegetables. Whilst the literature search produced very limited
results, this was to be expected as the database is in the early stages of development and anthocyanins are
an emerging area of research. As more analytical data becomes available from organisations and
independent researchers, updates will be made to produce a robust database that will facilitate accurate
measurement of anthocyanin consumption in Australian population studies and clinical trials.
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6.1.2

Part 2: Estimated dietary anthocyanin intake and major food sources in
Australia from the National Nutrition and Physical Activity component of
the Australian Health Survey and association with blood pressure in older
adults

This section of Chapter 6 describes the secondary analysis of the National Nutrition and Physical Activity
Survey (NNPAS) component of the Australian Health Survey (AHS). Following the development of the
Australian anthocyanin database (Chapter 6.1), a secondary data analysis of the 2011-12 National Nutrition
and Physical Activity component of the Australian Health Survey was conducted to estimate the intake of
both total anthocyanins and their sub-groups, identify food sources of anthocyanins, as well as determine
association between anthocyanin intake and measured BP in older adults aged 50+ years. Results showed
that mean anthocyanins intake was 24.17±0.32mg/day in the total population. Across age-groups, berries
were the top sources: blackberry (5-65%); cherry (2-24 %); blueberry (2-13%) and raspberry (3-12%).
There was also an observed significant inverse association between anthocyanin intake in older adults aged
50+ years and systolic BP (β =-0.04, p<0.01) and diastolic BP β= -0.01, p<0.01), in models that adjusted
for covariates (age, gender, body mass index, high blood pressure (BP) diagnosis, smoking status and
physical activity). In comparison to the world composite database, anthocyanin intake in the Australian
population was above average (24.17±0.32mg/day vs 18.05±21.14 mg/d). Berries made up the primary
sources thereof. Anthocyanin intake in older adults aged 50+y was inversely associated with BP.

The majority of this chapter section is the substantive content of the published articles:

Igwe, E.O., Charlton, K.E., and Probst, Y.C. 2019. Usual dietary anthocyanin intake, sources and their
association with blood pressure in a representative sample of Australian adults. Journal of Human
Nutrition and Dietetics (In press).
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6.1.2.1 Introduction

Incorporating fruits and vegetables in the usual diet have been proven to exert protective effects on health.
These observed effects have been attributed to the presence of minerals, antioxidant vitamins,
phytochemicals and dietary fibre in these foods. These substances, independently and as a group in fruits
and vegetables have been associated with reduced mortality [3] weight loss [4] cardiovascular diseases and
some cancers [6]. With these observed beneficial health effects, inter-individual variability and optimal
intake are still significant limitations in anthocyanin research. Although the source of bioactive
compounds, found mainly in fruits and vegetables, cannot be regarded as the primary determining factor
responsible for inter-individual variability, evidence has shown that it could have a significant effect on
cardiovascular and metabolic responses associated with consumption of these compounds [368, 369]. This
could also be attributed to the synergistic effect of other diverse compounds present in the source foods.

Accurate measurement of nutrient intake, in this case, anthocyanins, tailored specifically to individual
countries and regions is an important consideration in both epidemiological and experimental studies.
There is an observed variation in nutrient content of foods produced across different regions [89, 90] which
has led to the development of country/region specific food composition databases. The same is also evident
in the micronutrient databases. Currently the American USDA Database for the Flavonoid Content of
Selected Foods and the European Phenol-Explorer, exist for the measurement of polyphenol (anthocyanin)
intake [345, 346]. As mentioned earlier, these databases have been compared with observed discrepancies
[347] which led to the first stage development of an Australian anthocyanin database to determine the
amount of anthocyanins consumed by Australians [310] (Chapter 6.1).

Following the development of this database, this study aimed to estimate anthocyanin intake in the
Australian population, to describe total and individual anthocyanin intake in the Australian population
according to sociodemographic subgroups, and to determine the major sources of total and individual
anthocyanins in the diet. Results from this secondary analysis may provide evidence on the possible role of
anthocyanins in reducing risks of chronic diseases in Australian older adults.
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6.1.2.2 Methods

This study was a secondary data analysis of the 2011–12 National Nutrition and Physical Activity Survey
(NNPAS) data from the Australian Bureau of Statistics (ABS) using Basic Confidentialised Unit Record
Files (CURF). No ethics approval was required for this study because it was a secondary analysis.
However, approval to carry out a secondary analysis with the NNPAS component of the AHS data was
obtained by the researchers from the Australian Bureau of Statistics prior to conducting this study.

The National Nutrition and Physical Activity Survey 2011-12
The NNPAS 2011-12 is a component survey of the larger 2011-12 AHS which involved a total of 12,153
persons. It was carried out between 29 May 2011 and 9 June 2012 in approximately 9,500 private abodes
selected throughout non-very remote areas of Australia. Face-to-face interview (and by telephone for the
second NNPAS interview) was used to collect data on general demographic information (including age,
sex, marital status and country of birth) on all individuals while detailed information was collected from
one adult and one child aged 2-17 years. This survey covered about 97% of the people living in Australia.

The study design for the 2011-12 NHS and NNPAS was a stratified multistage area sample of private
dwellings. To achieve the design objectives, sampling fractions according to state and territories were set
as shown in the Table 6-5 below, which also shows the corresponding expected number of completely
responding households.

Table 6-5: National Nutrition and Physical Activity Survey, State/territory sample

NSWa

Vic.b

QLDc

SAd

WAe

Tas.f

NTg

ACTh

Aust.i

Approximate sampling fractions

1/1649

1/1568

1/1131

1/551

1/665

1/208

1/102

1/169

1/901

Expected fully responding households

1 750

1 650

1 580

1 250

1 310

920

740

820

10020

Source: ABS [370] aNew South Wales; bVictoria; cQueenland; dSouth Australia; eWestern Australia; fTasmania; gNorthern Territory;
h
Australian Capital Territory; iAustralia
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6.1.2.2.1 Data collection

Data for the NNPAS 2011-12 was collected using face-to-face interviewer administered questionnaire. The
questionnaire involved multiple approaches to collection. Information collected from the primary
questionnaire included:
•

Household information - basic demographic data about usual residents of the household (e.g. sex,
age, date of birth, birthplace, Indigenous status, marital status) and details of the relationship
between individuals in each household.

•

Personal Adult Interview - information was collected from the selected adult about demographic,
socio-economic and health characteristics (e.g. physical measurements, selected long-term health
conditions, and risk factors).

•

Personal (or proxy) Child Interview - information was collected on selected demographic and
health characteristics, including specific physical activity modules for 2-4 years and 5-17 years.
Questions on socio-economic characteristics and smoking were not asked of children aged under
15 years. Physical measurements were taken for children aged 2 years and older (5 years and older
for blood pressure measurements).

6.1.2.2.2 Estimated dietary anthocyanin intake and major food sources in
Australian adults

Estimation of anthocyanin intake occurred by applying a newly developed Australian anthocyanin database
to the dietary records. There is a total of 5740 foods in the Australian Food and Nutrient Database
(AUSNUT) 2011-13; of these, anthocyanin values were assigned to 318 individual foods.
The AUSNUT 2011–13 is a food composition database of food, dietary supplement and nutrient intake
estimates that was compiled from participants’ responses to the 2011‒12 NNPAS. For the current analysis,
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the NNPAS data was expanded to include anthocyanin content of reported foods and total intakes were
calculated based on the amount of food (g) consumed for each day of recall.
Using the two separate days of 24hr dietary recall data, usual anthocyanin intake was calculated using the
multiple source method (MSM) [371, 372]. The MSM comprises three steps. First, for each respondent in
the study sample, the probability of consumption of the response variable on a randomly selected day was
calculated. Secondly, the usual amount of food group intake on reported consumption days was estimated,
and finally, the usual overall intakes were calculated by multiplying probability of consumption of the
response variable with usual amount of intake on consumption days. Intake values were calculated within
the MSM model assuming all participants were habitual consumers, given anthocyanins are primarily
found in fruit and vegetables, with age and gender included as covariates. Two variables were produced in
the MSM output; usual daily intake of anthocyanins for the total population calculated by the MSM (e.g.
measure of habitual intake assuming population are consumers) and the usual intake of anthocyanins in
consumers only from the 24-h dietary recall calculated by the MSM. Both variables were used in the
statistical analysis (Figure 6-2).

6.1.2.2.3 Statistical Analysis

Statistical analysis was carried out using SAS (release 9.4, 2012; SAS Institute). Daily anthocyanin intake
was calculated and expressed as mean and standard error (SE). The total population analysis was based on
usual daily total anthocyanin intake for all participants and the consumer population analysis was based on
the usual intake of anthocyanins for consumers only. Intake of the major sub-classes of anthocyanins
(cyanidins, delphinidins, malvidins, pelargonidin, peonidins and petunidins) was also calculated.
Weighting factors (person weights and replicate weights produced by ABS [370]) were applied to the data
in order to generalise results to the total Australian population at the time of the survey and to account for
sampling discrepancies.
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Figure 6-2: Participant flowchart for secondary analysis of the Australian Health Survey, NNPAS
component

Mean anthocyanin intake for the total population and across sub-groups (age-groups, sex, Body Mass Index
(BMI), level of education, smoking status and level of physical activity) was calculated. Age-groups were
categorised according to those used in the National Health and Medical Research Council Nutrient
Reference Values (NRVs) for Australia and New Zealand [373]. For the purpose of the analysis, categories
of BMI, education, smoking and physical activity were grouped according to the ABS classifications with
similar classes grouped together (e.g. underweight Class 3, underweight Class 2 and underweight Class 1
grouped as ‘underweight’) and individuals aged less than 15y were classified as ‘not applicable’ to
maintain the integrity of the weighting factors applied [374].

Linear regression analysis was used to determine the relationship between anthocyanin intake and blood
pressure in the subgroup of adults aged 50+ y (Figure 6-2), while adjusting for age and gender (model 1)
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and adjusting for age, gender, BMI, physical activity, smoking status and whether diagnosed with high
blood pressure (by a health professional and/or measured BP >=140/90 mmHg) (model 2). Inclusion
criteria for this analysis were: i) adults aged 50 years and above and ii) who had a valid blood pressure
measurement
Level of significance was set at 0.05 and calculated from t-test for pair-wise comparisons or ANOVA to
determine if there are differences in any of the subgroups where appropriate.

6.1.2.3 Results

Dietary anthocyanin intake from the NNPAS was estimated to be 24.17 ± 0.32 mg/d for the total
population (n = 12,153) and 37.68mg/d for the consumer population (n = 8,958). Mean intakes for total and
subclasses of anthocyanins according to sociodemographic (gender, age-group, level of education) and
lifestyle (BMI, smoking status and physical activity) are reported in Table 6-6. There were more adults
than children (n = 9,341 vs 2,812) with no statistically significant difference in anthocyanin intake.
Respondents who had high physical activity levels consumed more anthocyanins compared to those who
had a sedentary lifestyle (30.04mg/d vs 20.42mg/d, <0.001). A similar trend was also observed for
respondents with a Bachelor’s degree compared to those with a diploma or lower (29mg/d vs 24mg/d, t-test
p-value <0.001).
The top ten food sources stratified by age are shown in Table 6-7. Berries are highly concentrated sources
of anthocyanins [310, 375] and were the top contributors to total anthocyanin intake across all age-groups.
The top ten food sources were reported as these made up more than 50% of the total anthocyanin intake
across all age-groups.

There was a significant inverse association between measured systolic and diastolic blood pressure and
anthocyanin intake (Table 6-8). This was evident for both systolic (β = -0.04, F (df) = 7.77 (2), R square =
0.01, p=0.001) and diastolic (β = -0.01, F (df) = 5.72 (2), R square = 0.01, p=0.005) blood pressure (Model
1: adjusted for age and gender). After controlling for further confounders (Model 2: age, gender, BMI,
physical activity, high BP diagnosis, smoking status and physical activity), the association remained
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significant (β = -0.04, F (df) = 16.8 (6), R square = 0.05, p<0.01 for systolic BP; and β = 0.01, F (df) = 5.35
(6), R square = 0.013, p<0.01 for diastolic BP).
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Table 6-6: Anthocyanin intakes by demographic and lifestyle factors for the Australian population (and consumer population) in 2011–12 NNPAS

Stratification
variable

N

Anthocyanins(mg/d)
Mean
SE
P

Cyanidins (mg/d)
Mean
SE
P

Delphinidin (mg/d)
Mean SE
P

Malvidin (mg/d)
Mean
SE
P

Pelargonidin (mg/d)
Mean SE
P

Peonidin (mg/d)
Mean SE
P

Petunidin (mg/d)
Mean SE
P

Total NNPAS
population
(consumer
population)

12153

24.17

0.32

9.33

0.13

3.03

0.07

7.61

0.20

0.12

0.01

1.12

0.02

1.05

0.04

(8958)

(37.68)

(0.41)

(15.22)

(0.23)

(5.07)

(0.12)

(14.14)

(0.42)

(0.21)

(0.02)

(1.99)

(0.05)

(1.98)

(0.08)

Gender

<0.001
(<0.001)

<0.001

<0.001

<0.001

<0.001

<0.001

<0.001

Male

5702
(4030)

23.62
(38.27)

0.41
(0.63)

9.41
(16.04)

0.17
(0.33)

2.83
(4.89)

0.06
(0.11)

7.46
(14.46)

0.29
(0.67)

0.11
(0.21)

0.01
(0.03)

1.08
(1.98)

0.03
(0.07)

1.00
(1.97)

0.04
(0.09)

Female

6451
(4928)

24.72
(37.14)

0.47
(0.67)

9.27
(14.49)

0.18
(0.29)

3.22
(5.24)

0.13
(0.22)

7.76
(13.85)

0.23
(0.48)

0.13
(0.21)

0.01
(0.02)

1.16
(2.00)

0.04
(0.08)

1.10
(2.00)

0.06
(0.13)

Age group (yrs.)

<0.001
(<0.001)

<0.001

<0.001

<0.001

<0.001

<0.001

<0.001

Children (≤18)

2812
(2071)

22.46
35.25

0.58
0.90

10.97
(17.96)

0.28
(0.45)

2.51
(4.04)

0.11
(0.18)

4.86
(9.33)

0.33
(0.72)

0.11
(0.20)

0.01
(0.02)

0.89
(1.58)

0.05
(0.09)

0.57
(1.08)

0.07
(0.14)

2-3

464
(378)

21.51
(31.11)

1.40
(1.86)

7.54
(11.06)

0.43
(0.83)

3.45
(5.59)

0.28
(0.44)

6.34
(11.18)

0.89
(1.53)

0.14
(0.27)

0.02
(0.04)

0.99
(1.67)

0.13
(0.21)

0.83
(1.49)

0.16
(0.27)

4-8

789
(633)

26.06
(37.04)

1.30
(1.78)

12.31
(18.60)

0.75
(1.17)

3.12
(4.59)

0.34
(0.52)

6.51
(11.55)

0.67
(1.25)

0.16
(0.26)

0.02
(0.03)

1.51
(1.87)

0.11
(0.19)

0.83
(1.40)

0.19
(0.31)

9-13

787
(576)

22.92
(36.29)

0.91
(1.40)

12.02
(20.01)

0.53
(0.86)

2.11
(3.42)

0.12
(0.21)

4.38
(8.54)

0.49
(1.14)

0.09
(0.16)

0.01
(0.02)

0.83
(1.50)

0.06
(0.11)

0.43
(0.87)

0.06
(0.15)

14-18

772
(484)

18.56
(33.69)

0.87
(1.74)

9.80
(18.13)

0.51
(1.09)

1.94
(3.29)

0.12
(0.22)

3.06
(6.41)

0.44
(1.22)

0.07
(0.14)

0.01
(0.02)

0.64
(1.25)

0.06
(0.15)

0.36
(0.72)

0.07
(0.18)

Adults (≥19)

9341
(6887)

24.66
38.38

0.35
0.44

8.87
(14.43)

0.13
(0.23)

3.17
(5.37)

0.07
(0.13)

8.39
(15.52)

0.23
(0.47)

0.12
(0.21)

0.01
(0.02)

1.18
(2.11)

0.03
(0.06)

1.19
(2.24)

0.04
(0.08)

19-30

1592
(1017)

19.24
(34.24)

0.68
(1.07)

8.48
(15.73)

0.29
(0.60)

2.42
(4.60)

0.13
(0.25)

4.62
(10.08)

0.45
(1.43)

0.16
(0.33)

0.04
(0.09)

0.78
(1.61)

0.05
(0.15)

0.57
(1.29)

0.06
(0.16)

31-50

3565
(2543)

25.66
(40.55)

0.66
(0.91)

9.58
(15.79)

0.27
(0.45)

3.22
(5.48)

0.14
(0.25)

8.40
(15.84)

0.41
(0.85)

0.11
(0.17)

0.01
(0.01)

1.19
(2.13)

0.05
(0.09)

1.24
(2.35)

0.07
(0.15)

51-70

2907

27.75

0.65

8.88

0.24

3.55

0.13

10.97

0.49

0.11

0.01

1.46

0.06

1.54

0.08
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Stratification
variable

71+

N
(2300)

Anthocyanins(mg/d)
Mean
SE
P
(40.20) (0.97)

Cyanidins (mg/d)
Mean
SE
P
(13.39) (0.42)

Delphinidin (mg/d)
Mean SE
P
(5.71) (0.27)

Malvidin (mg/d)
Mean
SE
P
(18.96) (0.98)

Pelargonidin (mg/d)
Mean SE
P
(0.18) (0.02)

Peonidin (mg/d)
Mean SE
P
(2.46) (0.11)

Petunidin (mg/d)
Mean SE
P
(2.75) (0.16)

1277
(1027)

24.61
(33.64)

7.29
(10.80)

3.64
(5.37)

9.60
(14.16)

0.14
(0.23)

1.27
(1.91)

1.39
(2.14)

1.15
(1.37)

BMI (kg/m2)

0.32
(0.48)

<0.001
(<0.001)

0.22
(0.33)

<0.001

0.61
(0.99)

<0.001

0.05
(0.09)

<0.001

0.09
(0.16)

<0.001

0.15
(0.24)

<0.001

<0.001

< 25

4876
(3668)

24.38
(37.76)

0.59
(0.83)

9.91
(16.04)

0.21
(0.39)

3.02
(4.99)

0.14
(0.22)

7.29
(13.73)

0.30
(0.64)

0.14
(0.24)

0.02
(0.03)

1.12
(1.99)

0.04
(0.08)

1.03
(1.96)

0.07
(0.13)

25 to < 30

3044
(2274)

25.51
(39.10)

0.58
(0.87)

9.21
(14.92)

0.25
(0.41)

3.10
(5.24)

0.09
(0.19)

8.96
(16.70)

0.45
(0.96)

0.12
(0.21)

0.02
(0.04)

1.25
(2.24)

0.05
(0.10)

1.24
(2.36)

0.06
(0.14)

≥ 30

2258
(1607)

23.23
(37.02)

0.76
(1.06)

8.53
(14.09)

0.30
(0.53)

3.08
(5.34)

0.15
(0.28)

7.36
(13.36)

0.46
(0.99)

0.09
(0.17)

0.02
(0.04)

1.06
(1.91)

0.06
(0.12)

1.00
(1.90)

0.07
(0.18)

Measurement
not taken

1975
(1409)

22.46
(35.68)

0.69
(1.09)

8.96
(14.74)

0.31
(0.56)

2.86
(4.71)

0.13
(0.27)

6.51
(11.67)

0.43
(0.92)

0.09
(0.16)

0.01
(0.01)

0.97
(1.62)

0.05
(0.10)

0.82
(1.47)

0.06
(0.13)

Level of
education

<0.001
(<0.001)

<0.001

<0.001

<0.001

<0.001

<0.001

<0.001

Not applicable

2180
(1676)

23.64
(35.87)

0.70
(1.08)

11.36
(18.06)

0.35
(0.61)

2.65
(4.21)

0.14
(0.22)

5.39
(10.10)

0.38
(0.81)

0.12
(0.22)

0.01
(0.02)

0.96
(1.68)

0.06
(0.11)

0.62
(1.16)

0.09
(0.17)

Post-Grad

770
(629)

30.09
(44.42)

1.47
(1.92)

10.08
(15.66)

0.57
(0.81)

3.70
(5.88)

0.22
(0.40)

11.46
(20.61)

0.86
(1.68)

0.12
(0.20)

0.02
(0.02)

1.57
(2.69)

0.10
(0.20)

1.71
(3.09)

0.14
(0.28)

Bachelors

1615
(1304)

29.90
(44.07)

1.22
(1.63)

10.84
(16.84)

0.35
(0.54)

3.75
(6.13)

0.27
(0.46)

10.07
(18.23)

0.65
(1.27)

0.17
(0.32)

0.04
(0.08)

1.46
(2.52)

0.09
(0.17)

1.54
(2.86)

0.13
(0.26)

Diploma/TAFE
Courses

3252
(2341)

24.61
(39.10)

0.56
(0.77)

8.74
(14.39)

0.21
(0.38)

3.07
(5.23)

0.12
(0.19)

8.71
(16.56)

0.35
(0.74)

0.12
(0.19)

0.02
(0.03)

1.22
(2.24)

0.04
(0.10)

1.21
(2.35)

0.06
(0.14)

No Non-School
Qualification

4190
(2893)

20.57
(32.99)

0.43
(0.71)

8.08
(13.54)

0.22
(0.44)

2.72
(4.68)

0.07
(0.17)

6.07
(11.02)

0.25
(0.59)

0.10
(0.18)

0.02
(0.04)

0.89
(1.55)

0.03
(0.06)

0.80
(1.48)

0.04
(0.08)

Level not
determined

146
(115)

29.06
(41.95)

2.40
(3.71)

9.32
(14.21)

1.04
(1.69)

4.43
(7.32)

0.67
(0.35)

10.25
(17.42)

1.60
(3.00)

0.09
(0.15)

0.02
(0.04)

1.35
(2.15)

0.17
(0.31)

1.53
(2.70)

0.27
(0.53)

Smoking status
Not applicable

<0.001
(<0.001)
2180
(1676)

23.64
(35.87)

0.70
(1.08)

<0.001
11.36
(18.06)

0.35
(0.61)

<0.001
2.65
(4.21)

0.14
(0.22)

<0.001
5.39
(10.10)

0.38
(0.81)

<0.01
0.12
(0.22)

0.01
(0.02)

<0.001
0.96
(1.68)

0.06
(0.11)

<0.001
0.62
(1.16)
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0.09
(0.17)

Stratification
variable

N

Anthocyanins(mg/d)
Mean
SE
P

Cyanidins (mg/d)
Mean
SE
P

Delphinidin (mg/d)
Mean SE
P

Malvidin (mg/d)
Mean
SE
P

Pelargonidin (mg/d)
Mean SE
P

Peonidin (mg/d)
Mean SE
P

Petunidin (mg/d)
Mean SE
P

Smoker

1813
(1073)

18.21
(32.61)

0.68
(1.10)

7.28
(13.38)

0.34
(0.68)

2.20
(4.14)

0.11
(0.25)

5.27
(10.52)

0.33
(0.87)

0.15
(0.26)

0.05
(0.11)

0.78
(1.43)

0.04
(0.10)

0.73
(1.47)

0.05
(0.13)

Ex-smoker

3096
(2365)

27.68
(41.65)

0.88
(1.34)

9.40
(14.81)

0.28
(0.45)

3.38
(5.42)

0.12
(0.21)

10.44
(18.77)

0.56
(1.10)

0.11
(0.17)

0.01
(0.01)

1.42
(2.48)

0.07
(0.13)

1.52
(2.82)

0.09
(0.18)

Never smoked

5064
(3844)

24.33
(37.41)

0.45
(0.70)

9.18
(14.79)

0.20
(0.33)

3.24
(5.46)

0.11
(0.20)

7.65
(14.01)

0.27
(0.58)

0.12
(0.22)

0.01
(0.03)

1.12
(1.97)

0.03
(0.07

1.06
(1.96)

0.05
(0.10)

Physical activity

<0.001
(<0.001)

<0.001

<0.001

<0.001

ns

<0.001

<0.001

Not applicable

2718
(2010)

22.64
(35.28)

0.60
(0.93)

10.99
(17.91)

0.28
(0.48)

2.54
(4.09)

0.11
(0.19)

4.98
(9.53)

0.35
(0.75)

0.11
(0.20)

0.01
(0.02)

0.90
(1.60)

0.05
(0.10)

0.57
(1.09)

0.08
(0.15)

High

1328
(1066)

30.04
(43.83)

1.11
(1.24)

11.34
(17.63)

0.48
(0.67)

3.92
(6.33)

0.35
(0.53)

9.58
(17.28)

0.72
(1.26)

0.11
0.20)

0.01
(0.02)

1.45
(2.49)

0.09
(0.17)

1.47
(2.73)

0.14
(0.24)

Moderate

2574
(1950)

25.99
(39.50)

0.69
(0.96)

9.17
(14.55)

0.28
(0.43)

3.32
(5.53)

0.10
(0.20)

9.33
(17.07)

0.40
(0.83)

0.13
(0.21)

0.02
(0.04)

1.31
(2.30)

0.05
(0.10)

1.39
(2.62)

0.07
(0.15)

Low

3351
(2461)

23.57
(37.13)

0.57
(0.83)

8.44
(13.92)

0.20
(0.37)

2.99
(5.06)

0.10
(0.19)

8.12
(15.05)

0.38
(0.78)

0.10
(0.19)

0.01
(0.03)

1.13
(2.01)

0.05
(0.09)

1.08
(2.01)

0.06
(0.12)

Sedentary

2075
(1398)

20.42
(34.05)

0.73
(1.27)

7.40
(12.56)

0.27
(0.49)

2.68
(4.74)

0.15
(0.31)

6.44
(12.04)

0.45
(1.04)

0.15
0.25)

0.04
(0.08)

0.90
(1.63)

0.05
(0.13)

0.86
(1.62)

0.07
(0.17)

Not stated

107
(73)

26.59
(39.30)

4.93
(6.77)

12.55
(19.03)

3.28
(5.12)

3.28
(4.86)

0.67
(1.15)

7.15
(11.82)

1.54
(3.13)

0.21
(0.37)

0.12
(0.23)

0.99
(1.57)

0.17
(0.32)

1.00
(1.78)

0.22
(0.45)

p values significant at <0.05 using ANOVA
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Table 6-7: Top ten food sources of anthocyanins in the diet of the Australian population, by age-group
% total anthocyanin intake per age group
Age (years)
n

2-3
464

4-8
7891

9-13
787

14-18
7722

19-30
1592

31-50
3565

51-70
2907

71+
1277

1.

Blackberry,
raw

36.6

Blackberry,
raw

65.2

Blackberry,
raw

37.5

Cherry, raw

23.9

Grape, raw,3

15.4

Eggplant,4

8.1

Eggplant,4

23.1

Eggplant,4

26.4

2.

Raspberry,
raw

12.8

Blueberry,
raw

8.3

Blueberry, raw

12.7

Eggplant,4

15.7

Cherry, raw

8.5

Blackberry,
raw

7.4

Grape, raw,3

9.1

Wine, red,

10.3

3.

Blueberry,
raw

10.3

Grape, raw3

4.9

Grape, raw3

11.2

Grape, raw3

14.9

Cranberry,
raw

8.2

Cherry, raw

5.7

Blackberry,
raw

8.4

Cherry, raw

8.3

4.

Grape,
raw3

8.6

Cherry, raw

2.6

Cherry, raw

7.3

Raspberry,
purchased
frozen

8.9

Eggplant,4

5.3

Blueberry,
raw

5.1

Wine, red

7.8

Blueberry,
raw

7.1

5.

Cabbage,
red, raw

8.8

Raspberry,
purchased
frozen

2.4

Eggplant4

7.0

Blueberry, raw

8.5

Plum,
unpeeled,
raw

4.9

Raspberry,
raw

4.9

Blueberry,
raw

7.1

Blackberry,
raw

5.1

6.

Cherry,
raw

4.0

Plum,
unpeeled, raw

2.4

Plum,
unpeeled, raw

4.8

Cabbage, red,
raw

5.9

Bean, black,5

4.5

Cranberry,
raw

4.8

Cherry, raw

6.3

Plum,
unpeeled, raw

4.9

Raspberry,
purchased
frozen

3.4

Blueberry,
purchased
frozen

2.1

Raspberry, raw

3.2

Plum,
unpeeled, raw

5.4

Raspberry,
purchased
frozen

3.9

Grape, black
sultana, raw

4.6

Plum,
unpeeled, raw

4.7

Raspberry,
purchased
frozen

4.7

7.

Plum,
unpeeled,
raw

3.2

Eggplant4

2.0

Raspberry,
purchased
frozen

2.6

Blueberry,
purchased
frozen

2.0

Blueberry,
raw

3.8

Radish,
peeled or
unpeeled, raw

4.4

Raspberry,
raw

2.9

Grape,
Thompson,

3.4

8.

Eggplant4

2.7

Raspberry,
raw

1.3

Apple, red
skin, unpeeled,
raw

1.6

Apple, red
skin,
unpeeled, raw

1.7

Wine, red

3.8

Raspberry,
purchased
frozen

4.3

Blueberry,
purchased
frozen

2.6

Radish, raw

3.2

Blueberry,
purchased
frozen

1.4

Apple, pink
lady,
unpeeled, raw

0.9

Pear, unpeeled,
raw, not further
defined

1.3

Pear,
unpeeled, raw,
not further
defined

1.5

Raspberry,
raw

3.2

Wine, red,
sparkling

4.1

Cabbage, red,
raw

2.4

Raspberry,
raw

2.9

9.

10

91.8

92.1

89.2

88.5

61.6

53.5

74.4

76.3

Sum
1

n=2 excluded due to implausible dietary consumption data, 2n=1 excluded due to implausible dietary consumption data, 3 Combination of Grape, raw, Grape, red, raw, and Grape, Thompson, seedless; 4Eggplant, peeled or unpeeled, fresh or frozen, raw; 5Bean, black, dried, boiled, microwaved or steamed, drained
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Table 6-8: Association between anthocyanin intake and change in blood pressure in adults aged 50+yrs

BP
parameters

Anthocyanin intake in all population (consumer population)
Effect size (regression coefficient and 95% Confidence Interval) per unit (mg) increase

Regression
coefficient

Model 11
n=4184 (3327)
95% CI

p value

Regression
coefficient

Model 22
n=4184 (3327)
95% CI

p value

Systolic BP

-0.04
(-0.03)

-0.06, -0.01
(-0.05, -0.01)

0.001*
(0.002)*

-0.04
(-0.03)

-0.06, -0.01
(-0.05, -0.01)

<0.01*
(<0.01)*

Gender

-2.50
(-2.51)

-4.28, -0.72
(-4.45, -0.58)

0.01
(0.01)

-2.67
(-2.68)

-4.40, -0.94
(-4.62, -0.74)

0.003*
(0.01)*

0.06
(0.1)

-0.002, 0.12
(-0.004, 0.1)

0.06
(0.07)

High BP
diagnosis

-7.92
(-7.38)

-9.80, -6.05
(-9.63, -5.12)

<0.001*
(<0.001)*

Smoking
status

0.70
(1.06)

-0.06, 1.46
(0.11, 2.01)

0.07
(0.03)*

Physical
activity

0.09
(0.15)

-0.61, 0.78
(-0.63, 0.92)

0.80
(0.7)

BMI

Diastolic BP

0.01
(0.01)

-0.01, 0.02
(-0.01, 0.02)

0.005*
(0.03)

0.01
(0.01)

-0.01, 0.03
(-0.01, 0.02)

<0.01*
(0.02)*

Gender

-1.56
(-1.31)

-2.51, -0.62
(-2.40, -0.22)

0.002
(0.02)

-1.52
(-1.30)

-2.49, -0.54
(-2.42, -0.18)

0.002*
(0.02)*

BMI

0.06
(0.06)

0.03, 0.09
(0.02, 0.11)

<0.001*
(0.01)*

High BP
diagnosis

-0.77
(-0.54)

-1.76, 0.22
(-1.64, 0.55)

0.12
(0.33)

Smoking
status

-0.24
(-0.19)

-0.64, 0.16
(-0.68, 0.30)

0.24
(0.44)

Physical
activity

-0.09
(-0.04)

-0.53, 0.35
(-0.49, 0.42)

0.68
(0.88)

1

Model 1 covariates = age (included as a class variable) and gender; 2Model 2 covariates = age (included as a class variable), gender,
BMI, hypertension diagnosis, Physical activity and smoking status; * Significant at p<0.05; values in bracket represent analysis for
consumer population.
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6.1.2.4 Discussion

Using nationally representative dietary survey data, this study reports an observed wide distribution of
anthocyanin intake in the Australian population. The estimated mean intake was 24.17 ± 0.32mg/d which is
midway between estimates reported for other populations that range between 2.9 and 42.79mg/d (Table 69), and was above average in comparison to the world composite database [376]. There were variations in
anthocyanin intake across subgroups analysed, for example a higher anthocyanin intake in the 51-70y agegroup (27.75 ± 0.65 mg/d) compared to the lowest consumption (18.56 ± 0.87 mg/d) in the 14-18y agegroup (p<0.001). Adults with a post-graduate qualification had higher anthocyanin intakes (30.09 ± 1.47
mg/d) compared to those without school qualifications (20.57 ± 0.43mg/d) (p<0.001), while highly active
adults (30.04 ± 1.11mg/d) had higher intakes compared to sedentary respondents (20.42 ± 0.73mg/d)
(p<0.001). These results are consistent with previous reports on the significant association between sociodemographic and lifestyle factors and fruit and vegetable consumption [377-380]. Surprisingly, ex-smokers
reportedly consumed significantly higher daily anthocyanins (27.68 ± 0.88 mg/d), more than both smokers
(18.21 ± 0.68 mg/d) and non-smokers (24.33 ± 0.45 mg/d). Zamora-Ros et al.(2010) [381] similarly
reported that ex-smokers consumed more anthocyanins (11.16mg/d) than non-smokers (10.62mg/d).

Estimation of anthocyanin intake in the Australian population is an important preliminary step in
understanding anthocyanin-health relationships. Despite increased research interest on the observed health
benefits of anthocyanins provided by food and beverages, the accompanying increased prevalence of
consumption of processed foods translates to a reduced consumption of dietary anthocyanins [382]. In the
1970s, average daily dietary anthocyanin intake in the USA. was estimated at 215 mg/d in the summer and
180 mg/d during winter [383]. Current estimates show that dietary anthocyanin intake ranges between 343mg/day across countries and tends to be higher in Southern compared to Northern European countries
(Table 6-9).
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Table 6-9: Reported anthocyanin intake (mg/d) in population studies by country

Country (reference)

Sample size

Age/Gender1

Dietary assessment

Total anthocyanin
intake (mg/d)

Australia (this study)

12,153

≥2yrs

2 x 24h DR (MSM
method)

24.17

Australia [337]

10,851

≥2yrs.

24h DR

1.4

Australia [338]

79

≥49yrs

4-day WFR

7.0

1393

35-75

FFQ

282

35-74yrs.

FFQ (GA2LEN)

China [384]
Europe [385]
Denmark
Finland
Sweden
UK
Portugal
Belgium
Germany
Netherlands
(Amsterdam)
Poland
Europe [386]
Greece
Spain
Italy

268
122
1,085
139
233
107
305
174

7.5
5.9
6.5
9.8
22.1
10.5
5.5
8.1

116

9.2
35-74yrs.

2,687
3,220
3,953

24h DR
31.82
31.58
42.79

35-74yrs./F (1 out of
5 centres)

France
Germany
The
Netherlands
UK

4,735
4,415
3,980

Denmark
Sweden
Norway

3,917
6,050
1,797

35-74yrs./F

Finland [387]

1950

42-60yrs./M

4-day food record

6.2

Finland [388]

2007

25-64yrs.

48h diet recall

47

France [389]

4942

45-60yrs.

≥6 24h diet recall

35

Spain [381]

40,683

35-64yrs.

Diet history
questionnaire

18.88

United Kingdom [390]

1,997

18-76yrs./F

FFQ

18

USA [391]

8,809

>19yrs.

24h diet recall

3.1

USA [392]

5,420

≥20

24h diet recall

11.48

1,280

37.42
35.09
22.56

35-74yrs./F

35-74yrs./F (1 out of
2 centres)

26.12
28.21
20.96
26.56

1

gender specified when sample size is gender specific; WFR, weighted food record; 24hrDR, 24hr dietary recall; 2excludes malvidin
and petunidin

Consumption of anthocyanin subclasses were also reported for the total and consumer populations.
Cyanidins and malvidins were the most prevalent anthocyanins in both the general and consumer
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populations and across subgroups. In the 51-70y age-group, malvidins were the most prevalent
anthocyanins. This could be explained by the difference in consumption pattern of the major food
contributors of anthocyanins in this age-group being red wine, which has a high content of malvidins. A
similar trend was also observed in other Australian population studies [337, 338] with red wine being
reported as a major contributor of anthocyanins in older participants. The highest contributing foods (top
10) of dietary anthocyanin in the Australian population were berries, principally blueberries, blackberries,
raspberries, and cherries. Berries are known to contain a very high concentration of anthocyanins [393].
Given this, anthocyanin research has generally focused on berries at the expense of other high anthocyanin
foods, such as plums and eggplants which also made up some of the top 10 contributors of anthocyanins in
the Australian population. Accordingly, it might be worth further exploration to gather epidemiological
evidence of the health-related benefits related to these foods.

Results from this study showed a significant association between anthocyanin intake in older adults and
lower blood pressure. This result is in agreement with current evidence from clinical and epidemiological
studies on the effect of dietary anthocyanins on blood pressure in acute settings and over the longer term
[214, 301, 394] . Anthocyanins have also been classified as nutraceuticals in their ability, as part of a food
component, to provide health and medical benefits [395]. However, it is unlikely that these health benefits
are the independent effects of anthocyanins but rather represent a synergistic effect with other polyphenols
found in foods [396]. This emphasises the importance of studying anthocyanin food sources, consistent
with this study, rather than isolated anthocyanin extracts. A review by Pascual-Teresa et al. (2010) [397]
observed that evidence related to the protective effects of anthocyanins, as part of the diet, against
cardiovascular disease risks has been consistent over the years. Dietary patterns high in fruits and
vegetables such as blueberries, apples, and leafy greens that are high in natural antioxidants and
polyphenols (anthocyanins) have been shown to reduce the risk of high blood pressure [398] and other
chronic diseases evident in the Dietary Inflammatory Index (DII) [399]. This evidence has been consistent
with similar dietary patterns. Using the Dietary Inflammatory Index, Steck et. al (2014) [400] found that
the Mediterranean diet showed anti-inflammatory potential based on the resulting DII scores. In addition,
the Nordic diet significantly reduced 24-h ambulatory diastolic blood pressure (DBP) and mean arterial
pressure in comparison to a control diet based on mean nutrient intakes in Nordic countries [401]. Other
dietary patterns that emphasise high fruit and vegetable intake (the Dietary Approach to Stop
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Hypertension), low-carbohydrate, Palaeolithic, high-protein, low-glycaemic index, low-sodium, and lowfat diets) were also found to significantly reduce blood pressure (systolic blood pressure (−8.73 to
−2.32 mmHg) and DBP (−4.85 to −1.27 mmHg)) in comparison to control/usual diets [402]. Attributable
risk related to the polyphenols present in these diets (i.e. anthocyanins) cannot be disentangled from other
health-promoting components of key foods included in these blood pressure lowering dietary patterns.

Previous studies have estimated the dietary flavonoid intake in selected Australian populations using
weighed food records [338] and from National Nutrition Survey (1995) data using a single 24-h dietary
recall questionnaire [337]. Our results using the latest nationally representative survey data differ
significantly from earlier studies with higher values reported in the current study. This is possibly due to
differences in the method of dietary assessments, as well as the use of the MSM to calculate usual daily
intake from two repeated 24-h dietary recalls. Differences could also be as a result of difference/change in
population characteristics. Our analysis indicates that the Australian population consume intermediate
quantities of anthocyanins compared to other populations (Table 6-9), but that are similar to estimates from
some European countries including Belgium, Norway, Sweden and Denmark [385, 386]. A need for
tailored food composition databases for nutritional epidemiological studies cannot be overemphasised.
Following the development of the first Australian food composition database in the mid-1980s,
comparative analysis showed that using the UK and US databases overestimated specific nutrient contents
by up to 60% [403]. As a result, it is imperative that databases be tailored to the specific food supply of the
population under study. However, development of nutrient databases is fraught with incomplete coverage
of all nutrients hence, borrowing and calculating nutrient values is a known validated method in the
absence of analytical values [404].

To our knowledge, this is the first time that dietary anthocyanin intake in the Australian population has
been estimated using an Australian-specific anthocyanin database, this being a major methodological
strength. Another notable strength is the use of a representative sample of the Australian population, as
well as the validated method (MSM) of calculating usual nutrient intake from repeated 24h dietary recalls
[371]. Some of the limitations of this study include the use of 24-h diet recall questionnaires in the NNPAS
(1-2). The single 24-h diet recall has been deemed insufficient because of the retrospective method of
dietary assessment and an inability to describe the typical diet from a single day’s intake. In addition, the
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recall is dependent on the memory and cooperation of the participant [405]. Four repeated 24-h diet recalls
have been recommended as the most appropriate method for large surveys,[406] while two were applied in
the NNPAS. This study analysis applied a regression model to these data to better represent usual intake
although no adjustments were made to potential misreporting of the data. A further limitation relates to the
effects of processing and storage [407] which was not taken into consideration in the borrowed data used
from USDA and Phenol-Explorer food composition databases. In addition, the omission of anthocyanin
intake from dietary supplements is a notable limitation of this study. It is however unlikely that such
supplements are widely used in Australia, and composition of supplements and extracts in the AUSNUT
food composition database did not include polyphenols (anthocyanins). Finally, out of the 5,700 foods in
the AUSNUT database, about 300 of them, which did not include recipes, were assigned an anthocyanin
value. Each of these elements could have led to both over- and underestimation of anthocyanin intake. In
addition, for the purpose of this study, total anthocyanins were considered to be the major anthocyanin
subgroups (cyanidin, delphinidin, peonidin, petunidin, pelargonidin and malvidin).

The cross-sectional nature of this study limits interpretation of the inverse association found between
anthocyanin intake and blood pressure. However, evidence is beginning to emerge from experimental
studies that support a protective role of anthocyanins on CVD risk in both young and older adults [408].
For two foods, plum and red cabbage, the Australian analytical data only reported total anthocyanins but
not anthocyanin subclasses. Many fruits and vegetables that are high in anthocyanins are seasonal,
available only in summer and autumn in Australia, therefore contribution to total intake will depend on the
time of year that surveys are conducted. For example, red cabbage is a rich source of anthocyanins but
accounted for less than 1% (0.2%) of total anthocyanin intake in the Australian population. This could also
be as a result of not many people consuming red cabbage.

Although different methods have been described for estimating usual intake, the MSM method involves
similar steps to the National Cancer Institute (NCI) method but uses different modelling procedures and
handling of non-consumers [409]. Comparison of the different methods, including those from Iowa State
University (ISU), NCI, MSM and Statistical Program to Assess Dietary Exposure (SPADE), showed that
with small sample sizes (n = 150), the ISU, MSM and SPADE methods were more reliable and showed
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more precise estimates than the NCI method, mainly for the 10th and 90th percentiles. The observed
differences between methods became less significant with larger sample sizes (n = 300 and n = 500) [410].

6.1.2.5 Conclusion

In conclusion, this study estimates for the first time, mean daily intake of anthocyanin in the Australian
population, according to sociodemographic characteristics, using an Australian-specific anthocyanin food
composition database. Given the rapidly emerging evidence base related to the beneficial effects of
anthocyanins on cardiovascular risk factors, it is timeous to assess population-level intake of this flavonoid
subgroup. Anthocyanin intake in the Australian population was similar to that reported in southern
European countries, and higher than in Northern Europe and USA. Identification of major dietary sources
of anthocyanins (blackberry, raspberry, blueberry, cherry, red cabbage, eggplant and red wine) allows for
focused dietary messaging.

It is worth noting that association does not infer causation and in the general overview of this body of
work, results are not comparable across studies (Chapters 3, 5 and 6.2) due to the difference in study and
experimental designs: acute crossover trial vs longer-term randomised crossover trial vs secondary analysis
of cross-sectional data, respectively. However, results from this secondary analysis showed that there was a
significant association between a mean intake of 24.17mg/d of anthocyanins and BP in adults aged 50+
years. In comparison to the acute crossover trial (Chapter 3) and longer-term RCT (Chapter 5), anthocyanin
intake in the Australian population was lower than the amount provided in the acute trial intervention
(369mg) but higher than the RCT intervention (50mg/L) which further limits comparison of results.
Despite this, the current analysis of population-based data on anthocyanin intake provides a minimum
benchmark against which to compare anthocyanin interventions in the design of future clinical trials. In
addition, the main sources of anthocyanins identified in this nationally representative sample of Australians
(berries) are consistent with the anthocyanin sources that have generally been provided in intervention
studies. It is unknown whether the research focus to date on berries has influenced consumer behaviour, or
if the dietary survey data reflects cultural cuisine or other influences on dietary behaviour. A broader focus
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of health-related research that extends to other anthocyanin-containing foods such as plums and other less
studied foods with varying anthocyanin profiles may result in changes in fruit preferences in future.
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7

CHAPTER 7

7.1 CONCLUSIONS AND RECOMMENDATIONS
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7.1.1

Overview of core findings

The body of research presented in this thesis used a mixed method approach to address the central research
question. This approach covered domains of: a) current knowledge synthesis (systematic literature
reviews), b) knowledge generation (clinical trials) and, c) knowledge translation (epidemiological analysis
to identify key dietary sources of anthocyanins in the Australian population for application of clinical trial
data to dietary guidance). The central research question investigated was the extent to which consumption
of anthocyanins from plums improved health outcomes, specifically the role of anthocyanins derived from
the Queen Garnet Plum, on various domains of cognitive function, blood pressure parameters and changes
to the gut microbiota. To contextualise these findings, the dietary anthocyanin intake of the Australian
population was identified by applying a novel anthocyanin food composition database to national nutrition
survey data.

Anthocyanins are ubiquitously distributed in dark red and purple plant foods, with the highest
concentration found in berries. As a result, research into the beneficial health effects of anthocyanins to
date has focused on this food source [21]. However, the focus on berries in anthocyanin research limits
generalisation of findings to broader dietary advice. Anthocyanin-rich foods are classified into three main
groups according to their major type of anthocyanin aglycone complexes present in the food: namely,
pelargonidin; cyanidin/peonidin; and multiple anthocyanins. Berries have been classified under these three
different groups i.e. strawberries (pelargonidin), blueberries (multiple anthocyanins) and raspberries/plums
(cyanidin/peonidin) [98] which highlights the need to generate evidence from the different anthocyanin
group classifications. With the availability of numerous fruits and vegetables that are rich in anthocyanins
but limited in clinical evidence, one of the main objectives of this research was to further investigate the
beneficial health effects of anthocyanins from a different anthocyanin-rich source i.e. plum juice.

As a first step, a systematic literature review was undertaken to summarise the evidence on the beneficial
health effects of plums (Chapter 2). Results from the review showed that the largest amount of clinical trial
evidence relates to the prevention and management of osteoporosis and overall bone health. However,
many of the study designs were of low quality and the research conducted with non-healthy participants.
Although a number of outcomes have been studied in animal models, there was no confirmatory clinical
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evidence from trials in humans, thus limiting the usefulness of the current literature. For example, there
was no available evidence from clinical trials on the effects of plum consumption on cognition even though
this outcome has been studied using animal models and, likewise, there was only limited evidence related
to cardiovascular responses.

To address this gap in the literature on the health effects of plum consumption in humans, a pilot cross-over
study was designed to assess the acute impact of differing doses provided by the Queen Garnet plum juice
on cognition, blood pressure and bioavailability which was assessed by determination of urinary
biomarkers in both younger and older adults (chapter 3). This study was conducted early on in the PhD
work in order to further inform the design of a later clinical trial regarding the effect of consuming a
previously demonstrated effective physiological dosage of anthocyanins [214] in three smaller quantities
rather than as a single dose. Queen Garnet Plum juice was provided to participants, either as a single 300
mL dose (equivalent of 123mg anthocyanins) or as 3x100mL doses consumed over a 3h period. The crossover study design was used in this study in order to reduce between-subject variability, with each subject
acting as their own control, and thus increasing the study power [411]. Results from the pilot crossover
study demonstrated a significant reduction in blood pressure for both young and older adults following
consumption of QGP juice, with more obvious BP reduction in the older age-group. There was no observed
dose-timing effect, nor was there an acute effect on cognitive function.

Following the completion of the acute pilot crossover study, an 8-week randomised crossover trial was
planned. To further develop the hypothesis from the pilot trial and better elucidate proposed mechanisms of
effect of plum juice anthocyanins, changes in gut microbiota were investigated. Additionally, in order to
understand and summarise the current evidence on the effect of anthocyanins on gut microbiota, a second
systematic literature review (chapter 4) was undertaken. The gut-brain axis is influenced by the microbiota
populations in the gut [412], and this is a rapidly emerging area. The review did not identify any
experimental evidence on the effects of anthocyanins derived from plums, specifically on gut microbiota
profiles, and there was a general paucity of evidence in totality for the anthocyanin-gut microbiota
relationship. With over 1000 species of bacteria in the gut, results from this review highlighted potential
bacteria species that might be affected by anthocyanin consumption. There was an observed proliferative
effect on Bifidobacterium spp., known for their wide use in probiotics and for the treatment of Irritable
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Bowel Syndrome and inhibition of Clostridium histolyticum, which has been shown to be pathogenic in
humans. The review also informed our analysis of the gut microbiota data obtained in our RCT.

An 8-week randomised crossover clinical trial was undertaken to determine the effect and within patient
variation of daily consumption of 200mL of anthocyanin-rich Queen Garnet plum juice or raspberry cordial
(control) on cognition and ambulatory blood pressure in healthy older adults (55+ years) (chapter 5).
Secondary outcomes included anti-inflammatory markers (C-reactive protein and BDNF), urinary
anthocyanin metabolites, changes in anthropometrics and physical abilities and gut microbiota. Results
from this study showed that the acute blood pressure effects observed in the pilot study were no longer
evident in the longer term, while a lack of effect on cognitive function remained for both studies. There
were also no demonstrated effects on anti-inflammatory biomarkers; however, anthocyanins derived from
QGP, may affect total population of gut bacteria, but not necessarily impact on specific gut bacteria. The
clinical significance of this finding warrants further exploration.

This study has significantly contributed to the body of evidence on the health effects of dietary
anthocyanins. For the first time, a well-designed crossover human clinical trial has explored the effects of
anthocyanins from plums on outcomes related to the gut-brain axis in otherwise healthy adults. Our results
indicate that the effects seen in older adults with dementia are not translatable to healthy ageing
individuals. Even though results from the acute trial were not comparable to the longer-term 8-week trial,
this research highlighted issues for future considerations in anthocyanin research.

The final study in this thesis comprised development of an Australian anthocyanin food composition
database (chapter 6.1). This database development is the first step in achieving appropriate measurement of
flavonoid intake, with anthocyanins being the first step, for use in Australian epidemiological studies, as
well as dietary clinical trials. Following the development of this database, a secondary data analysis of
anthocyanin intake in the Australian population was undertaken. This was done using the National
Nutrition and Physical Activity Survey component of the Australian Health Survey (chapter 6.2). Even
though this is the first stage in the development of an Australian-specific food composition database for
anthocyanin content of local foods, it was adequate to measure anthocyanin intake in the Australian
population. Results showed an intermediate anthocyanin intake among Australians, as compared to intakes
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in other countries that are reported in the world composite database (24.17 ± 0.32 in the current study vs
18.05 ± 21.14 mg/day). Further progression of the Australian anthocyanin database will include updates in
order to produce a robust database which will further facilitate measurement of anthocyanin consumption.
In the future, efforts will be made to expand this database to include the full range of other flavonoid
classes and subclasses.

7.1.2

Strengths and limitations

The different methods employed in this body of research have their strengths and limitations which are
briefly outlined below. These strengths and limitations have been described more comprehensively in each
of the thesis chapters.

As research on anthocyanins continues to show beneficial health effects, it is important to note that
nutrients are not consumed individually but are consumed within food matrices within a more complex
dietary pattern. As such, there is a possibility that any demonstrated health effects may be due to the
anthocyanins present in foods or as a result of the synergistic effect of the anthocyanins with other nutrients
of non-nutritive components in the same food or present in other foods consumed at the same time as part
of a meal. As a result, there needs to be a strong evidence base from confirmatory studies. As a first step,
anthocyanin-rich foods rather than anthocyanin standards of individual components should be utilised in
clinical trials. For the research included in this thesis, QGPJ was utilised. The QGP was processed to juice
using methods that minimise nutrient degradation and utilised 100% of the fruit flesh and skin.

In assessing the positive health effects of anthocyanins, high levels of evidence are needed. Within this
framework, the research presented in this thesis has summarised existing evidence but also generated novel
findings related to consumption of anthocyanins from plums. The inter-individual variability in the
metabolism of anthocyanins have been well documented [41] therefore the cross-over study design was
considered best for both the acute and longer term clinical trials (Studies 2 and 4), because participants
acted as their own control.
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This research highlighted the limitations in precise measurement of flavonoid (anthocyanin) intake in
population studies due to a lack of appropriate food composition databases available. Study 5 of this thesis
addressed this knowledge gap in the first stage development of an Australian anthocyanin database in order
to better estimate anthocyanin intake, and in the long-term flavonoid, intake in Australian population
studies.

There are a number of limitations related to this body of research on the effects of anthocyanins from QG
plum on cognition, blood pressure, inflammatory biomarkers and the gut microbiota population. The
research main focused on anthocyanins and used a specially bred Japanese plum hybrid that was high in
anthocyanins as the food delivery vehicle. Extrapolation of the findings to plums in general is limited,
therefore it may be worth conducting similar studies with regular plum varieties to confirm these findings.
Additionally, current evidence shows that the potential positive health effects of anthocyanins from food
may be due to their circulation in blood as phenolic acid metabolites [413]. This body of research was
limited in resources to conduct this analysis. Hence the lack of characterisation of these plasma metabolites
in the current body of work is a limitation.

Another limitation in the body of anthocyanin research which prevents direct comparison of results across
studies is the low stability of anthocyanins and differences in concentrations provided in clinical trials.
Anthocyanin stability is affected by a number of factors including; temperature, pH, the structure and
concentration of the pigment, light, co-pigments, enzymes, oxygen, metallic ions, sulphur dioxide, and
sugar [414]. Processing, and storage have been shown to significantly degrade anthocyanins [342]. The
processing of fruits to juice/powder usually involves high temperatures to ensure microbiological stability.
In the case of anthocyanins which are heat sensitive, they have been shown to degrade up to 90% when
exposed to high temperatures [343]. This is a major limitation in intervention studies in which anthocyaninrich foods are usually delivered in their juice or power forms [21]. This is not unusual as statistics show
that in developed countries, 50% of plum produce are consumed in processed forms [415].This emphasises
the need for more efficient ways of processing anthocyanin foods without degrading a significant part of its
anthocyanin content [416]. High temperature processing of anthocyanins leads to the production of
furfural compounds during the degradation of sugars and ascorbic acid, thereby degrading them in foods
[415]. As anthocyanins are responsible for the red, purple and blue pigments in fruits, colour is an

177

important determinant in product quality hence minimising the pigment losses during processing is an
important consideration in the processing and storage of anthocyanin-rich foods [417]. Long-term storage
of anthocyanin-rich foods have also been shown to degrade anthocyanin. When plum juice, for example,
was stored for a period of 6 months at room temperature, its anthocyanins degraded drastically up to 90%,
with lower storage temperature (4oC) reducing the degradation process (50%) [343]. In the present body of
work, there was a considerable difference in the storage times of study beverages used in the acute dosetiming study (2 months frozen) compared to the 8-week RCT (10 months frozen and then refrigerated) as
well as duration of the two trials (4 weeks vs 8 months). It is also important to note that the study juice was
supplied in batches and as a result stored for the duration of the study. Processing, storage as well as the
low stability of anthocyanins has limited results comparison across anthocyanin research, as well as their
use in the food industry [416].

Additionally, in assessing the amount of anthocyanin intake in the Australian population and its association
with blood pressure, the cross-sectional nature of the data is a major limitation which does not allow for
determination of causality.

7.1.3

Future research and recommendations

This research has made a significant contrition to the area of anthocyanin research, specifically in relation
to QGP. Nonetheless, there is a need for ongoing research to further contribute to a stronger evidence base.
Following on from the findings of this research, a number of key points and recommendations for future
research are highlighted below:

•

As a first step, this research resulted in the development of an Australian anthocyanin database,
and further expansion of using generated analytical values for anthocyanins and flavonoids in
general is required. The effect of processing on the flavonoid content of these Australian foods
needs to be taken into consideration in order to progress this database development and improve
its accuracy;
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•

Identifying the nutritive and non-nutritive composition of regular plums and prunes in comparison
to QG plums and the effects of processing on their bioactivity are also important for future
research in order to define the overall health effects of plums/prunes. Further clarification of the
mechanisms of action of plum polyphenols, identification of potential adverse effects and the
effects of dosage on outcomes is necessary to inform dietary guidelines for chronic disease
prevention and management;

•

To confirm these observed effects of anthocyanins, it is recommended that further research is
conducted using other high anthocyanin foods. This is required in order to identify the synergistic
effects of nutrients and food matrices that may be contributing to observed effects. There is also
the need for future studies to focus on ways to stabilise or reduce degradation of anthocyanins in
foods from processing as a first step. In addition, measuring anthocyanin content for the duration
of a trial to monitor anthocyanin deration over time is also an important consideration in order to
compare and generalise conclusions across studies.

7.1.4

Conclusion

In conclusion, this body of research has summarised and addressed knowledge gaps in relation to the acute
and longer-term health effects of dietary anthocyanins, specifically provided by a high anthocyanin variant
of plum (Queen Garnet), as well as developed an Australian anthocyanin food composition database. A
total of five studies were undertaken to address the research question on the acute and longer-term effects
of consumption of anthocyanin containing plum juice on cognition and other health parameters in older
adults.

Each study constituting this thesis contributed novel and original evidence. Current evidence was
synthesised and gaps in current literature were identified from the systematic literature reviews. As part of
addressing these gaps and generating new evidence, two RCTs were conducted which added to the
evidence base of anthocyanin research. Finally, a knowledge translation aspect of this thesis related to
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identifying key sources of anthocyanin in the Australian population and amount of intake. Collectively,
these studies progress scientific evidence around knowledge gaps on dietary anthocyanins and in a larger
context how nutrients as part of food and diet, appropriately modified, can impact health outcomes in
humans and influence chronic diseases.

180

8 List of References

1.

Rodriguez-Casado, A., The health potential of fruits and vegetables phytochemicals: notable
examples. Crit. Rev. Food Sci. Nutr., 2016. 56(7): p. 1097-1107.

2.

Patra, A.K., An overview of antimicrobial properties of different classes of phytochemicals, in
Dietary phytochemicals and microbes. 2012, Springer. p. 1-32.

3.

Hjartåker, A., M.D. Knudsen, S. Tretli, and E. Weiderpass, Consumption of berries, fruits and
vegetables and mortality among 10,000 Norwegian men followed for four decades. Eur. J. Nutr.,
2015. 54(4): p. 599-608.

4.

Bertoia, M.L., K.J. Mukamal, L.E. Cahill, T. Hou, D.S. Ludwig, D. Mozaffarian, et al., Increased
Consumption of Fruits and Vegetables and Weight Change Over Time. 2014, Am Heart Assoc.

5.

Probst, Y.C., V.X. Guan, and K. Kent, Dietary phytochemical intake from foods and health
outcomes: a systematic review protocol and preliminary scoping. BMJ Open, 2017. 7(2): p.
e013337.

6.

Wang, X., Y. Ouyang, J. Liu, M. Zhu, G. Zhao, W. Bao, et al., Fruit and vegetable consumption
and mortality from all causes, cardiovascular disease, and cancer: systematic review and doseresponse meta-analysis of prospective cohort studies. BMJ, 2014. 349: p. g4490.

7.

Ganesan, K. and B. Xu, A critical review on polyphenols and health benefits of black soybeans.
Nutrients, 2017. 9(5): p. 455.

8.

Konczak, I. and W. Zhang, Anthocyanins—more than nature's colours. BioMed Research
International, 2004. 2004(5): p. 239-240.

9.

Mazza, G., Anthocyanins in Fruits, Vegetables, and Grains. 1993, Boca Raton: CRC Press,
https://doi.org/10.1201/9781351069700.

10.

Miguel, M.G., Anthocyanins: antioxidant and/or anti-inflammatory activities. Journal of Applied
Pharmaceutical Science, 2011. 1(6): p. 7-15.

11.

Basílio, N. and F. Pina, Chemistry and photochemistry of anthocyanins and related compounds: a
thermodynamic and kinetic approach. Molecules, 2016. 21(11): p. 1502.

12.

Jenner., A., The importance of bioavailability and metabolism on the bioactivity of dietary
phenolics and health benefits of fruit anthocyanins. Paper presented at: Nutrition Society of
Australia, Newcastle 2014 - Scientific Meeting. 2014.

13.

Fanning, K.J., B. Topp, D. Russell, R. Stanley, and M. Netzel, Japanese plums (Prunus salicina
Lindl.) and phytochemicals–breeding, horticultural practice, postharvest storage, processing and
bioactivity. J. Sci. Food Agric., 2014. 94(11): p. 2137-2147.

14.

de Pascual-Teresa, S. and M.T. Sanchez-Ballesta, Anthocyanins: from plant to health.
Phytochemistry reviews, 2008. 7(2): p. 281-299.

15.

Yang, M., S. I Koo, W. O Song, and O. K Chun, Food matrix affecting anthocyanin
bioavailability. Curr. Med. Chem., 2011. 18(2): p. 291-300.

16.

He, J. and M.M. Giusti, Anthocyanins: natural colorants with health-promoting properties.
Annual Review of Food Science and Technology, 2010. 1: p. 163-187.

181

17.

Shih, P.-H., Y.-C. Chan, J.-W. Liao, M.-F. Wang, and G.-C. Yen, Antioxidant and cognitive
promotion effects of anthocyanin-rich mulberry (Morus atropurpurea L.) on senescenceaccelerated mice and prevention of Alzheimer's disease. The Journal of Nutritional Biochemistry,
2010. 21(7): p. 598-605.

18.

Spencer, J.P., The impact of fruit flavonoids on memory and cognition. Br. J. Nutr., 2010.
104(S3): p. S40-S47.

19.

Ross, J.A. and C.M. Kasum, Dietary flavonoids: bioavailability, metabolic effects, and safety.
Annu. Rev. Nutr., 2002. 22(1): p. 19-34.

20.

Kalt, W., J.E. McDonald, S.A. Fillmore, and F. Tremblay, Blueberry Effects on Dark Vision and
Recovery after Photobleaching: Placebo-Controlled Crossover Studies. J. Agric. Food Chem.,
2014. 62(46): p. 11180-11189.

21.

Pojer, E., F. Mattivi, D. Johnson, and C.S. Stockley, The case for anthocyanin consumption to
promote human health: a review. Comprehensive Reviews in Food Science and Food Safety,
2013. 12(5): p. 483-508.

22.

Wang, L.S. and G.D. Stoner, Anthocyanins and their role in cancer prevention. Cancer Lett.,
2008. 269(2): p. 281-290.

23.

Abuja, P.M., M. Murkovic, and W. Pfannhauser, Antioxidant and prooxidant activities of
elderberry (Sambucus nigra) extract in low-density lipoprotein oxidation. J. Agric. Food Chem.,
1998. 46(10): p. 4091-4096.

24.

Halvorsen, B.L., K. Holte, M.C. Myhrstad, I. Barikmo, E. Hvattum, S.F. Remberg, et al., A
systematic screening of total antioxidants in dietary plants. The Journal of Nutrition, 2002.
132(3): p. 461-471.

25.

Moyer, R.A., K.E. Hummer, C.E. Finn, B. Frei, and R.E. Wrolstad, Anthocyanins, phenolics, and
antioxidant capacity in diverse small fruits: Vaccinium, Rubus, and Ribes. J. Agric. Food Chem.,
2002. 50(3): p. 519-525.

26.

Kumar, S. and A.K. Pandey, Chemistry and Biological Activities of Flavonoids: An Overview.
The Scientific World Journal, 2013. 2013: p. 16.

27.

Matsumoto, H., H. Inaba, M. Kishi, S. Tominaga, M. Hirayama, and T. Tsuda, Orally
administered delphinidin 3-rutinoside and cyanidin 3-rutinoside are directly absorbed in rats and
humans and appear in the blood as the intact forms. J. Agric. Food Chem., 2001. 49(3): p. 15461551.

28.

Jakesevic, M., J. Xu, K. Aaby, B. Jeppsson, S. Ahrné, and G.r. Molin, Effects of Bilberry
(Vaccinium myrtillus) in Combination with Lactic Acid Bacteria on Intestinal Oxidative Stress
Induced by Ischemia–Reperfusion in Mouse. J. Agric. Food Chem., 2013. 61(14): p. 3468-3478.

29.

Matuschek, M.C., W.H. Hendriks, T.K. McGhie, and G.W. Reynolds, The Jejenum is the main
site of absorbtion for anthocyanins in mice. The Journal of Nutritional biochemistry, 2006. 17(1):
p. 31-36.

30.

Velderrain-Rodriguez, G.R., H. Palafox-Carlos, A. Wall-Medrano, J.F. Ayala-Zavala, C.O. Chen,
M. Robles-Sanchez, et al., Phenolic compounds: their journey after intake. Food and Function,
2014. 5(2): p. 189-197.

182

31.

Kalt, W., Y. Liu, J.E. McDonald, M.R. Vinqvist-Tymchuk, and S.A. Fillmore, Anthocyanin
metabolites are abundant and persistent in human urine. J. Agric. Food Chem., 2014. 62(18): p.
3926-3934.

32.

D’Archivio, M., C. Filesi, R. Varì, B. Scazzocchio, and R. Masella, Bioavailability of the
polyphenols: status and controversies. International Journal of Molecular Sciences, 2010. 11(4):
p. 1321-1342.

33.

Hollman, P.C., J.H. de Vries, S.D. van Leeuwen, M.J. Mengelers, and M.B. Katan, Absorption of
dietary quercetin glycosides and quercetin in healthy ileostomy volunteers. The American Journal
of Clinical Nutrition, 1995. 62(6): p. 1276-1282.

34.

D Archivio, M., C. Filesi, R. Di Benedetto, R. Gargiulo, C. Giovannini, and R. Masella,
Polyphenols, dietary sources and bioavailability. Annali-Istituto Superiore di Sanita, 2007. 43(4):
p. 348.

35.

Marín, L., E.M. Miguélez, C.J. Villar, and F. Lombó, Bioavailability of dietary polyphenols and
gut microbiota metabolism: antimicrobial properties. BioMed Research International, 2015. 2015:
p. 905215-905215.

36.

McKay, D.L., C.Y.O. Chen, C.A. Zampariello, and J.B. Blumberg, Flavonoids and phenolic acids
from cranberry juice are bioavailable and bioactive in healthy older adults. Food Chemistry,
2015. 168(0): p. 233-240.

37.

Chen, J., H. Lin, and M. Hu, Metabolism of flavonoids via enteric recycling: role of intestinal
disposition. J. Pharmacol. Exp. Ther., 2003. 304(3): p. 1228-1235.

38.

Coates, P.M., M. Blackman, J.M. Betz, G.M. Cragg, L. M.A, J. Moss, et al., Encyclopedia of
dietary supplements (No. Ed. 2). Informa Health. 2010.

39.

Pandey, K.B. and S.I. Rizvi, Plant polyphenols as dietary antioxidants in human health and
disease. Oxidative medicine and cellular longevity, 2009. 2(5): p. 270-278.

40.

Khoo, H.E., A. Azlan, S.T. Tang, and S.M. Lim, Anthocyanidins and anthocyanins: colored
pigments as food, pharmaceutical ingredients, and the potential health benefits. Food & nutrition
research, 2017. 61(1): p. 1361779-1361779.

41.

Manach, C., G. Williamson, C. Morand, A. Scalbert, and C. Rémésy, Bioavailability and
bioefficacy of polyphenols in humans. I. Review of 97 bioavailability studies. The American
Journal of Clinical Nutrition, 2005. 81(1): p. 230S-242S.

42.

Senn, S.S. and S. Senn, Cross-over trials in clinical research. Vol. 5. 2002: John Wiley & Sons.

43.

Chow, S.-C., Bioavailability and Bioequivalence in Drug Development. Wiley interdisciplinary
reviews. Computational statistics, 2014. 6(4): p. 304-312.

44.

Del Rio, D., A. Rodriguez-Mateos, J.P. Spencer, M. Tognolini, G. Borges, and A. Crozier,
Dietary (poly) phenolics in human health: structures, bioavailability, and evidence of protective
effects against chronic diseases. Antioxidants & redox signaling, 2013. 18(14): p. 1818-1892.

45.

Bitsch, R., M. Netzel, T. Frank, G. Strass, and I. Bitsch, Bioavailability and biokinetics of
anthocyanins from red grape juice and red wine. BioMed Research International, 2004. 2004(5):
p. 293-298.

183

46.
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9.1 Appendix A – Quality rating of included clinical studies (Chapter 2)
Relevant quality rating criteria from The Delphi List, Cochrane Back Review Group and The CONSORT Statement [418-420]
A eligibility criteria specified, B randomization appropriate, C treatment allocation concealed, D similarity at baseline, E outcome measures and control intervention
explicitly described, F co-intervention comparable, G outcome measures relevant, H adverse events and I drop-outs fully described, J sample size based on a priori power
calculation, K point estimates and measures of variability presented for the primary outcome measure, L appropriate timing giving a Total Score (TS) of 12
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9.2 Appendix B - Search Strategy Sample (chapter 2 & chapter 4)
Medline (OVID)

Searches
"plum*1".m_titl.
limit 1 to English language
Prunes.m_titl.
limit 3 to English language
"prunus domestica".m_titl.
limit 5 to English language
"prunus salicina".m_titl.
limit 7 to English language
2 or 4 or 6 or 8
(9 not "plum blossom needle").m_titl.
limit 10 to English language
(9 not "plum pox").m_titl.
limit 12 to English language
(12 not "plum curculio").m_titl.
limit 14 to English language
(15 not "plume").m_titl.
limit 16 to English language

1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17

a)

Scopus search strategy (Chapter 4)

TITLE-ABS-KEY ( anthocyan* AND "gut microbiota" ) AND ( LIMIT-TO ( DOCTYPE , "ar" )
OR LIMIT-TO ( DOCTYPE , "cp" ) OR LIMIT-TO ( DOCTYPE , "ip" ) ) AND LIMIT-TO (
EXACTKEYWORD , "Human" ) OR LIMIT-TO ( EXACTKEYWORD , "Intestine Flora" ) OR
LIMIT-TO ( EXACTKEYWORD , "Humans" ) OR LIMIT-TO ( EXACTKEYWORD ,
"Polyphenols" ) OR LIMIT-TO ( EXACTKEYWORD , "Metabolism" ) OR LIMIT-TO (
EXACTKEYWORD , "Polyphenol" ) OR LIMIT-TO ( EXACTKEYWORD , "Article" ) OR
LIMIT-TO ( EXACTKEYWORD , "Nonhuman" ) OR LIMIT-TO ( EXACTKEYWORD ,
"Anthocyanins" ) ) AND ( LIMIT-TO ( LANGUAGE , "English" ) )

215

9.3 Appendix C – Published paper: A Systematic Review on the Health
Effects of Plums (Prunus domestica and Prunus salicina)

216

Article removed for copyright reasons:
Igwe, E. O. and Charlton, K. E. (2016) `A Systematic Review on the Health Effects of Plums (Prunus
domestica and Prunus salicina)', Phytotherapy Research: PTR, 30(5), pp. 701 -731. doi: 10.1002/ptr.5581.
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9.4 Appendix D – Published paper: First stage development of an
Australian anthocyanin food composition database for dietary
studies – A systematic process and its challenges
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9.5 Appendix E – Published paper: Anthocyanin-rich plum juice
reduces ambulatory blood pressure but not acute cognitive function
in younger and older adults: A pilot cross-over dose-timing study
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9.6 Appendix F – Published paper: A systematic literature review of the
effect of anthocyanins on gut microbiota populations
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Article removed for copyright reasons:
Igwe, E. O. et al. (2019) `A systematic literature review of the effect of anthocyanins on gut
microbiota populations', Journal of Human Nutrition & Dietetics, 32(1), pp. 53 -62.
doi: 10.1111/jhn.12582.
Final manuscript can be accessed from Research Online
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9.7 Appendix E – Published paper: Usual dietary anthocyanin intake,
sources and their association with blood pressure in a representative
sample of Australian adults
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Article removed for copyright reasons, please refer to citation:
Igwe, E. O., Charlton, K. E. and Probst, Y. C. (2019) `Usual dietary anthocyanin intake,
sources and their association with blood pressure in a representative sample of
Australian adults', Journal Of Human Nutrition And Dietetics: The Official Journal Of The
British Dietetic Association. doi: 10.1111/jhn.12647.
Final manuscript can be accessed from Research Online
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